ࡱ>  RTIJKLMNOPQ#` [bjbj\.\. I>D>D "$>"(TR77788 *9bz<F@CVCVCXCL*wd 4$h] N|K0Lה4 CCD}}}'<C C}}}2hX 6 C< е7c. Z0=rK \"!~DFN*}x4UFFFU(FFFbzbzbz7bzbzbz7R"%4 (  UNIT 9 Alterations in Cardiovascular Function Karen L. Then RN, MN, PhD Associate Professor Faculty of Nursing University of Calgary Unit 9 Table of Contents TOC \o "1-3" \h \z   HYPERLINK \l "_Toc20018678" Overview  PAGEREF _Toc20018678 \h 5  HYPERLINK \l "_Toc20018679" Aim  PAGEREF _Toc20018679 \h 5  HYPERLINK \l "_Toc20018680" Objectives  PAGEREF _Toc20018680 \h 5  HYPERLINK \l "_Toc20018681" Resources  PAGEREF _Toc20018681 \h 5  HYPERLINK \l "_Toc20018682" Web Links  PAGEREF _Toc20018682 \h 5  HYPERLINK \l "_Toc20018683" Section 1: Atherosclerosis  PAGEREF _Toc20018683 \h 6  HYPERLINK \l "_Toc20018684" Objectives  PAGEREF _Toc20018684 \h 6  HYPERLINK \l "_Toc20018685" Introduction  PAGEREF _Toc20018685 \h 6  HYPERLINK \l "_Toc20018686" Pathophysiology  PAGEREF _Toc20018686 \h 7  HYPERLINK \l "_Toc20018687" Etiology  PAGEREF _Toc20018687 \h 8  HYPERLINK \l "_Toc20018688" Pathogenesis  PAGEREF _Toc20018688 \h 8  HYPERLINK \l "_Toc20018689" Clinical Manifestations  PAGEREF _Toc20018689 \h 8  HYPERLINK \l "_Toc20018690" Evaluation and Treatment  PAGEREF _Toc20018690 \h 10  HYPERLINK \l "_Toc20018691" Prognosis/Trajectory  PAGEREF _Toc20018691 \h 11  HYPERLINK \l "_Toc20018692" Section 2: Hypertension  PAGEREF _Toc20018692 \h 12  HYPERLINK \l "_Toc20018693" Introduction  PAGEREF _Toc20018693 \h 12  HYPERLINK \l "_Toc20018694" Requirements  PAGEREF _Toc20018694 \h 12  HYPERLINK \l "_Toc20018695" Objectives  PAGEREF _Toc20018695 \h 12  HYPERLINK \l "_Toc20018696" Definition  PAGEREF _Toc20018696 \h 12  HYPERLINK \l "_Toc20018697" Categorization Scheme  PAGEREF _Toc20018697 \h 13  HYPERLINK \l "_Toc20018698" Prevalence  PAGEREF _Toc20018698 \h 14  HYPERLINK \l "_Toc20018699" Etiology  PAGEREF _Toc20018699 \h 15  HYPERLINK \l "_Toc20018700" Pathophysiology  PAGEREF _Toc20018700 \h 15  HYPERLINK \l "_Toc20018701" Clinical Manifestations  PAGEREF _Toc20018701 \h 16  HYPERLINK \l "_Toc20018702" Evaluation and Treatment  PAGEREF _Toc20018702 \h 18  HYPERLINK \l "_Toc20018703" Prognosis  PAGEREF _Toc20018703 \h 19  HYPERLINK \l "_Toc20018704" Section 3: Myocardial Ischemia (Angina) and Infarction  PAGEREF _Toc20018704 \h 20  HYPERLINK \l "_Toc20018705" Introduction  PAGEREF _Toc20018705 \h 20  HYPERLINK \l "_Toc20018706" Objectives  PAGEREF _Toc20018706 \h 20  HYPERLINK \l "_Toc20018707" Requirements  PAGEREF _Toc20018707 \h 20  HYPERLINK \l "_Toc20018708" Angina  PAGEREF _Toc20018708 \h 21  HYPERLINK \l "_Toc20018709" Myocardial Infarction (MI)  PAGEREF _Toc20018709 \h 21  HYPERLINK \l "_Toc20018710" Section 4: Congestive Heart Failure (CHF)  PAGEREF _Toc20018710 \h 38  HYPERLINK \l "_Toc20018711" Definition  PAGEREF _Toc20018711 \h 38  HYPERLINK \l "_Toc20018712" Etiology  PAGEREF _Toc20018712 \h 38  HYPERLINK \l "_Toc20018713" Pathophysiology  PAGEREF _Toc20018713 \h 39  HYPERLINK \l "_Toc20018714" Clinical Manifestations and Diagnostic Findings  PAGEREF _Toc20018714 \h 41  HYPERLINK \l "_Toc20018715" Evaluation and Treatment  PAGEREF _Toc20018715 \h 41  HYPERLINK \l "_Toc20018716" Learning Activity #1Case Study: A Person Suffering from a Myocardial Infarction  PAGEREF _Toc20018716 \h 44  HYPERLINK \l "_Toc20018717" References  PAGEREF _Toc20018717 \h 50  HYPERLINK \l "_Toc20018718" Glossary  PAGEREF _Toc20018718 \h 51  HYPERLINK \l "_Toc20018719" Acronym List  PAGEREF _Toc20018719 \h 52  HYPERLINK \l "_Toc20018720" Answers to Learning Activities  PAGEREF _Toc20018720 \h 53  HYPERLINK \l "_Toc20018721" Learning Activity #1Case Study: A Person Suffering from a Myocardial Infarction  PAGEREF _Toc20018721 \h 53   UNIT 9 Alterations in Cardiovascular Function Although there are numerous cardiovascular conditions which could be addressed in this unit it is important for you to gather a basic understanding of how the cardiac system functions. Many cardiovascular conditions are so closely interrelated it is very difficult to clearly separate them. At times, therefore, throughout this unit you may find some areas choppy. Try to keep in mind how conditions may be linked together in the overall functioning of the cardiovascular system. For the purposes of this unit, four components will be addressed. These will include: atherosclerosis hypertension angina and myocardial infarction heart failure Overview Aim Upon completing this unit you will be familiar with the terminology specific to this area and be able to describe the development and implications of the specified cardiac disorders. Objectives Objectives will be presented individually for each section of this unit. Resources Resources will be presented individually for each section of this unit. Web Links All web links in this unit can be accessed through the Web CT system. Section 1: Atherosclerosis Objectives Upon completing this section you should be able to: 1. Describe the etiology, risk factors and pathophysiology of atherosclerosis. Identify the clinical pathological conditions resulting from atherosclerosis. Describe the management of atherosclerosis. Introduction Atherosclerosis has its beginnings at an early age. Autopsies on infants have revealed the presence of fatty streaks on the intimal lining of blood vessels which is the earliest sign of atherosclerosis. Although atherosclerosis has its beginnings in the first decade of life, its process is insidious with clinical manifestations not being evident for 20-40 years or longer. Definition Atherosclerosis, from the Greek word athere refers to gruel or porridge while sclerosis means hardening. Atherosclerosis is a common arterial disorder characterized by thickening and hardening of the inner walls and the tunica media layers of large and medium sized arteries. The thickening of the inner wall is caused by deposits of yellowish plaques. The plaque is composed of cholesterol, lipids, fibrin and cellular debris that will harden over time. Prevalence Atherosclerosis is not a single disease entity but can take several forms. Atheromatous lesions are major causes of hypertension, cerebral ischemia, coronary heart disease, angina pectoris, myocardial infarction, and other cardiac disorders. In 1995, cardiovascular disease (CVD) was responsible for 79,117 (37%) deaths in Canada (21% was from ischemic heart disease, 7% from stroke, 9% other CVD, and 63% all other diseases). (Heart and Stroke Foundation of Canada, 1997). Pathophysiology Populations at Risk Non-modifiable Risk Factors Gender:Males are affected more frequently than women. Women are protected due to higher estrogen levels up until menopause. Following menopause the gender distribution of atherosclerosis becomes equal. Age:Atherosclerosis is an insidious progressive pathological process which begins at birth and most often becomes evident only in the third to the seventh decades of life. Familial:A number of genetically determined conditions such as hypertension, hyperlipidemia, hypercholesterolemia, and diabetes appear to increase the risk for the predisposition to atherosclerosis. It has also been suggested that there might be an inherent genetic weakness of the intimal arterial wall lining. Race:Race which is also an inherited risk factor has been implicated in the development of atherosclerosis. It is thought that the predisposition of some races, e.g. Black Americans to hypertension, increases their risk for atherosclerosis and coronary heart disease. Modifiable Risk Factors Cigarette Smoking Hyperlipidemia Hypertension Diabetes Mellitus Obesity Sedentary life style Hormone therapy Alcohol Type A PersonalityGiven that a large proportion of the population know these are modifiable risk factors why do you think they continue to be a major problem?  Etiology The etiology of atherosclerosis is not clear. Although risk factors have been identified by epidemiological studies the exact mechanisms by which they contribute to the development of atherosclerosis remains controversial. Two major hypotheses regarding the pathogenesis of atherosclerosis are: injury to arterial endothelium accumulation and infiltration of cholesterol and lipids The fatty streak (the earliest atherosclerotic lesion) is often referred to as an atheroma or an atheromatous plaque.. Breaking News: More recently research is being done looking at the possibility of bacterial and infectious processes and their role in the development of altherosclerosis. Pathogenesis A diagrammatic sketch of the pathogenesis of atherosclerosis is clearly outlined in Porth (7th ed) p. 484. The occlusion of the arterial lumen is a gradual and insidious process. The clinical condition resulting from atherosclerosis will depend upon the anatomical location of the atherosclerotic lesion. It most commonly affects the terminal portion of the aorta and iliac arteries but can also significantly affect other arteries such as: the coronary, femoral, popliteal, internal carotid, vertebral, basilar, thoracic aorta, and the circle of Willis. Clinical Manifestations Clinical manifestations of atherosclerosis will depend on the vessel involved, the site of the lesion, and the risk factors involved (as previously discussed). It has been suggested that 60% of the arterial lumen is already occluded when symptoms are manifested. Clinical manifestations will be subdivided into two sections: those affecting the coronary arteries and those affecting peripheral arteries. The primary focus of this module is the effects of atherosclerosis on the coronary arteries, although the effects on the peripheral arteries are mentioned in less detail. Common Manifestations of Coronary Atherosclerosis Chest pain or angina is the most common symptom that usually occurs with coronary atherosclerosis. It has been described in a variety of ways and affects each person individually. It can occur at rest but initially usually begins or occurs with exercise. As atherosclerosis progresses and gradually further occludes the coronary arteries the likelihood of the person suffering a myocardial infarction increases. Although angina is the most common symptom of atherosclerosis it usually occurs when 60% or more of the coronary artery affected is occluded. Other symptoms may include shortness of breath, cyanosis, pallor, exercise intolerance, diaphoresis and nausea. These symptoms and others are further described under the clinical manifestation section of myocardial infarction. Common Manifestations of Atherosclerosis in Peripheral Arteries Pain An aching, burning, persistent, cramp-like pain may occur, in the lower extremities with exercise, which is caused by intermittent claudication. Severe ischemia of tissues, and ischemic neuropathy, may cause shooting or severe ache/pain or a gnawing pain during rest. Cold Extremities or Cold Sensitivity Patients often complain of coldness in their fingers and toes. Exposure to a cold environment may precipitate blanching or cyanosis of the digits. Impaired Arterial Pulsations Significant alterations or more specifically diminished pulsations may be evident in the posterior tibial and/or the dorsalis pedis arteries. Color Changes In advanced disease, cyanosis or an abnormally red color (rubor) may be seen, particularly in the skin of the lower extremities. The degree of color change is related to the extent and severity of vascular occlusion. Ulceration and Gangrene These lesions may occur either spontaneously or as a result of trauma to the affected ischemic extremity. Edema Edema of the feet and legs may occur in severe cases. It primarily occurs, though, when the legs are in a dependent position. Other Trophic Changes Moderate to severe chronic ischemia may result in finger/toe nail thickening and deformity; or conversely, the nails may become paper-thin. Table 9.1 Clinical and Pathologic Effects of Atherosclerosis in Different Anatomic Sites Site Clinical and Pathologic EffectsAbdominal/terminal aortaIschemic effects in lower extremities; gangrene of toes, feet; effects of fusiform abdominal aneurysm; embolism of atherosclerotic debris to smaller arteries Aortoiliac and femoral arteriesIntermittent claudication; gangreme of toes, feet; aneurysm formation in iliac arteries Coronary arteries Angina pectoris; conduction disturbances; myocardial infarction Carotid and vertebral arteriesTransient ischemic attacks; cerebrovascular accident (CVA) or stroke Renal arteryHypertension; renal ischemia (hematuria, proteinuria) Mesenteric arteriesIntestinal ishcemia (ileus, bowel perfromation with peritonitis)  Adapted from Pathophysiology adaptations and alterations in function (2nd ed.). (p. 358) by B. L. Bulloch and P. P. Rosendahl, 1988, Glenview, Illinois: Scott Foresman Company. Copyright 1988 by B. L. Bulloch. Reprinted by permission. Evaluation and Treatment Essential components of the treatment and surveillance regimen include a complete health history and physical exam. Affected vessels may be identified through the use of X-ray films, electrocardiography, ultrasonography, nuclear scanning, and angiography. Optimal daily cholesterol intake should not exceed 250-300 mg. It is important to monitor the risk factor modification strategies and revise as necessary. There is no cure for atherosclerosis. Progression of the disorder may continue despite all interventions. Strategies targeted at risk factor modification may prove beneficial in alleviating symptoms associated with coronary heart disease and peripheral atherosclerosis. These strategies may improve coronary and peripheral arterial blood flow in addition to improving the clients general health status. Segments of severely damaged or obstructed coronary arteries may be reopened by performing a percutaneous transluminal angioplasty or replaced by patch grafts or bypassed, as in coronary artery bypass surgery. An endarterectomy may be performed to clear a major peripheral artery (not done with coronary arteries) that is blocked by a clot or accumulation of plaque by surgically removing the intimal lining of the artery. A more detailed description of interventions aimed at treating patients with coronary occlusion will be discussed in the component on myocardial infarction that follows later in this unit. Risk factor modification may play a key role in the management of coronary atherosclerosis. A diet low in cholesterol, calories, and saturated fats, adequate exercise, and the avoidance of smoking and stress may help prevent further development of atherosclerosis. Antilipidemic agents may also be used to decrease the lipid levels but will not reverse the atherosclerotic process. Prognosis/Trajectory The atherosclerotic process may progress despite all interventions. Atherosclerosis in the vessels of the brain or the heart, leading to cerebral or myocardial ischemia may present as a life-threatening event. Atherosclerosis resulting in cardiovascular disorders is the leading cause of death in North America. Section 2: Hypertension Introduction Hypertension has for years been recognized as a major risk factor in the development of kidney failure as well as cardiovascular disorders (particularly stroke, heart attack and heart failure). Individuals with hypertension may often be symptom free, therefore they may fail to seek medical attention prior to the development of complications. The widespread nature of the condition demands that nurses as health care professionals be cognizant of the pathological process and systemic ramifications of hypertension. Requirements A basic understanding of the normal anatomy and physiology of the arterial system is presumed. Learners are encouraged to review an anatomy and physiology text if necessary prior to proceeding. The term hypertension will be used synonymously with high blood pressure throughout the component. Objectives Upon completing this section you should be able to: Define hypertension and its classifications Describe the etiology, pathophysiology, and clinical manifestations of hypertension Describe the management of hypertension Definition Hypertension, a common, often asymptomatic disorder, is characterized by a persistently elevated systemic blood pressure greater than 140/90.. Categorization Scheme A variety of classifications for hypertension exist. High blood pressure can be classified according to the level of severity, the cause, or the type of hypertension. A hypertension classification system which depicts systolic and diastolic pressure readings is illustrated in Table 9.2. Table 9.2 Recommended scheme for categorizing arterial pressure in individuals aged 18 years and older. Range mm Hg Category*Diastolic< 85Normal blood pressure85 - 89High normal blood pressure90 -104Mild hypertension105  114Moderate hypertension>115Severe hypertension Systolic, when diastolic blood pressure is < 90<140Normal blood pressure140- 159Borderline isolated systolic hypertension>160Isolated systolic hypertension *Classification based on the average of two or more readings on two or more occasions. *A classification of borderline isolated systolic hypertension (SBP 140 TO 159 mm Hg) or isolated systolic hypertension (SBP > 160 mm Hg) takes precedence over high normal blood pressure (diastolic blood pressure, 85 to 89 mm Hg) when both occur in the same person. High normal blood pressure (DBP 85 to 89 mm Hg) takes precedence over a classification of normal blood pressure (SBP < 140 mm Hg) when both occur in the same person Note: This is based on the WHO and the Canadian Coalition of High Blood Pressure definitions that elevated blood pressure is one that is greater than 140/90 mmHg. Blood pressure consistently >130/85 on home readings is also a significant finding which needs follow up. Hypertension is often described as being either primary or secondary depending on whether or not there is a known cause or underlying disease/condition. Primary HypertensionOften called essential or idiopathic hypertension is manifested by a chronic elevation of blood pressure without evidence of other disease. It effects 90-95% of all hypertensive patients and has no known cause. Secondary HypertensionDevelops from a specific underlying disorder. Prevalence Hypertension is a significant public health problem in Canada. Approximately one in five Canadians are at increased risk of developing cardiovascular disease due to high blood pressure, with about one in three being unaware of their condition, (National Institutes of Health, 1988). Risk Factors The prevalence of high blood pressure is linked to a number of risk factors which include: cigarette smoking family history of hypertension advancing age hypertension has been found to rise with age, except for men where it seems to plateau beyond age 45 male gender black race obesity high sodium intake glucose intolerance (diabetes mellitus) changeable (labile) blood pressure or borderline hypertension heavy alcohol consumption Etiology The cause of primary hypertension remains in question. It is believed that numerous complex mechanisms interact in the body producing long term elevations of high blood pressure. These factors include hemodynamic, neural, humoral, and renal mechanisms. It is improbable that there is a single factor responsible for the development of primary hypertension. Several hypotheses for the development of primary hypertension have been proposed and are discussed in Porth, p.514 516. Secondary hypertension is caused by a systemic disease process. This process raises peripheral vascular resistance or cardiac output. Although secondary hypertension affects less than 10% of all hypertensive adults, more than 80% of the hypertension that occurs during childhood is secondary to a specific physiological condition For more details on specific underlying diseases and/or disorders which may cause secondary hypertension refer to Porth p. 520 522. Note also malignant hypertension (p. 522) and hypertension in pregnancy (p.522-524). Pathophysiology Pathogenesis You must have a good understanding of the normal mechanisms controlling blood pressure in order to understand the pathophysiology of hypertension. Blood pressure is a product of cardiac output and total systemic vascular resistance. Numerous factors play a part in the regulation of these two major variables to balance blood pressure. Cardiac output is affected by changes in heart rate and contractility, as well as changes in extracellular fluid volume (affected by alterations in sodium intake, renal function, and mineralocorticoid activity). Systemic vascular resistance is influenced by sympathetic nervous system stimulation, humoral controls including the renin-angiotensin-aldosterone system, catecholamines, E2 prostaglandins, kinins, corticosteroids, and vasopressin (antidiuretic hormone). Autoregulation is an intrinsic property of vascular smooth muscle which regulates blood flow in accordance to tissue metabolic needs. Autoregulation therefore may also serve as a possible link between cardiac output and peripheral resistance. Alterations in any of these factors which lead to elevation in either cardiac output and/or total systemic vascular resistance can cause an increase in blood pressure resulting in sustained hypertension. Clinical Manifestations Hypertension is often termed the silent killer since there are few signs and no symptoms until it becomes severe and target organ damage has occurred. The only sign is the presence of elevated arterial blood pressure readings. Untreated hypertension may lead to the damage of small arterioles. This in turn may cause target organ dysfunction. Target organs that are subjected to vascular damage may include the heart, eyes, brain and kidneys. See Table 9.3 for the effects of hypertension on target organs. Table 9.3 Hypertensive Effects on Target Organs Organ EffectManifested byHeart Myocardial infarction ECG changes; enzyme elevations Congestive failure Decreased cardiac output; S3 or summation gallop auscultated; cardiomegaly on radiograph Myocardial hypertrophy Increased voltage R wave in V3-V6; increased frequency of angina; left ventricular strain, manifested by ST and T wave changes Dysrhythmias Usually ventricular dysrhythmias or conduction defects Eyes Blurred or impaired vision Nicking arteries and veins; hemorrhages and exudates on visual examination Papilledema Brain Encephalopathy Severe occipital headache, paralysis, speech difficulties, coma Kidney Cerebrovascular accident Rapid development of confusion, agitation, convulsions, death Renal insufficiency Nocturia, proteinuria, elevated BUN, creatinine Renal failure Fluid overload, accumulation of metabolites, metabolic acidosis  Evaluation of high blood pressure should be done on at least two separate readings/occasions. Ongoing home evaluation of blood pressure is often helpful to avoid the white coat syndrome (increase of blood pressure when an individual is in the presence of a health care professional). Evaluation of blood pressure using a 24 hour home monitoring system is helpful in detecting daily fluctuations and baseline (BP) readings. Evaluation and Treatment Hypertension is a chronic, lifelong disease which requires ongoing blood pressure monitoring to ensure adequate treatment. Medications may be adjusted (added or deleted) as necessary based on the individuals response. Clinical tests such as blood work, X-ray films and other diagnostic tests may be useful in the detection of secondary hypertension or associated complications. The management of hypertension focuses on the treatment of the underlying cause. An extensive assessment should include a careful history and physical examination to determine target organ involvement, the presence of cardiovascular risk factors other than hypertension, and the type of hypertension (essential or secondary). The main goal of treatment is to achieve and maintain an arterial blood pressure below 140/90. In primary hypertension this may be accomplished by risk factor modification strategies and/or pharmacological agents. In secondary hypertension the treatment goals are aimed at the control or correction of the underlying disease process. Classifications of drugs that are available for the treatment of hypertension include: diuretics angiotensin-converting enzyme (ACE) inhibitors adrenergic antagonists which include beta blockers, central acting adrenergic inhibitors, Alpha-1 adrenergic blockers, and combined alpha-beta adrenergic blockers vasodilators, which include venodilators, arteriodilators and arterio-venodilators calcium channel blockers antianxiety agents or benzodiazepines Each of these drugs has its own mechanisms of action either alone or in combination when individualized to specific patient needs in the treatment of hypertension. Drugs are often added in a step-wise approach until the blood pressure is reduced to the goal level. Following this, maintenance doses of drugs are established. Other nonpharmacologic interventions can include: regular physical exercise reduced alcohol intake decrease in salt intake (especially in the elderly) adequate dietary intake of calcium and potassium increase in diet with high fiber, fruit, vegetables and low saturated fat stress and coping with stress weight reduction (for individuals with BMI >25) Prognosis The prognosis of hypertensive individuals worsens with higher blood pressure levels. Arteries and arterioles throughout the body experience the wear and tear effects associated with hypertension. Stroke (cardiovascular accident) remains the leading sequela of hypertension with diastolic pressures above 110 mmHg. Other major morbid sequelae include myocardial infarction, renal failure, and encephalopathy. A downward trend in deaths due to these sequelae has been seen since the introduction of antihypertensive drug therapy and the development of risk factor modification strategies. Section 3: Myocardial Ischemia (Angina) and Infarction Introduction Myocardial ischemia occurs when blood flow through the coronary arteries falls below the level required for normal cellular metabolism. The ischemia that occurs can be reversed if oxygen demands decrease or blood flow is increased. If these factors do not change irreversible cell damage and muscle death occurs, that is, myocardial infarction (MI). MI is the leading cause of death in North America. Objectives Upon completing this section you should be able to: Describe the etiology and pathogenesis of myocardial infarction Discuss the clinical manifestations, management and complications of MI Differentiate between right and left ventricular heart failure Discuss the clinical implications of MI in relation to ventricular heart failure, dysrhythmias and cardiogenic shock Requirements A requirement of this module is that you complete the readings from Porth (2005). Prior to commencing it is recommended that you complete and review the component on atherosclerosis. You may also find it necessary to review the structure and function of the cardiovascular system as discussed in Porth (7th ed., Chapter 23). For more detailed anatomy and physiology, refer to an anatomy and physiology text. Read: Albert, M. (1999). Heart failure: The physiologic basis for current therapeutic concepts. Critical Care Nurse Supplement, June, 3-15. Dracup, K.A. (1999). Combination treatment strategies for management of acute myocardial infarction: New directions with current therapies. Critical Care Nurse Supplement, April, 12-13. Wright, S.M. (1990). Pathophysiology of congestive heart failure. Journal of Cardiovascular Nursing, 4 (3), 1-18. Angina Definition Angina is the clinical syndrome of transient myocardial ischemia that occurs with an imbalance between oxygen supply and demand. Types of Angina Stable Angina Pectoris (exertional angina) Stable angina is often precipitated by physical exertion, cold, or emotional stress. It can last from a few minutes to 15 minutes and is usually relieved by rest, removal of the provoking factors, or administration of nitroglycerine. Unstable Angina Pectoris Unstable angina may also be referred to as crescendo angina, preinfarction angina, angina decubitus, and nocturnal angina. Unstable angina may occur without obvious provoking factors. It can occur with exertion but often occurs at rest. Each attack of unstable angina is unique in its onset and course of pain. Pain usually occurs more frequently and is of greater intensity and of longer duration with each subsequent attack. Variant (Prinzmetal) Angina Variant angina can occur at rest in early hours of the morning and is often associated with ST segment elevations. This type of angina is often referred to as cyclical, occurring at the same time each day. Variant angina is thought to be caused by vasospasm of one or more of the major coronary arteries. It is believed that a decrease in myocardial oxygen consumption during sleep or rest may lead to coronary artery vasoconstriction which is responsible for the spasm. Angina can often occur off and on over years, then become unstable, and finally result in a MI. Angina, may also occur suddenly and result in myocardial infarction immediately. It is important to remember that there is no set pattern that leads to myocardial infarction and each individual must be treated separately. Myocardial Infarction (MI) Definition Angina may lead to MI. MI refers to the process by which myocardial tissue is destroyed in regions of the heart that are deprived of their blood supply after closure of the coronary artery or one of its branches either by a thrombus or by obstruction of the vessel lumen by atherosclerosis. The key factor contributing to MI is the imbalance between myocardial oxygen supply and demand. Prevalence According to statistics Canada, in 1985 MI killed 26,945 people (16,597 males, 10,448 female). In Alberta in 1986 heart disease was responsible for 39% of male deaths and 42% of female deaths. Populations at Risk The populations at risk for MI include those with a previous MI, myocardial ischemia, smokers, obesity (although some are questioning the extent of obesity and MI). Please review information provided in the module dealing with atherosclerosis and hypertension for further explanations since these areas are closely linked. Etiology The etiology of MI may vary with one or more of the following factors being implicated. Progression of Coronary Artery Atherosclerosis MI may occur as a natural sequela of advancing atherosclerosis. It has been suggested that at least 60% of the coronary tissue blood supply usually is occluded prior to the development of signs and symptoms of MI. See p. 543 - Figure 26-6 in Porth (7th ed.). Acute Coronary Thrombosis The rupture of an atheromatous plaque in a coronary artery may lead to secondary thrombosis superimposed on the ulcerated plaque. Coronary Artery Embolism Coronary embolism is a rare cause of MI but when it does occur it is believed that the clot often is formed in the left side of the heart. This clot may develop due to mitral valve prolapse, mitral stenosis, or infective endocarditis. Coronary Artery Spasm Although implicated as a cause in a limited number of MI patients, the genesis of coronary artery spasm remains a controversial issue. Factors such as increased sympathetic nervous activity, irritation of the arterial wall from an atheroma, production of histamine and serotonin causing vasoconstriction, increase in calcium flux within arterial smooth muscle, and an imbalance in the manufacture or release of prostaglandins such as thromboxane A2 (causes vasoconstriction), and prostacyclin (causes vasodilation) have all been implicated in the cause of spasm. Decrease in Oxygen Supply in the Presence of Coronary Artery Disease (CAD) Any event that causes a decrease in oxygen supply such as an alteration of pulmonary function or anemia which develops as a result of haemorrhage can precipitate the occurrence of MI. This is especially evident with individuals experiencing some degree of CAD. Increase in Myocardial Oxygen Demand in the Presence of Significant CAD Myocardial oxygen demand may be increased by a number of factors/situations. Some of these factors include: physical exertion, pain, and tachyarrhythmias. In general any event which increases heart rate, blood pressure and/or causes an increase in catecholamine release can, in the presence of CAD cause an increase in myocardial oxygen demand and consumption therefore potentially leading to MI. Pathophysiology Pathogenesis The pathophysiology of MI is clearly documented in Porth p. 547-553. Key points related to this section are listed under the following headings. Cellular Injury hypoxia can cause electrocardiographic changes within 30-60 seconds but death of cardiac cells occurs in approximately 20 minutes myocardial contractility is influenced by oxygen and electrolyte (calcium, potassium, magnesium) balance Cellular Death Zones zone of ischemia is reversible and therefore leaves no permanent damage; zone of hypoxic injury may progress to necrosis or return to normal depending on the treatment and its effect; zone of necrosis occurs within 6 hours. This necrotic tissue cannot be revived. the boundaries of these zones may change dependent on: time between onset of symptoms and treatment successful treatment resulting in revascularization of the ischemic and hypoxic areas development of collateral circulation Structural and Functional Changes Impairment of myocardial function is dependent on: size of infarct location and extent of infarct collateral blood supply previous history of MI Repair wound healing and tissue repair begins with inflammation fibrous scar tissue forms within 3-6 weeks. This scar is nonfunctioning and permanent the myocardium cannot regenerate although preliminary research hints that the injection of stem cells into the damaged myocardium MAY regenerate cardiac muscle. Types of Infarctions Endocardial (endocardium) affects the inner wall of the heart Transmural includes all layers of the myocardium (endocardium, myocardium, epicardium) Subendocardial common and involves necrosis of the inner layers of the myocardium often see signs and symptoms of heart failure and mural thrombi myocardium is injured and begins to die in subendocardial layers and then extends outward on a wavefront pattern to the epicardial region Epicardial (epicardium) affects the outside wall of the heart may result in signs and symptoms of pericarditis most common area affected is the left ventricle Figure 9.1 Types of Infarctions  Location of Infarcts Anatomical location of MI depends on which coronary artery is affected (see Table 9.4). Primary Location of MI Table 9.5 Artery Affected MI TypeKeyLAD (distal occlusion) Anterior MI LAD Left anterior descending coronary artery RCA Inferior Wall MI RCA Right coronary artery Circumflex (CX)Lateral Wall MILCA Left circumflex coronary artery LMS occlusion Death usually occurs since left main stem supplies 70% of left ventricle LMS Left main stemLAD: (more proximal occlusion) Anterolateral MI LCA: (mid and posterior margin branch occlusion) Posterior MI LCA Left coronary arterial-posterior marginal branches RCA occlusion right coronary artery (usually proximal occlusion) Right Ventricular Infarction. (Usually occurs with an inferior infarction of posterior interventricular septum.) Clinical Manifestations Chest pain chest pain due to MI generally differs from the pain of angina mainly in intensity and duration location of painsubsternal, midsternal or in the shoulder, jaw, epigastric, neck or arms. Pain may occur in any of the above areas in isolation or in combination sensationburning, squeezing, heaviness, smothering, aching, pressure durationconstant, 30 minutes or longer, not relieved by rest or nitrates (e.g., nitroglycerine) qualitymild to severe onset varies, occurring at rest or with exertion Breaking News: It is important to realize that not every patient who is having an acute myocardial infarction will present the typical symptoms of chest pain pallor and diaphoresis. Elderly men (75 years and older) are at a high risk for presenting atypically with vague symptoms of fatigue, cough and perhaps nausea. [Then, Rankin & Fofonoff (in press). Atypical presentation of acute myocardial infarction in three age groups. Heart & Lung: The Journal of Critical Care. Nausea and vomiting occurs due to stimulation of vomiting centres (vagal stimulation), pain or decreased cardiac output should be avoided if possible as it can cause vasovagal response resulting in a decrease in myocardial oxygen supply as a result of decreased BP and decreased heart rate Dyspnea and Orthopnea shortness of breath is more common in the elderly but can occur at any age dependent on the degree of imbalance of oxygen supply/oxygen demand Anxiety, Severe Apprehension, and Denial may be related to fear of the unknown, pain, death and/or stimulation of sympathetic nervous system Skin diaphoresis, cold, clammy, cyanosis, mottling skin changes are due to decreased cardiac output and increased peripheral vascular resistance Vital signs blood pressure hypotension may occur secondary to a decrease in cardiac output or from beta-adrenergic stimulation (causing vasodilation) in response to severe pain pulse depending on the location of the MI and duration of the chest pain the pulse may be tachycardiac, bradycardiac, or irregular and is often weak and thready temperature may rise within 24 hours and last up to 7 days. The temperature correlates with the extent of myocardial damage Dysrhythmias the occurrence of dysrhythmias is high during the first 24 hours after infarct the type and severity of the dysrhythmia is dependent upon the location and extent of myocardial damage Heart sounds heart sounds are often muffled S4 gallop is common in MI, indicating possible ventricular dysfunction development of murmurs may signify papillary muscle dysfunction, thus valve dysfunction pericardial friction rub may indicate pericarditis Other Other clinical manifestations may include jugular vein distension, ankle, and sacral edema, and a decrease in urine output. These are all signs of ventricular dysfunction and heart failure. Electrocardiographic (ECG) Findings See Figure 9.2 for a diagram depicting ECG changes during MI Ischemia ST segment depression T wave inversion Injury stage beyond ischemia, but still reversible ST segment elevation epicardial injury and ischemia T wave elevation epicardial injury and ischemia ST segment returns to isoelectric position within a few days Infarction Q waves changes may indicate pathology ST segment changes elevated in lead over or facing infarcted area reciprocal changes (ST segment depression) will be found in leads 180 degrees from area of infarction may occur hours to weeks after infarct T wave changes may last for weeks and return to normal or remain inverted for the patients life Normal IschemiaInjuryInfarction/necrosisInverted T waveElevated ST segmentPresence of q waveFigure 9.2 Electrocardiographic Changes with Myocardial Infarction Evaluation and Treatment Laboratory Tests elevations in white blood count may be proportional to myocardial tissue damage diagnosis of MI depends on the measurement of cardiac enzymes and isoenzymes Enzyme OnsetPeakReturn to NormalCPK (0-225 units/L)2-5 hours24 hours2-3 days SGOT (0-41 units/L)6-8 hours24-48 hours4-8 daysLDH (60-200 unites/L)6-12 hours48-72 hours7-10 days CPK-MB (1-10)4-8 hours 16-24 hours48-72 hoursLDH1 (17.5-28.3%)6-24 hours24-48 hours72-96 hours Table 9.5 Evolution of Cardiac Enzymes Following MI CPK alone not indicative of MI CPK-MB very specific for MI except in marathon athletes LDH1 specific for MI if LDH increased and LDH1 is the predominant isoenzyme then diagnosis of MI can be made. This allows detection of MI several days old CPK = creatine phosphokinase LDH = lactate dehydrogenase SGOT = serum glutamic oxaloacetic transaminase CPK-MB = creatine phosphokinase myocardial band Figure 9.3 Chronological serum enzyme activities following MI PLEASE NOTE: There have been changes in the utilization of cardiac enzymes specifically the introduction of measuring the troponin levels. Troponins are 3 contractile proteins that regulate the interaction of actin and myosin. Troponin C does not have a specific cardiac muscle sub unit. Troponin I and T do have these sub units although Troponin TI is thought to be a more exact cardiac damage marker than Troponin T. Treatment The danger of death from MI is greatest during the first two weeks postinfarction but is particularly severe during the first 24 to 48 hours (with most deaths occurring within the first two hours of onset of pain). Goals The major goals of care for patients with acute MI include: successful treatment of the acute attack and prompt alleviation of symptoms prevention of complication and further attacks rehabilitation and education of the patient and significant others Treatment Treatment involves four main areas: Decrease oxygen demand of the heart Continued relief/prevention of pain Monitoring to prevent electrical problems Treatment of pump failure 1. Decreasing Oxygen Demands bedrest is recommended for 2-3 days then progressive gradual ambulation a 20% increase in oxygen demand can occur during bathing in a stable ICU patient, therefore supplemental oxygen should be given especially during activity, (e.g., eating, bathing) 2. Pain Relief and Prevention Pain increases oxygen consumption by causing tachycardia and increased contractility Continued chest pain may signal ongoing myocardial damage a. Thrombolytic Therapy types of thrombolytic therapy include streptokinase, tissue type plasminogen activator (TPA) and urokinase the goal of this therapy is to reduce or dissolve thrombus formation(s) occluding the coronary arteries the goal is obtained through the lysis of existing thrombi and the reperfusion of myocardial tissue it is essential that thrombolytic therapy is commenced within the first few hours following the presentation of chest pain in order to limit infarct size, thus preserving myocardial function and life b. Nitrates: Nitroglycerine and Isordil reduces oxygen demands and improves coronary blood flow potent vasodilators improves myocardial oxygen supply while decreasing oxygen demand this decreases preload more than afterload decreases end diastolic volume (EDV) and ventricular wall tension therefore decreases myocardial workload and oxygen consumption reduces infarct size especially if given IV within first 4 hours after onset of signs and symptoms, also decreases likelihood of heart failure, myocardial infarction, extensions, or cardiac death c. Beta-adrenergic agents: Propranolol, Atenolol, Metoprolol, Timolol inhibits effects of catecholamines at beta-adrenergic receptor sites, therefore decreases sympathetic tone primary therapeutic effectdecreases heart rate and response to exercise may reduce mortality rate by 20% and reduce infarct size thought to decrease acute myocardial ischemic injury by improving balance between oxygen supply and demand blocks sympathetic stimulation of myocardium (B1 receptors) results in decreased HR, myocardial contractility, cardiac output, B.P., which results in decreased myocardial oxygen consumption enhances myocardial blood supply by redistributing blood flow also affects the electrical system of the heart: decreased automaticity in SA, delay through AV node, decreased excitability of atria and ventricles d. Calcium Channel Blockers: Verapamil, Diltiazem, Nifedipine, Sinoatrial (SA), Atrioventricular (AV) relaxes smooth muscle, decreasing resistance and increasing blood flow in coronary arteries and the peripheral circulation decreases calcium influx into cells and produces smooth muscle relaxation (decreases contractility) results in vasodilation of coronary and peripheral blood vessels, decrease in cardiac contractility, cardiac output, automaticity, atrioventricular conduction, platelet aggregation reverses coronary spasm in some patients improves blood flow in ischemic areas by vasodilation of coronary arteries decreases myocardial oxygen demands by decreasing afterload, heart rate and contractility e. Analgesics: Morphine decreases venous return, therefore decreases congestion decreases oxygen demand f. Oxygen g. Antiarrhythmic agents: Lidocaine, Procainamide a variety of antiarrhythmic drugs are used to treat dysrhythmias occurring following MI h. Anticoagulation Heparin and ASA agents are often used to decrease platelet aggregation and thrombus formation 3. Mechanical Interventions PTCA: percutaneous transluminal angioplasty coronary angioplasty is a procedure used to open or dilate occluded coronary arteries by pressing lipid deposits back against the intimal lining of the artery Pacemaker a variety of conduction defects may result from damaged or ischemic myocardial tissue a pacemaker (temporary or permanent) may be necessary to reestablish effective electrical stimulation of myocardial tissue CABG: coronary artery bypass graft surgery severely damaged or obstructed coronary arteries may be bypassed to facilitate the improvement and/or re-establishment of coronary blood flow IABP: intra-aortic balloon pumping a IABP is a counter pulsation device that is placed in the descending aorta is used to support circulation temporarily when the injured myocardium cannot generate adequate cardiac output principles of therapy include decreasing left ventricular workload, partially supporting the systemic circulation and enhancing oxygen supply to the injured myocardium Complications 1. Dysrhythmias and conduction disturbances 95% of patients experience some disturbance of cardiac rate or rhythm due to immediate ischemic effects on ventricular muscle, cardiac dysrhythmias slow the initial phase of depolarization in the ischemic myocardium or enhance the automaticity of ventricular cells most common are ventricular extrasystoles (80%) often occurs within 12-14 hours after infarct dangerous because have the potential to trigger ventricular tachycardia or fibrillation which is life threatening AV conduction disturbances occur 12-15% of the time; occurs 2-3 times more often in patients with inferior infarction (RCA supplies AV node in 90% of patients) bundle branch blocks and complete heart blocks are more likely with anterior infarct (LAD supplies conduction system below the Bundle of His) 2. Cardiogenic shock heart fails to pump effectively resulting in a decrease in stroke volume causing tissue ischemia and hypoxia syndrome of hypotension and peripheral circulatory insufficiency secondary to primary cardiac dysfunction most common cause of death in patients in CCUs post MI autopsies show that there is usually 40% acute necrosis of the left ventricle The Unit on Shock deals with this in more depth 3. Extension of Infarction implies additional myocardial necrosis from transient nonperfusion of compromised portion of the coronary arterial circulation frequency -- 17-23% of patients 4. Pericarditis usually due to transmural MI (results when damage to entire wall has occurred) this pain differs from MI pain in that pericarditis pain increases on deep inspiration the pain may not necessarily be severe but annoying and is relieved by ASA or antiinflammatories occurs in 15% of MI patients 5. Pulmonary Embolism the blockage of a pulmonary artery by foreign matter such as thrombus can occur with atrial fibrillation, transmural MI or subendocardial MI involving the right ventricle treated prophylactically with ASA, heparin, and/or oral anticoagulants 6. Systemic Embolism originates in deep veins of lower extremities 7. Myocardial Rupture (Cardiorrhexis) 85% of ruptures occur in left ventricle wall (few patients survive) a slit-like tear can result in bleeding into pericardial sac (cardiac tamponade) or rupture of the wall classic clinical clue indicating free wall rupture is electromechanical dissociation (when electrical heart activity persists without detectable pulse or blood pressure) leads to congestive heart failure, cardiogenic shock and death 8. Papillary Muscle Dysfunction with decreased coronary perfusion the papillary muscles are susceptible to injury dysfunction occurs because of rupture of papillary muscles if the entire papillary muscle structure ruptures, it usually is fatal within minutes to hours because of severe mitral regurgitation 9. Rupture of Interventricular Septum causes left to right shunting leading to decreased oxygenation of systemic blood, CHF, and shock 10. Ventricular Aneurysm a localized dilation or protrusion in the wall of the left ventricle complications of ventricular aneurysms are ventricular tachycardia, impaired ventricular function, arterial embolism, and ventricular rupture 11. Musculoskeletal localized chest tenderness and pain is often referred to as chest wall pain chest wall pain is often difficult to distinguish due to high levels of anxiety it can be caused by fractured ribs from CPR, bruising, and anxiety 12. Genitourinary a decrease in cardiac blood flow and cardiac output leads to a decrease in blood flow to the kidneys which may result in acute renal failure 13. Gastrointestinal hiccoughing (often seen with inferior MI) can interrupt sleep and increase anxiety nausea and vomiting often occurs from MI but can be caused by use of opiates and other drugs retching may cause a vagal stimulation, therefore increasing the incidence of serious dysrhythmias nausea and vomiting are often treated with antiemetics to decrease the incidence of complications 14. Dresslers Syndrome an autoimmune disorder that may occur several days after MI or cardiac surgery results from bodys immunologic response to damaged myocardium and pericardium is often treated with ASA and corticosteroids 15. Psychological patients may experience and exhibit feelings of denial, anxiety, anger and depression though these are often considered normal reactions they must not be overlooked since they can significantly affect the physical well-being of the patient 16. Cardiac Arrest the sudden cessation of cardiac output and effective circulation when it occurs the delivery of oxygen and removal of waste products stops factors affecting the incidence of cardiac arrest include the length of time between the onset of pain and the initiation of treatment, the extent and location of the MI, and past medical history 17. Congestive Heart Failure this complication is addressed in more depth in the following section because it is not only a complication of MI but it may also occur in a variety of other conditions Section 4: Congestive Heart Failure (CHF) Definition A state in which the heart is unable to maintain a cardiac output sufficient to meet the needs of the body. Acute pulmonary edema or the presence of excess fluid in the lungs is the direct result of ventricular failure. Etiology CHF is often referred to as heart failure and ventricular heart failure. CHF is often further defined as left and right failure. There are many conditions which may contribute to the development of CHF, some of which are outlined in Table 9.6. Table 9.6 Conditions which may contribute to heart failure Left Heart Failure Right Heart Failureatherosclerotic heart disease acute myocardial infarction tachycardia/bradycardia cardiomyopathy increased circulating volume aortic stenosis or insufficiency, mitral insufficiency coarctation of aorta ASD or VSD cardiac tamponade, constrictive pericarditisleft heart failure atherosclerotic heart disease acute myocardial infarction tachycardia/bradycardia pulmonary embolism fluid overload/excess sodium intake COPDpulmonary hypertension mitral stenosis ASD or VSD pulmonary outflow stenosis  Pathophysiology Although either right or left heart failure can be precipitated by a variety of conditions the progression of events is similar. Left heart failure to right heart failure: a diseased left ventricular myocardium cannot pump blood returning from the lungs into systemic circulation, therefore causing a decrease in cardiac output pressure increases in the lungs owing to the accumulation of blood in the lungs. Fluid therefore leaks into the pulmonary interstitial space, resulting in pulmonary edema as pressure increases in the lungs, pressure in the right heart increases owing to the backflow of pressure in the pulmonary vasculature the right side of the heart cannot pump its blood into the pulmonary system due to this backflow of pressure, therefore venous return is impeded pressure continues to back up, and eventually body organs become congested with venous blood For further explanations or review on the pathophysiology in CHF please refer to Porth p. 603-616. Please pay special attention to the figures depicting the sequence of events of heart failure throughout these pages. Table 9.7 Clinical Manifestations of Heart Failure Left Heart FailureRight Heart Failure anxiety, restlessness air hunger nocturnal dyspnea, dyspnea on exertion, orthopnea cough with frothy sputum tachycardia, diaphoresis basilar crackles, bronchial wheezing (respiratory system) cyanosis or pallor, hypoxia, respiratory acidosis gallop rhythm (S3) insomnia and palpitations hyperventilation pulsus alternans left ventricular heave cheyne-Stokes respirations fatigue weakness dependent pitting edema, peripheral edemea venous ditention, jugular distention bounding pulses, disorientation, cerebral edema (CNS) oliguria (kidneys) dysrhythmias fatigue split S2 right ventricular gallop tricuspid insufficiency murmur right ventricular heave liver engorgement (GI) nausea anorexia S3 pleural effusion Clinical Manifestations and Diagnostic Findings Weight gain Upper abdominal pain (Hepatosplenomegaly) Nocturia Anorexia and nausea (caused by edema of the bowel) Chest x-ray shows pulmonary clouding (interstitial density) and cardiac hypertrophy Evaluation and Treatment Key elements of medical management include: Removing or controlling the underlying or precipitating cause of the failure Improving myocardial contractility cardiac glycosidesDigoxin results in augmenting contractility, increasing stroke volume and cardiac output sympathomimetic aminesDopamine, Dobutamine are used in acute situations at specific dosages to increase myocardiac contraction, cardiac output and stroke volume coxygen therapy Reduction in myocardial workload reduce preload through the use of diuretics, fluid and sodium restriction, and venous vasodilators reduce afterload through the use of arterial vasodilators and stress reduction rest Nursing Management Place patient in upright position, head and shoulders up, feet and legs hanging down to favour pooling of blood in dependent portions of body by gravitational forces to decrease venous return Ongoing physical assessment Administer oxygen therapy Monitor intake and output closely Weigh patient daily Maintain a relaxed, quiet environment to provide rest Organize nursing care to allow for rest periods Administer drugs as ordered For example: Morphinedecreases anxiety, reduces pain, induces vasodilation, decreases venous return to the heart, decreases myocardial oxygen consumption Diureticsto promote excretion of water from the body Aminophyllinerelaxes bronchospasm, increases renal blood flow and enhances diuresis, decreases pulmonary arterial pressure, decreases peripheral venous pressure, and peripheral resistance If patient is on bed rest for prolonged period, institute measures to prevent hazards of immobility Monitor lab data Allow patient to verbalize feelings Give explanations to the patients of treatments being implemented Involve patient in the plan of care *Although these nursing management strategies are listed under management of the patient with congestive heart failure they are also applicable to the nursing management of the MI patient. Ongoing Evaluation and Surveillance The ongoing assessment of a patient experiencing MI and/or CHF may include the following parameters: cardiac rhythm monitoring serial enzyme collection ongoing physical examination radionucleotide imaging electrocardiograms Prognosis/Trajectory 25% die before they reach the hospital mortality rate in hospitalized patient range from 3-30% depending on the infarct size the first coronary event is more often fatal in women than men (39% vs. 31%) patients who develop heart failure have higher mortality rates prognosis after discharge is determined by: the degree of left ventricular dysfunction the extent of residual ischemic myocardium the presence of ventricular dysrhythmias mortality rate after 1 year is 8%, with half of the deaths occurring in first three months after that the mortality rate averages 4% per year Long-term impairment depends upon: Size of infarct Location and extent of infarct Coronary collateral blood supply Previous medical history Learning Activity #1Case Study: A Person Suffering from a Myocardial Infarction Personal/Social History Name: Kevin Zabou Age: 44 Sex: Male Race/Culture: Canadian Occupation: Oil Executive Marital Status: Married Religion: Catholic Mr. Zabou lives with his wife and two teenagers (one daughter, Kathy, age 15; and one son, Mark, age 13) in a five-bedroom, 3000-square-foot home. He works approximately 10 hours a day, 5 days a week, and often works at home or at the office during the weekend. Mr. Zabou is a top executive at a large oil company and is responsible for supervision of 10 coordinators and 1500 employees. He finds his work challenging but at times hard on the nerves. Mr. Zabou eats well and states that over the last year he has put on 20 lbs. due to the numerous business lunch and supper meetings. He has tried to compensate for this by not eating breakfast but instead will just have a cup of coffee with cream. His exercise regime includes walking the family dog every evening for about 15 minutes. He is an ex-smoker for the past five years but does state that many of his co-workers do smoke. He also states that he has no time for hobbies. Past Health History Usual childhood diseases; no hospitalizations or surgeries. complaints of indigestion for last three months off and on but went away on its own takes no medications except Tylenol for headaches has not had a physical examination for the last five years Family History Father died at age 74 from an MI Mother had breast Ca but underwent surgery with no further problems Has two brothers, one who recently underwent PTCA for an 95% blockage for his RCA and Circumflex arteries, and another who is presently undergoing a cardiovascular follow-up due to chest pain No family history of diabetes, epilepsy, hypertension, psychiatric problems, muscular problems, or neurological problems History of Present Illness While working in his office following lunch Mr. Zabou developed mild midsternal burning pain and pain in his jaw. He phoned his dentist to set up an appointment thinking something was wrong with one of his teeth. He then continued to work and gradually noticed the pain went away. Later on in the day he drove out to one of the oil field sites to consult with his co-workers. On the way back he again developed this pain when sitting in the middle of a traffic jam. He continued on back to work but was convinced by his secretary to go to the hospital and get checked out. After a short period of time in the Emergency Department he was admitted to a cardiology floor with the diagnosis of possible angina. Physical Assessment Height: 6 feet, 1 inch Weight: 102 kilograms Vital signs: T-36.9C HR: 80 BP: 148/75 R: 16 CVS: S1, S2 audible, no S3, S4 or murmurs, no apical impulse, no jugular venous distention with the head of the bed elevated 30 degrees bilaterally, no ankle edema Resp: color pink, no cyanosis, breath sounds audible to all lungs fields, no adventitious sounds GI: abdomen soft, round, no tenderness on palpation, bowel sounds audible X 4 quadrants, no nausea GU: voiding qs light amber colored urine, specimen sent CNS: alert, but restless, states he does not feel he needs to be in here and is quite upset Psychological: angry that he came to hospital for an upset stomach and then to be admitted. States he has to get back to work, people are relying on him and he has five major jobs that he must finish today. Treatment Ordered Admit to cardiac unit Cardizem 30 mg QID Nitroglycerine .3 sl prn X 3 Stat ECG with chest pain Cardiac profile X 3 SMA12 Cholesterol levels Activity as tolerated Low Na diet Captopril 12.5 mg TID Prior to the nurse starting any of the above orders Mr. Zabou developed the following: midsternal burning/pressure radiating to jaw and left arm (7/10) diaphoretic nausea and vomited 150 cc of brown fluid SOB Colorpale grey Mr. Zabou was given 3 Nitroglycerine without effect, a stat ECG was done showing increased ST segments in leads II III and AVF. An intravenous line of D5W was started in his left arm and infusing TKVO. His vital signs were: BP: 95/50; HR: 94; R: 20. He was then given 2.5 mgs IV morphine push by the physician and was given Thrombolytic therapy. He was then transferred to the ICU. ICU orders: Start nitroglycerine gtt at 20 mcg/min and titrate for pain. Maintain BP greater 90 syst. Morphine 2.5 mgs IV prn O2 at 3L/NP Bedrest Heparin drip 1100 u/hr to maintain PTT 60-100 Continue all previous orders Six hours later blood work showed the following: CK - 500 Na - 135 LD - 190 K - 4.1 AST - 12 Cholesterol - 7.90 CKMB - 7% PTT 92 Troponin T 0.65ug/L Questions to Case Study Identify risk factors in Mr. Zabous life which may have contributed to his myocardial infarction and complete the following table. Risk Factor Rationale and Associated PathophysiologyNonmodifiable Modifiable  Compare Mr. Zabous experience of typical anginal pain to the pain he experienced when he suffered a myocardial infarction. AnginaMI Location Factors giving relief Discuss the rationale and effects for the following medications ordered. (You may need to use a pharmacology book to help you with this.) Thrombolytics:    Cardizem:    Captopril:    After 24 hours in CCU Mr. Zabou again developed midsternal chest pain (6/10). He had no radiation to other areas but stated it increased on deep inspiration and was very sharp. What might Mr. Zabous chest pain be caused by?      What assessment data might help identify the reason for Mr. Zabous pain.      Mr. Zabous ECG showed an increase in ST segments. What does an elevation of ST segments indicate?      Mr. Zabou is diagnosed as having an inferior wall MI. Which coronary artery is affected?  References Albert, M. (1999). Heart failure: The physiologic basis for current therapeutic concepts. Critical Care Nurse Supplement, June, 3-15. American Heart Association. Heart drawings: Anterior, posterior, and coronal cross sectional veins. Dallas, TX: Author. Bulloch, B. L., & Rosendahl, P. P. (1988). Pathophysiology adaptations and alterations in function (2nd ed.). Glenview, IL: Scott Foresman Company. Canadian Medical Association (1999). 1999 Canadian recommendations for the management of hypertension including case-based applications of the recommendations. Canadian Medical Association Journal (Supp. 12), 161. Dracup, K.A. (1999). Combination treatment strategies for management of acute myocardial infarction: New directions with current therapies. Critical Care Nurse Supplement, April, 12-13. Greenfield, D., Grant, R., & Lieberman, E. (1976). Children can have high blood pressure too. American Journal of Nursing, 76(5), 770-772. Heart and Stroke Foundation of Canada. (1997). Heart Disease and Stroke in Canada. Ottawa, Canada. Porth, C.M. (2005). Pathophysiology Concepts of Altered Health States (7th ed). Philadelphia:Lippincott. Rodman, M. J. (1991). Hypertension: First-line drug therapy. RN, 91(1), 32-40. U.S. Department of Health and Human Services. (1988). 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (NIH Publication No. 88-1088). Bethesda, MD: National Institutes of Health. Van De Graaff, K. M., & Fox, S. I. (1992). Concepts of human anatomy and physiology, (3rd ed.). Dubuque, IA: Wm. C. Brown. Glossary preload: determined by myocardial fibre length at end of diastole and before the beginning of a contraction afterload: resistance to left ventricular ejection; amount of pressure that must be built up to overcome the forces that oppose ejection from the ventricle akinesis: area of ventricle involved does not move at all dyskinesis: area of ventricle involved expands and bulges during systole, paradoxical motion of ventricular wall cardiac index: the cardiac output per square meter of the body surface area; normal is 25-40 litres/minute/meter2 cardiac output: volume of blood pumped out of the ventricle in one minute normal is 5-6 litres/minute contractility: refers to the ability of the heart to develop tension and/or shorten automaticity: the ability of the heart to transmit an electrical impulse heart failure: pathophysiological state in which the heart is unable to pump an adequate supply of blood for the metabolic needs of the body, provided there is adequate venous return to the heart myocardial ischemia: a condition of oxygen deprivation to myocardial tissue accompanied by inadequate removal of metabolites secondary to tissue hypoperfusion; does not occur until the oxygen demand of myocardial tissue exceeds the oxygen supply myocardial infarction: irreversible cellular injury and necrosis to a given region of the myocardium as a consequence of a prolonged reduction in coronary blood flow below a critical level stroke volume: amount of blood pumped out of the ventricle during one contraction; normal is 65-86 ml/systolic period Acronym List ACE Angiotensin-converting enzyme AMI Acute myocardial infarction AV Atri-ventricular BMI Body Mass Index BP Blood pressure CPK Creatine phosphokinase CPK-MB Creatine phosphokinase myocardial band EDV End diastolic volume HF Heart failure LAD Left anterior descending LCA Left coronary artery LCXA Left circumflex artery LDH Lactate dehydrogenase LMS Left main stem MI Myocardial infarction PTCA Percutaneous transluminal angioplasty RCA Right coronary artery SA Sino-atrial SGOT Serum glutamic oxaloacetic transaminase TPA Tissue type plasminogen activator Answers to Learning Activities Learning Activity #1Case Study: A Person Suffering from a Myocardial Infarction 1. Answer Risk Factor Rationale and Associated Pathophysiology Nonmodifiable Age Sex Family History increased incidence of MI with age atherosclerosis build up over years males are more susceptible to MI at earlier age than females males usually have more progressed atherosclerosis than female up until females reach menopause where incidence equals. Female hormones protect women up until that time. father died at age 74 which is not very significant two brothers presented with cardiac symptoms Risk Factor Rationale and Associated Pathophysiology Modifiable Weight gain (20 lbs) Smoking (second hand) Diet Exercise Stress  patient weighs 102 kg. increase in weight or obesity causes an increase in cardiac workload and oxygen demand weight gain is also associated with increased levels of LDLS, tendency to hypertension, and glucose intolerance the risk of second hand smoke is controversial and depends upon amount of smoke exposure causes adrenergic stimulation carbon monoxide rather than oxygen is bound to hemoglobin therefore stimulating hyperplasia of the smooth muscle layer causes peripheral and coronary vasoconstriction associated with decreased HDL levels no specific diet followed -- patient eats well ? increased intake of fats, cholesterol, sugar, salt and total calories although patient is getting some exercise by walking his dog it does not indicate the level of exercise he achieves exercise can help increase levels of HDL rather than LDL there is a decreased incidence of CAD with well-conditioned persons patient feels responsible for employees increase in stress causes the release of catecholamines increase in circulating catecholamines leads to an increase in cardiac workload, thereby stressing the myocardium see sympathetic nervous system stimulation 2. Answer Angina MI Location of pain Radiation of pain Nature of pain Duration Other symptoms Precipitating factors Factors giving relief Substernal or across chest Neck, jaw, arms, back Dull, heavy discomfort, etc. - pressure or squeezing 3-8 min. rarely longer None usually Extremes in weather, exertion, stress, meals. Does not usually occur at rest. Stopping physical activity, reducing stress, Nitroglycerine Same as angina Same as angina Same as angina but more intense > 30 mins. Perspiration, weakness, nausea and vomiting, plae grey color Often none Nitroglycerine may give incomplete, or no relief. ( 3. Answer Thrombolytics are clot busters that actually dissolve clots and therefore improve blood flow through the coronary arteries. The most common thrombolytics include streptokinase and t-PA. Not all patients meet the criteria to receive thrombolytics. Some new clot busting drugs are presently being tested. Cardizem is a calcium channel blocker. It dilates coronary arteries and peripheral arterioles, therefore reducing total peripheral resistance (afterload), and decreasing blood pressure. Cardizem is also used to inhibit coronary artery spasm. also used to decrease heart rate. Captopril is a angiotensin-converting enzyme (ACE) inhibitor. It inhibits the action of the renin-angiotensin-aldosterone system. Inhibition of ACE causes: a decrease in vascular tone (therefore decreases blood pressure) inhibits aldosterone release (therefore reduces sodium & water reabsorption, and leads to a decrease in blood pressure an increase in renin activity (decreases blood pressure). Captopril has been reported to improve survival in postmyocardial patients with left ventricular dysfunction 4. Answer Pericarditis. The pain Mr. Zabou is experiencing may be caused by the rubbing together of the pericardial sac lining and the outer lining of the heart. 5. Answer Ausculation of heart sounds may identify a pericardial friction rub (squeaking sound) caused by the rubbing together of the heart wall linings. Pain on deep inspiration due to the increased intrathoracic pressure. 6. (a) Answer An elevated ST segment is indicative of cardiac injury. (b) Answer The artery which must be occluded is the right coronary artery (RCA).      PAGE 28 Unit 9 Alterations in Cardiovascular Function Rankin, Reimer & Then. 2000 revised edition. NURS 461 Pathophysiology, University of Calgary PAGE \# "'Page: '#' '"  9:=?Y ˿음vlffUlfPFPjhhU hh!jhh>*B*Uph hh0J!jhh0J!UhhmHnHuhh5CJOJQJ\!jhh5CJOJQJU\$jhh0J5<OJQJU\hh6CJOJQJ]^JhhCJOJQJ^Jhh5CJOJQJ\^J hhCJ hhCJ4 hhCJHhhjhhCJUmHnHu   9:;<=>?Ym-$ 8]^a$$`a$$  n J &]`a$ ]^##[[ T 3 & v d  m UD8U        - . / 0 3 4 5 N O P Q R S T U V q r ĹČrarVrİĹhut mHnHu jqhhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHu,jhh>*B*UmHnHphuhhmHnHuhh0J!mHnHujhh0J!UmHnHu hh5]jhh0J!U hut jhhUj{hhUr s t ~    ٍقkZٍق j]hhUmHnHu,jhh>*B*UmHnHphuhh0J!mHnHuhhmHnHuhut mHnHu jghhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHujhh0J!UmHnHu,jhh>*B*UmHnHphu      - . / 0 1 2 3 4 5 P Q R S m n o ٍ}y}h}cYcNYIY hut jIhhUjhhU hh!jhh>*B*Uphhh hh0J!jhh0J!UhhmHnHuhut mHnHu jShhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHujhh0J!UmHnHu,jhh>*B*UmHnHphu    ! " # $ % ޾鱦{d鱦S{ j5hhUmHnHu,jhh>*B*UmHnHphuhut mHnHu j?hhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHu,jhh>*B*UmHnHphuhhmHnHuhh0J!mHnHujhh0J!UmHnHu hh5] % & ' ( C D E F U V W p q r s t u v w x 淬j淬Y j! hhUmHnHu,jhh>*B*UmHnHphuhut mHnHu j+hhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHu,jhh>*B*UmHnHphuhh0J!mHnHujhh0J!UmHnHuhhmHnHu"     ) * + , C D E ^ _ ` a b c d e f ķjķY j hhUmHnHu,j hh>*B*UmHnHphuhut mHnHu j hhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHujhh0J!UmHnHu,j hh>*B*UmHnHphuhhmHnHuhh0J!mHnHu"        ́jÝOjhh0J!U j hhUmHnHu,j~ hh>*B*UmHnHphuhhmHnHuhut mHnHu j hhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHujhh0J!UmHnHu,j hh>*B*UmHnHphuhh0J!mHnHu  1 2 3 4 K L M f g h j k l m n o ̼۵zmbSbjhhUmHnHuhhmHnHuhh0J!aJmHnHu,jjhh>*B*UmHnHphuhhmHnHuhh0J!mHnHujhh0J!UmHnHu hh5] hut j hhUjhhU hhjhh0J!U!jt hh>*B*Uphhh hh0J!    &'()345NżűōqżűZō,jVhh>*B*UmHnHphu jhhUmHnHuhhmHnHuhh0J!aJmHnHu,j`hh>*B*UmHnHphuhh0J!mHnHuhhmHnHujhh0J!UmHnHuhut mHnHujhhUmHnHu jhhUmHnHu NOPRSTUVWrstużűōqżűZō,jBhh>*B*UmHnHphu jhhUmHnHuhhmHnHuhh0J!aJmHnHu,jLhh>*B*UmHnHphuhh0J!mHnHuhhmHnHujhh0J!UmHnHuhut mHnHujhhUmHnHu jhhUmHnHu "#$=>?ABCDEFabcdlmnżűōqżűZō,j.hh>*B*UmHnHphu jhhUmHnHuhhmHnHuhh0J!aJmHnHu,j8hh>*B*UmHnHphuhh0J!mHnHuhhmHnHujhh0J!UmHnHuhut mHnHujhhUmHnHu jhhUmHnHu 1żűōqżűZō,jhh>*B*UmHnHphu jhhUmHnHuhhmHnHuhh0J!aJmHnHu,j$hh>*B*UmHnHphuhh0J!mHnHuhhmHnHujhh0J!UmHnHuhut mHnHujhhUmHnHu jhhUmHnHu 12356789:UVWXpqrżűōqżűZō,jhh>*B*UmHnHphu jhhUmHnHuhhmHnHuhh0J!aJmHnHu,jhh>*B*UmHnHphuhh0J!mHnHuhhmHnHujhh0J!UmHnHuhut mHnHujhhUmHnHu jhhUmHnHu 345NOPRSTUVWrstuż}xqffO,jhh>*B*UmHnHphuhh0J!mHnHu hh5] hut jwhhUjhhU hh!jhh>*B*Uphhh hh0J!jhh0J!UhhmHnHujhh0J!UmHnHuhut mHnHujhhUmHnHu jhhUmHnHuu  ؼجpؼجY,jhh>*B*UmHnHphu jchhUmHnHu,jhh>*B*UmHnHphuhh0J!mHnHuhhmHnHujhh0J!UmHnHuhut mHnHu jmhhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHu"U=L3&tfijklm)  678:;<=>?Z[\]cde~𹰹p𹰹Y,jhh>*B*UmHnHphu jOhhUmHnHuhh0J!aJmHnHu,jhh>*B*UmHnHphuhh0J!mHnHuhhmHnHujhh0J!UmHnHuhut mHnHu jYhhUmHnHuhhmHnHujhhUmHnHu"*+,EFGIJKLMNijklż}xqffO,jhh>*B*UmHnHphuhh0J!mHnHu hh5] hut j;hhUjhhU hh!jhh>*B*Uphhh hh0J!jhh0J!UhhmHnHujhh0J!UmHnHuhut mHnHujhhUmHnHu jEhhUmHnHulvwxؼجpؼجY,j!hh>*B*UmHnHphu j'!hhUmHnHu,j hh>*B*UmHnHphuhh0J!mHnHuhhmHnHujhh0J!UmHnHuhut mHnHu j1 hhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHu ,-.012345PQRSٹʮʞsbʮʞ j#hhUmHnHu,j"hh>*B*UmHnHphuhh0J!mHnHuhhmHnHujhh0J!UmHnHuhut mHnHu j"hhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHuhh0J!;aJmHnHunopٍقkZٍPjhh0J!U j$hhUmHnHu,j$hh>*B*UmHnHphuhh0J!mHnHuhhmHnHuhut mHnHu j $hhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHujhh0J!UmHnHu,j#hh>*B*UmHnHphu !#$%&'(CDEFRSTmnoqrstuv̼۵̼֙۵}̼۵j'hhU!jf'hh>*B*Uphj&hhU!jp&hh>*B*Uph hh5] hut j%hhUjhhU hhjhh0J!U!jz%hh>*B*Uphhh hh0J!1vDEF_`̼۵zmbSbB j)hhUmHnHujhhUmHnHuhhmHnHuhh0J!aJmHnHu,jR)hh>*B*UmHnHphuhhmHnHuhh0J!mHnHujhh0J!UmHnHu hh5] hut j(hhUjhhU hhjhh0J!U!j\(hh>*B*Uph hh0J!hh`acdefgmnstuw EF""P#Q#V##$ $:%;%A%H&I&c&d&&&̻zppiziziziz hh5\hh56\]hhOJQJ)jhh0J5<KHOJQJU^JhH hhCJ8 hhCJHjhhCJUmHnHuhh!jhh5CJOJQJU\hhmHnHujhh0J!UmHnHuhut mHnHujhhUmHnHu)!",0<G:] + & F + & F^)] h B"S"g""""O#P#Q#V###GkdH*$$Ifl0@  64 la B$IfB #$ $9%:%;%A%H&kGkd+$$Ifl0@  64 la B$IfGkd*$$Ifl0@  64 la H&I&J&b&c&v&&&&&&&&&}'B$IfBGkd}+$$Ifl0@  64 la &&|'))~)))+*,******>7I77778899H:I:W::IIZJJJJJJJJK KTKVKĺĶ֗քzqihhOJQJhh6OJQJhh56\]hh5OJQJ hh>* hh\ hh5hhB*OJQJphhh5B*OJQJphh0h0h05H*h0h05hhCJOJQJ hh5\hhOJQJ$jhh5CJU\mHnHuhHhh)}'~''(()))+*B$If ) & F^)Lkd+$$Ifl404 n n 64 laf4+*,*-*:*e,},..01;2@2L3q34!4BskdM,$$Ifl4   064 l` ap !444556666>7777777lkd-$$Ifl0v,"jL04 laB$If;7v8w8x8888nkd-$$Ifl;0v,"jL04 laB$If8899E9F9B$Ifnkd.$$Ifl0v,"jL04 laF9G9f999B$Ifnkd/$$Ifl0v,"jL04 la99999B$Ifnkds0$$Ifl0v,"jL04 la99:G:H:B$IfnkdF1$$Iflp0v,"jL04 laH:I:J:5;N;<}>@_BtBCCCEE GBnkd2$$Ifl0v,"jL04 la G GGIGuGvGGGGGGHHIZJrJtJJB$If + & F^+ & F ) & F^JJJJJJ0[kd3$$IflF 064 laB$Ifnkd2$$Ifl0F 064 laJJJKB$Ifnkd 4$$Ifl0F 064 laK K0KTKB$Ifnkd4$$Ifl0F 064 laTKVKhKKB$Ifnkd>5$$Ifl0F 064 laVKKKKKK"L&L,L.L0LdLfLLLLMMNNNPP(Q*Q.Q0Q:QRRASUS*T@TNTnT,Y@YZd[[[T^U^}bzrhhCJ EH2jhh0J56<KHOJQJU\]^Jh"&rhHhh56\]hhCJOJQJ hh5!jhh5CJUmHnHuhhOJQJhh6OJQJhh56OJQJ\hh56\hh>*OJQJhhOJQJhh,KKKKB$Ifnkd5$$Ifl0F 064 laKKK,L.L8L0[kd 7$$IflF 064 laB$Ifnkdr6$$Ifl0F 064 la8LdLfLxLLnkd7$$Ifl0F 064 laB$IfLLLMB$Ifnkd*8$$Ifl0F 064 laMMMMM(QB$Ifnkd8$$Ifl0F 064 la(Q*Q,Q.QRB$IfB]kd^9$$IflI F 064 laRRRAS)T*ToTzTUUUV.V{vtrpp)+ & F + & F^+ & Ftkd9$$Ifl44   064 l` af4p .VVVVVVV;WUWVW`WXe[u[[\]g``ea}bbbbbbB$If ) & F^)}bbbbbb c cyczc{cccccdd[d\dbdddd3e;eeeeee/f0f'v(vlvxvOwXwZw^w`wkwww!x@xxxIymyzHz4{M{|}ӂXcls}\l hh6]h_Qh%h%H*h%h"&rjhhCJUmHnHu hhH* hh\ hh5\hh hh5Ibbbbbbc c}wwwwwwB$Ifkd:$$IflvFF6 "r r 0    4 la c c cccxcyc}wwwwwB$Ifkdw;$$IflFF6 "r r 0    4 layczc{cccdd}wwwwwB$IfkdD<$$IflFF6 "r r 0    4 laddd"d#dZd[d}wwwwwB$Ifkd=$$Ifl FF6 "r r 0    4 la[d\dadbd}d~ddddd}wwwwwwwwB$Ifkd=$$IflJFF6 "r r 0    4 la dddddddd1e2e}wwwwwwwwB$Ifkd>$$IflFF6 "r r 0    4 la 2e3e:e;eTeUeee}wwwwwwB$Ifkd?$$IflFF6 "r r 0    4 laeeeeeeeezttttttB$IfkdS@$$Ifl4FF6 "`r r 0    4 laf4eeeee.f/fztttttB$Ifkd9A$$Ifl4FF6 " r r 0    4 laf4/f0fggnijlYlcll5mmmmzxvxxxxtttttt)kdB$$Ifl4YFF6 " r r 0    4 laf4 mm o?oYopooop=pmpnpxprrstttuucuduuuvv + & F^+ & F ) ) & F^v'vwwMxyyyyy zzHz3{4{M{|}~+FQԁ߁p^p+ & F + & Fp^p` + & Fp^p+ & F <Z(A,CvƊJZ܍ETU\g ) & F^)&km4KL”HRop!")*:%/NOVZvw%&RSrk hhCJ\jhhCJUmHnHu2jhh0J56<KHOJQJU\]^JhhCJ EHh% hh6]$jhh5CJU\mHnHu hh\ hh5\hhhh5CJjChhU$jhh0J5<OJQJU\h_Q hh5hh*gˏ!GHkΐ>56Mg + & F^+ & F + & F  ) & F^) & F  ) & Fp^p) & F   ^ gdh)6v?pÔٔ1HRbckoB$If + & Fp^p`+ & F + & F^+ & F + & Fop•ÕyyyyyyB$Ifkdߑ$$IflF B#@ @ @ 0!    4 la.Õĕȕɕڕە}wwwwwwB$Ifkd$$Ifl F B#@ @ @ 0!    4 la.;<}wwwwB$Ifkdu$$IflF B#@ @ @ 0!    4 la.<=KLMN}wwwwwwwB$Ifkd4$$Ifl?F B#@ @ @ 0!    4 la.˖̖ݖޖߖ}wwwwwB$Ifkd$$Ifl)F B#@ @ @ 0!    4 la.ߖ !}wwwwwB$Ifkd$$IflF B#@ @ @ 0!    4 la.!"[}wwwwwB$Ifkdq$$IflZF B#@ @ @ 0!    4 la.+69()}{ywwwwwwnd ) & F$If ) & F^)kd0$$IflF B#@ @ @ 0!    4 la.  -.Dӝԝabg) ) & F^jkd$$Ifl !p  0p64 lap Lʠנ&ZSxԣO ) & F^)Oʤ5¥#$%-.7>RB$If) & F   ^ gdh ) & F^)RSTUVWB$Ifkkd$$Ifl\p D%2 ~ $ %4 laWXYi}B$Ifmkd$$Ifl\p D%2 ~ $ %4 laզP§zzzzzB$If ) & F^)mkd$$Ifl\p D%2 ~ $ %4 la §ç()˨Ԩت٪S[RXJW78_h&Pxyhq&'Yc|jhhCJUmHnHuhh56\] hh;hhOJQJhnrhnr5h%h%h%5CJhnrj1hhU hh\ hh5 hh5\hh@§çקgaaaaaB$Ifkd;$$Ifl\4H=! Y!04 la (e____B$Ifkd`$$Ifl\4H=! Y!04 la()?JV`ae_____B$Ifkd_$$Ifl\4H=! Y!04 laabpz{e_____B$IfkdP$$IflL\4H=! Y!04 laɨʨe_____B$IfkdA$$IflC\4H=! Y!04 laʨ˨V0ecaaaXRRRB$If ) & F^)kd2$$Ifl1\4H=! Y!04 la 01ablت٪`fEkd%$$Ifl0 $ Th%4 la"$ /7n J &]9!$Ifa$B$If`ak׮956Tgϱ3$]q+ & F ) & F^)qݳ^"#jյW¶ST5Nwº5m ^` ) & F^)»/׼vw׽RS~ 0| ) & F^)6HYJz{78HOlm ) & F^)) & F   ^ gdh/vw&8wx%34M !5 ) & F^)&y>?W#$6&':{P{ ) & F^)bk_'lkdw%$$Ifl04t"0@4 laB$If'(EF}~56IJnoB$IfX TBCPc} ) & F^)lkd*&$$Ifl04t"0@4 laB$Ifcwxy=>plkd&$$Ifl0F!$04 laB$Ifpq 67\]B$If34;<EFIJ[B$If[\Sl $~y+ & F + & F^+ & F)lkd'$$Ifl0F!$04 la $v)*K12FG} + & Fp^p`+ & F + & Fp^p+ & F + & F^+ & F+ & F+ & F}~gh\];<`a+ & F + & Fp^p` + & Fp^pp^p+ & F + & F^B"#$%&;cHuQ + & Fp^p+ & F p  ^ gdh+ & F p  ^ gdh ) & F^)Qd|M/h ) & F^ + & F ^ gdh+ & F p  ^ gdh)hi[bry\a #X\#$(=%(8;<FgNQS OnFIɲhnr hhH* hh6],jhh0J5<KHOJQJU\^J#hh0J5<KHOJQJ\^J hh\h%hhB*OJQJph hh5 hh5\hh=hiG[r\ X "8DZ); ]9!^`Z[(,<=!9EM{(=V+ & F) ) & F^ !"#$%&'lkdC($$Ifl0j$0N4 laB$If + & F^ '(3456789:B$Ifnkd)$$Iflr0j$0N4 la :;<wqqqqB$If + & F^+ & F ; ]9!nkd)$$Ifl0j$0N4 layyyyB$Ifkd*$$IflF $^x x 0N    4 la}wwwwB$Ifkd+$$Ifl F $^x x 0N    4 layz}xvpjj$Ifp^pB+ & FkdN,$$Ifl F $^x x 0N    4 la?]kd-$$Ifl !064 la$If]kd)-$$Ifl !064 la7]kd.$$Ifl !064 la$Ifp^pB]kdU.$$Ifl !064 la?]kd0$$Ifl !064 la]kd/$$Ifl !064 la$If]kd0$$Ifl !064 la$Ifp^pB?=8+ & FB]kd1$$Ifl !064 la$If]kdC1$$Ifl !064 la?]kd3$$Ifl !064 la]kdo2$$Ifl !064 la$If?]kd14$$Ifl !064 la]kd3$$Ifl !064 la$If?]kd]5$$Ifl !064 la$If]kd4$$Ifl !064 la$If+ & F + & F^]kd5$$Ifl !064 la?]kd7$$Ifl !064 la$If]kd6$$Ifl !064 la?]kdK8$$Ifl !064 la$If]kd7$$Ifl !064 la     ?]kdw9$$Ifl !064 la$If]kd8$$Ifl !064 laDtuv$If+ & F+ & F + & F^]kd :$$Ifl !064 lavwxyz{|?]kd9;$$Ifl !064 la$If]kd:$$Ifl !064 la|}~?]kde<$$Ifl !064 la$If]kd;$$Ifl !064 la$If+ & F + & F^]kd<$$Ifl !064 latVk " ,  5 o  <]kd=$$Ifl !064 laIKOPjkZ     , 4   5 > o z   P S b     W f 1*VYx{46EHbe{ "$15^a8 hh\hhCJ EH hh5\ hhH* hh6]hnrhhhhhhH*R S   W GHVx4Eb{"1^^  678FGKLMQokd'>$$Ifl0 $b0,"4 la<B$If8E2<'> !!!|""""###### #!###$#*#+#-#.#/#######X[Y\YrYtYuYvYYYYYYYZZ5Z7Z8Z9Z\Z]ZsZuZvZͼ׬׬׬׬Ujhh0JU hh0Jhut 0JmHnHu hh0Jjhh0JUjhhU jqhhhu hh5\ hh\hh hh5CQRSTUdef BV$If^V ) & F$If^ )V$If^VB$If01B$IfBokd>$$Ifl0 $b0,"4 la<12=RSTUVWXaopqrstB$Ifokd_?$$Ifl0 $b0,"4 la<tuv{|}~tuvdBZ$If]Z^)Z$If]Z^B$If34%&N#$%Jkd @$$Ifl0 $b,"4 la< B$If^ )$If^BZ$If]Z^)Z$If]Z^%'129:=>?PQcdswkd@$$IflF* $x x 0!    4 laB$If stu~()@ANOP~B$If()fgrstuB$If}{ywnywwnyw ) & F^)BkdDA$$IflF* $x x 0!    4 la Q   !!!5"{"|""""###### #"###]#^## J+ & F + & F^+ & F+ & F###[YYZ\ZZZ[[[[[[[[[,You will notice as you look at this TOC that in Section 1 and Section 2, the headings for Pathophysiology, Etiology etc are level 2 headings and appear. In section 3, this is not the case. The reason is that Angina and MI act as the level 2 headings, and the Pathophysiology, Etiology are reduced to level 3 headings and do not appear in the TOC. PAGE \# "'Page: '#' '" I have added this heading for consistency. PAGE \# "'Page: '#' '" I am wondering if you want to combine the resources for the unit here, as is done in other units. PAGE \# "'Page: '#' '" Is this the correct heading level? PAGE \# "'Page: '#' '" In this heading correct (below Pathophysiology)? PAGE \# "'Page: '#' '" Is this the correct heading level? PAGE \# "'Page: '#' '" Each of the units has a few sentences that make up Final Thoughts. If you do not wish to have this, please delete this heading. vZwZZZZZZZZZZZ[[[ hh0JjhhUhhjhh0JU9 000&P/R / =!"$ #$% F*T' T`GR6JFIFC    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( (_z77-nnNg *EiZ*V+t kkWSCk v=O;^ï,ȹ]qϢjw ߺ<@0#}]oŚ꺮k`2GӞkvzlwZt\ۼ{hXq+ljV8E5'H4&Ծ߅7>4sIUsՉcZ?i2HJHU;떲K c$X?u}gᶒN=?fT2;dGy{ ~:Ӵ|U 0<$'MSB>O<#iyfu?&OzL@é ?|KmxUIVxT7(h+|E ɤjַ[v$x㺞G+ft:.lԟIpoV.¹VE˥n6,}ڀ=&tߊ:D">;Aq}?*%d#U@((((vi"CoBL 6i4-#WӔjxVb07E?;ė卌2h:T:#h?>qqW,MīMln\geO׏yH^0<̐ZԵ-H>p^%S^_}]]z>.-MW8^·1l5+kۤKgǑ=@%7-}_3m6jpZnK3o:L>g4QEk.tKLu zpRݦ(8G䆨^7/֥tJx_w~bZ-enQ@y?z׃O?gmGSR^Zsиme|Fnw)Hs^nP7x&FЄrO*zWA<@ T뉟?Y2Ew%zMumg1ʁ2*Z>j|:ЯnoNO]] Ҭ: TmfdP-&GP>Q[ז!4VN+!м8fah>ϴx/:11~׷]FY]VtپkVd|О\eίx. 1@leђJep<ÜPƴ-Y[*y?"=륮7%-{9&TSѿ e@Q@Q@ս]O0I#Uq Pg-!!+1Y s€9oݖ3wV%u VY胹ba\ĿV5L,P +r~j [|[#[{2[.-Ǣ/b>!ZiGχRcV'e|h|kƲǥHXdIz W}~ h?oפx/Ʃ oI]F3^>E'_mim<JM{XsvyjxE}Ul;D?ǘ8k iA.5tmV8}^\צ[iqZYX@Tb+Z֩kemc HT{Gui׻amq¯U(~xRV|;i?mH?+;Dw q})X>5YEƣ߼70E!7 0]~Q@_ >_fĠ+\'zƍ+[iTCʟε^SFTFk{ϔ܆ݵxd h-^h; 5?@G@9MM+W(Ǣꦽ2{--N!Ig1HdExτ=[['ts5vnې.ߙp [ m1,o2)>e?\@/l|?'zu[MvN=$|æzLHTSңdߞTkMW)gcy)9|c{f +VBI#a2A4EPKVkSu_[?Z_⥾oFdK`EǢ}zwW>+XT{K|A"nq}ŕ.[W2)ڣ+-gEib/ZϘpX3ۊx_Kwce [+ F.(c$zWö9&Wol:/A7kk3g?LPnΑyڝs7`Z[K cY"H\~?kyF/!McXᅈXpv>>u$xzԟ]y>1c8kmʧNoмþ5%^]wIW?{׈*I_iX6JHDZޣ ۶}/p-fsW>?jM r[u1-)q#\{ƾ񮗥M_׶rdx'$c/wp5 )md Ԋ_J42KܡUV }xčU/>x!=T`{E^WhʵJKP8]_8:3H 5%}_)෌-ۋ 1.GUKSP%k>0EH.&^F OZAiq#mƍ_ |FHQ[f ˖::=Ӷ@##v>;W>.ǎpD5*.K~bEGPBI$w=Q@>/e)tK}!u6s$Fd _ GǺ'uSV=p)p t45+o=.u[Q"u]LO e4bK{f< }EgxR=OF>e%Τ̲8cH0>n?щ(Y'ɦo'iﯰPvބߚI'|H֣'6]#Ss>,ĺs>!xab|Ic:TIv@}xUܤ&03מ(5^:vWm/djeNz;Z*"7:|˪Džy_m,cx:=QQ7VltGTtnAt~2o Xum6;eDB뎠P^]Gccqw/#i[2|yod1@HcEU~>;WZσKSKh7B2' ;_3<rxBG+j}2:M#p-#=dO|zfIlZJIoA^Zwh+4/T?ν|+i1ŤX{{1W9/]4w[ZkgΉeExqgϭyѰdj ao qM`^=kh3;ߵ e] -?ݓT.zZ0?Fz6hoPP'og<-)m+bқk~T'^x _esj H&,Y`tMOգuK7hwV(xZ\Sx ]1F"`3(}j¯N_}q wv\X"1Pkko%)ŐtEGxC u[kXG(2]k\QvӴIFI2q!OWxeվ5I"H%"PA)=IM&¾#4^& I"$g?OCX8[^1Gd%ӴM><ԥ%+|>QEZK߀7R4w34>_n?Vkԇ7ୋo]BP'8m];X\[MǠl`{ױ0iheB{P\Hq}k][G{as 2*dЫ  5t?֚RM$wvz 0rI(x|;M/-nǚ~˥,`HL+ [{KmoPS,}>Tv_]Jjz&Y*_[X_6VF$8̖({xnhn!IbaI25k?X% Աn(8]85 =^qg2mo1T:gEww&wcpѽ`[_A'X-Ѥj*%?ŎZ< =Cj6g|O,=ۛ&=@qoEu@ !}nŚ{w.c6QzzV֝WmFJ6wq@jrdjgoLPDX|kS~կj|Qwp88_Ik3^]z墋jN+?v9|u]Ww wu$Pox⧌~4Z^\Z躍l ȾYa {7Imt*G#_Po|)VKyG)`WM@#~zM&\^J9h?NXF+_ hCiv֊;~&(xig"ug`MKMdV##84ŋf@]zpd(~34}5,4qXjX.!Tvȡ~>"ơvj5FC˧>qZP3񄖏y65j]eTQ"UTwĞ <\c]l]\w%R$O.V@IzMS~ӴqW6<%D_O֚fE $㏙GָOqZ!:~ء[ɠuYjZ23lF<=xw^ +K .W@u{`1~hV2j(״}09%`w?DPzZx#X0 re+p7taޙet)G1i}ASߑJNWg jğrVZ?x#QA4eؓGjGхVмCxcR["[[8%z0e<kӬ~;y>{iCg1ݸ8995ީm0Rs'sGnϭ\E=#KtcO }FӠe<ƀ>mo>TI~OwKdȑ^ς 3Ibڍ)>> z-D"U ((((((((<1]SnoK<~aAn(&4߶u_D }q^{?t ևksc̟Vd3}8r1'{QEZѾ hPIxY%''SRR{Qbb"ݽ{?Н;wt-y&7nPBB]~~ѵkիtoK/_xt78x"]p~_ܹstYկ~Et:}4:u~_W_}E'O'N/~ :~8;v=J?ȑ#ta:tg?ҁ(&&~ӟҗ_~I}޽{'? ٳvMvǴsN/hǎoN۶m[Cڲe m޼6mD?hƍaZ~=}ߧuڵki͚5zjiժUrJZb}g|rZl-]>SZd -^O>EQTTEFFL .Z`}G4|7o͝;?>̙Caaaٳi֬Y4sLz(44f̘AӧOw}MFSN)S;C'OI&ĉi„ oSHH{7ƎKcƌ~4zh5j9z-1b > FwhСDC 7|L oAiԿׯԷo_ӧݛ^{5իٓzA*uޝuF]vW^ytBԹsgԩԱcGСoߞ^z%j׮mۖڴiC/"nݚZjE-[o}[ԢE j޼95k֌^xjڴ)?5i҄ח|||t N6dddv*ȦU|R]m:Iu~:XzZ}5TNWڃwm}iGzBkZgZ Q[Ztu9WѦѠ"=}U>oZ0hk4ߔ8 }=3+3_[F&u#zFzdlj3֮>p;3۔{CjC@Δ3jX{HAHOHۨϩUO.8 }ើfYd0RmgL7x~%O+W==/% ;F.яVsi."o`l4fǖZ`Yo{FkCz&y')71Z1Ƭ1 :;f6^<ј:lvшa:;bl1ɺǯa"o-VPGeVB/Bkڃ;#g/^z5;eϫ?$X} gF%!5 J^Km&z_y>)ɏedDыbUNL+\_j<7sg\ ϝD1 ݄dQ[g %eר4ϚHj"~w6jx&9'L| j3fCF~2;$T{y4T*FxXٹK2ұc=D>ܺޤhb[hwyE|wn;ً6?݃t:Xen7%AjV̼z Bj}GM,&2uq:nD5pT;dY]y~N;LoGmKS_qEZCj(w@:a }"HaD~ U5Ocrn z]HK<9=Z{S 7Cqyǜb}cmq`8?&FשaBD]9 E/QA4ܣ1js,^!{͙bnۙ`~ !V*J+qY| KCdi,dޙHrO#ꌾJ-̆:ͫ6Bl&Ki2jZQi7RwZCxыƹP3}j)Y\kමb'4t1a gk{T9k<#J]д%7^5]d=>[=@{NR-rm{=5ASr>[Y옥?428]*kڰ$1e֗q)RQ0# A,izn(>{}BI_#'0^n^ j+r!Muq#SKc7a 6$݄}WX\ sT]ؙm0e"]P+<6nYkd{] -I۾ycZB)HpsU##.,^3Xh0 R6 =`[Ng׆[y,ym|ߘEߑ:º=dlЂB4# 'KТMIږ)gnUE4/0V a 7r])CG{!.vמ-;vuN_(el(n=e"/DbΪ%>8Dy*T^2YLTż§<[y~ءɣ4W̚$!+=ᬰZ,0ლܰw0뜄ω8C}uSSأniIbf,w6f:ǵh{պb+j&r4}5qq&Sj-9@=>bzML]6]kPikOx#z"+#ך̷$?ILX6A7B^ARHoQ ^;v1?wH1y㜕թeU2`;S$ >ER,Ҝ 5mQ{WwasQ8NeװUyM6Fͫ.()?N֕mU11U*FߑoFW }o =4H2 8;bks3q_4%u]kl,Lɹ2Xo~^L^:'JmƧ02>w{%yr4r'y#.=2Զ7Žό~u>cegvn_9Z׎XY]9زP˞}2YĹn Wd_ҫDM[ݩ.Kߞz]{Xpsߙ|8#( G >7QY <|;uT}Y :Dg N 9-gs0*kInŊG\ sYƫŵzl\* D wk._,n~::׉-[ u8Y[UO>7ZL-ʖv'[$V> >WoaEj$)]N# ו(/ N*{2 3zU_)sڙ+uη=[Uwq:T-pA7оV/ްU8+roźvkf6XM4ם/Mf QTsi.Uqۣ"ot]Bs5hwbIkG;$%iosݵZ<Y֗؉uYkG4XL]k nrek;h~f8s|3YIR?8 I)ٹI`Fl^ug#Ǭ†\aFc'|iӟ#} 6}nCUZuVQgG[+IFqַE2YǸ8mbbb&8?9V^=u!Pu}QA!qh3[;{}%B[/bK.C} ]JvX!^ғ٦/edԻh0ۡJֱq͓(*ÊYsO)apg9^"v_Vy8<˫cE K^.o.z /mi"@+VF]PgO`{;X+Fb].©2lb=8,-Owi}ORmN|ؙ\"򒳌FVT">ȕ{)H{SSDZi@jumqE?)Xbd=md# K {wD?ꃜ} º? $B ;,֮ʧ{ƶ 2z0H/QBHMG "g"gFF}ܬ++ {c1_`܉heg.P!IY(kHGӟe1m&&3W`<۲s"6&CU̜NȾDeW~qyػ;btQ3In}˽U٘O_1B>]2yN>τfء_Ջv{f/:.C{%_L{GQA\LvD m<=dDi$%B?IOls!3s<4(1Mi7D;kڠ w(rٽQ8g8/MT;{e 7}3e ZY*>sC/u+8C@r)k, Y{g_hK~1L0g*Dݖ})'?2{BZ(^xXb1`A'VpeSSޞ6gz´eBۡyhl`da(@0?a J3w/+Q0&"^a\ý s-2D'sY<ݎ3]swc=t(I[ja6.ũ/>OspjFHe~M ie5c옉]KV^&sk^z'*D|*.A=Կ^հ+vNci]SkECIejxO$&\.V-s`g{Abmـye]LԢ"k E#yK7x=I0XB+*P3m#D^3-S[p}du~?.ZGz bCMҭT~\b?F]Ue3y̑wuƥ {p}j߸8P"h:E /oe,;z6莬'z0詬gsxT[ .2f}3٭cBE9׼#ߧ y;ndbn fϬaYBav.Q)00NofoE3rPwR3z q3^_ 1"rػcdgjN1 5!Ҳu7ǩ)b9L=M-\mm{s^kЇ%̅'aY.Ա8Z7WڼվBNEZ~&>MYSWR;=?0FOM[AV`ZDo O-vTۄf85 e*6m ;2Ii^ao<bW*w!\H5ty9F|ߢrlK|Ci_ +08ӣp{}ii /,;ՐVo* 5DVGv?P8{"e-~ό5w%J' 9"y!Acr^--oΔryʶBc5np\,T=?bne,T_T 5?T<\i{QҿǢ?eX~/Ȝ}^%~Ohm0Yg ґzWgw.|\"ocXVn)Mn)a(@+oS:n{^3VVn#sbEZvPѲȪB3S Ozjs=>P's9̺Ȟ)QYW~S6wm&䪢ħR~_hO39:eL -(hf|E"YyF^-?" rFSQf6feЛZbsH݀?h[i]9`Ԫ#`Nu5ڽĚ3-򌩘Qop{fȳ;֌ɘva{'UUsBUwLP_ U!TaW᷿Wa>UaTX[UTX *٩*ۮK~ ?U*l@6?Tύ*l٠*l{_ שc ;ר‡UصJ+USa .Wa2~[/U.VoTE*^‘*W0_cT8>WsTU8 fpz T MWV4.ũ*D ¥*\•_*\µ*DSp=B*ǿThnRH P!f w?WPb QOB §UHBrRR᳟O*DUEAO ;mF4 * '?O"ŀ  ^h`b mM 7X"Ot8h lb-'|peuVϹeE0  UJ6Ks`Hytn1}έrm8n0u`.sBmߋnhǣˎ9s. zOz;C}>f_cΙ;@ξ5X&4X}'gPAd >繚=g T|ӫCFK\{}cԷF503(#Inw{ۄzn6%:$ 0 аS`*ѥAgZdK#WC ;@cc6N&sP)3DxuOy[Rv'3^,=JtVsڠ` ojǫnmXǸ Yk!QҊiҎHyŞBF# %~!Uaw 8̓;M}ʳfKP4|k;W[HQB H&]+!Ϯ%%fu&9_cH}V/ъLf(~YO~AgMvB习zXROIb%E'r(1& #{i]_c&鄔0nvZŝ[B eK2hҪ6ҙ6i몘6ܣ4^i=iNNBlty+Kxf\7j;ST/^-rxe/a"JV\ -5q1m<>ǿ0ir• ͩRd[3m7WiiI˪gø^9V L|jNI|86XFzY%H0WX!bXaէ>tPȧ5(Fiiѝz2!mFR3֊^XSxӶXdҎw#26͹EXP3ڷ)0z(KK(:HZ+w}#iwz)/>" ̣ݟvV$[f{Ү0-*i?PZ |Fs* CX4M兒_2tbU)@JBbC\ae2 k >:1iUP4K)IN:graM&QEZRHeƴwf̴I5J XjlNIFks#5g`\ 9ΰ'|*UT4 NC<,^ D{F :L;N0jB$WfYoͦJ\.+: C3 f35-S^CRJ:\X7lݢ%r nv[fGI (n.R9њ$jϞ`]Bk;CwK$ja@g=$ju^ƾi /'|!ΦH%f,Xڥᴍ:yV7]|..3j'P'r髼)j<*/By r7Vy'$Sx3y\5JqkVݣ͌ǸD'cvF S9U(m݉~Sih>L%*VT38ѝ즨I鬂hDA7L^KrΜc>+MS9UZH^G`HaF5Yxv;H ]x8k!7t&Ji\.XaGK0{=A<@(S[Ss|)-4lm9Ah6>avsmjnc\!Q IFPm, d?JCN>[h/H9N‡iWZԳ@,6vbmc6N,[`<|3%ϡͽ8SSgyuq.FPȪ82(kQg|Ø7Qa$xy&Q#5}w'Ѩ|'%|>DOj8cظk"op; 1s8å/DFt_9瘅7'FtB2v.Z9îFw"3;{ H=_O%|摀+[o9|gOF'| ~$Wxwj2/xgܱ~|{C4OycV͏!18N4VMta3n4+o36xNh|+5'y)Z1R%Kֳ\eg+Bm H89ef8чX>7drbW".}?Nȹ:Ưj_M]Gd"U" 8g2[zedmI|\:)#c^6>6: G2WLญʁr@XyC~tu|6},g~zw_.#=WhN~U'gG#pZQǽ r+.K79lO[%_,=&Ĥ!良{=:JUQ~oy'rr|A^I@Y]Q+=^*Ǘ!8xhEPp;LOg/ܹ>)1)׷x#\\ Wh.d},/!÷>X c] t+nrLSt/p3Tr]G|涎\~D<: q99B剃ȫ ߖRut07E5wʇ++M}B?݂{#ۡ-ҋ!ןyFhbjNqn)7nN2PȮK_Fš"/wOɩ'̨5C(喜Ĵo@g&r!-v0cUބ9.]{ʂQMKx i`&p/ȨjZ+=y t> }Ƶ|f¬9U[øW$,vwD4SH\FIN4^^ϜcG`Gay7{E\1R=vOɉlUJ~Ep=9D0WA$\O"4ۯ6(fo˫vlMm{S޷mys66:PTJ mRٴNor %O,S+-iDS?R˷(ۖ^yCP<ǠW]"zx*F8eMsʆu!s=)ƃ:)5t!U bM?~9f久P-/T (GVl i omT[+ڼN'g/ 6d"zVzUuS*iUd {U*k$}1JJ@1{DJlo̬'_1;8(`T@V2~1B3֢M(~+D_8h΄~)@0Cgz:B19.(JV&\gF~T qi1B&/o ĭg\40tL ׾F}JZUxB5Xͤ֓J/]i]6r5kn &oŒCG}#;VȅFn6/- *mTHsBZi,> "׾t1DumM~eF,_q귓4@ D#`Ĥ.A_%Lo\Z B-Eo9CCsPm&Tu'$j+ +3Cn;P](s;TSwSk-Ǒ׿@hj7N6BG$9-*׾eh>OӃV͕%-قf +M6A/pKW# d +${| *"+Z/hGI/B X^pyAj 6nR}媟a(k!6>;c\/  G$ "1@+s!=\&cy_TAZ!!ܥ?+u`9˯b} /$'8PF?n Ԩ!@&i0̄}c(1 UQϐ[`xVmtN3X9 C!A ǁBtZ+gc r| IJ[ ESA|.'ώNJp70$-ӭ(w@I B]"`'ѯ_)Ii< %X\;gM dRD"|BBW V{je׶ 6uӧub@24E16"~FmhGaJIחD]nlVxJVw|V,R%(E $JN/.ܷ至j6ү|Y(*~<se7c!ؔ}xWO 5rlNme/x]]+ ޯF>q"z0MLl :\AѬo щvrJ oRWgEn"C(WQjA"CA*fș"ұ,5r`2V0 0xB_DmUK܌YȺછ8A;⛴J|i><+|ZOY=gdNq/uRȭln[ʸz'3CN|,%M}y:r]'3%M(S }D,殏ǙHe*w՝2:B,! >q5.iI݇lF _RjHp81FUT',rfp:sH=IErB*f 1Q2Ai,.*c55|ߗ:Bccm~ Y'$+ķJ~1!dX*zp_UZ`X009S# i u!?EiSe {'6 PqsWSLB ` lzϵIrGC]vzg QM :!:aHa2:\H5jEԭ"%2o¹P)btZbw#z+ N kTzN#_-ˇ@\HǢP(h L!XLcz`W%q<@!]l-AK*E>@fp ,Փ~w V!aOb|ӻȴh =do aޑmV?,LϩYrXmflXv@3huǁaMϝ=_q?&O=r%8}o ajm801(6[(66Y)u"Ȍѣ)&e䧕?]okf;9x@L#f^+B !f_*>s:(T2X(*R̆vkG5E^L%hYqou6l/}@]V[`8%xpb[[AxRs"`a܆'SM<~8n]+*ǡLKk(Å=s"\X-\:^̈ A%)ACr!l@=  Ecz/S k2R0dXjvǝu3ē#嶪HBt`saby?pw{5@;pCD赀I ֲ:"8 WzCTz-Ø5VW1P9+&!uOL.4 bp]܍Y N1biL(΄hTႊqTHܩ)@ ī[ DQ;x'X4E0 ,6r0<|w|/(3O:#4TD@R2jNR4RZI*6a@vbrx&_uu P{8eVv8xV7ٻC(s 1q7ɉ!Gpb:3k|P4w^jta~ްm8T98ZڼeO,وsN;bxzq7C {_v|Tʐ0\)(ׁ!-= y9vםT́Z' ,UA?$o(dI q0c]XΦuVթ协WN)Ub(W,7ώiZB9QsaZ}NÅ!ZXN,u10UIGnG'qL<rJbő05.!@ pJSE8*D껝 [ 'I/KTt1D>2u&غ4]IwK1\ط !IpT<ê00F7WZ;n_Ix@pFn!HO81yvEi:Nv]s)֬r L 8 /" r`yLړ-e2XNM)kzlㆵ5 .j9BK 2 T{3/̚ -3٧I$fo>,|8bsެoeTvn(-`V\>ELBf('Co|]dZuN ̐lz_{ы!#L/$)ZE~*Az!अ+(">+^f#aO,$0zJx &/<@Lɸ=#` ߸Ɋ| 0tJx\Se=-rUI1ΓNV'is. ՅEh4ZǕ4U<#Ǵ@,2<~*8? xbF])D'>oJͩZ߉TZ2P8xw!Zc}܀Z(Eq|Ќxk'V,duQp(zVL,>4,4B ]@{ۛ!})9.p j5F-<Ν[6P Fh0V!&%^xV:nkcїpؕ. ١.B]>?Ԇ!#Lu5{bbMcuhBQE@q%]`7B?>)o4A񾇯"Js8l_ ^,%&hvŚxI"v%zb,E_[4N4 *L [ARb8Xă(8n47`T(]#غ\`Ʉ4 S"岧G1_|k 71,o ̊S R3 cշ7`)=ĠX8/4BYP#u <\>SG8JBSf6Q܎$mwhmf6[I\  ~$mE.D)F)[wp[Ru ͮvcxGsc<Àx=UXkF`Oyb\& yUY[PS}8ʺ(:tNרDW wk1]U0ϕ| wiQz(7]y4FL0ZvmtKzCf7+7$vx|D.QTx.(lv[!qkKB]H[bS&Md\ 4xGQ &i/wƲ#;uE|u+nT*Jvչ28*مڙݎw|r:LF[T0t_V}_7w#d=?xҗ8g(IBt.DO3j!6P85^S&PĖ/~}UЧ:o"ՐxxNt}FsgMWg. (zi (#8OZ6c΁!s.dS΢kGE%pu4F|g fKh='6hC4=D`fEQyR7sQb_:E:Ck 9S |#+B(C.ILiV grIzGfEdxQQg:ADѥ5"9Czk`Dk*eŅ/\Ysk.Q0]2Xm_;ae)[eYqL>deH6zݫ4au,BѠYp߇Ĝ$9=) IH*Cv溷r!t`7CĜ99H9,fSAȗ9 2, 9Foj+{ @f+Dd VKc)uO'#{$^5QJ P B1nOqZ5ŠX=hoarG ʭGXQ倠'3Aai^XV'3 es~gi &ƌ{x\TQ&F-Ոyw l+Ѥ(BPΖm?rL:+֪6L?cݙll"HO}b5l{DCgց8~s ^ :'붅~09\x&zX(A0:0gNaC6ۦH9e̲EBCύ= +:=9L2_/"ŊX7qh7>H|g';Nn۪N\l/ ߖ̈́f$XCμcG#r)H}b$dޙZIXw_8J/?F@WӤG_@P\vkhJb-37P/&Jρ1eמS6(]WiZ/]3 ug"|(>E~oI^A<.Oz ._ "RwxAkda8É&ӁV.=Bj=ϾN; ԑ"`ȐRsgmn?JrFS::p{ѭ̋GޔLz RSKmۻY\q;ۀ.u(HX}B!7SV8/r{/)'j8InmX 9HRQHњ _7{Q[mf쵛_ q"xd#(A-,.w35vTd-ߐiDtAkw0o049_Gv< ʻlDSGrozYKY- {9/ ugui^x=(5J a = i@n؏_˝K,]?G5m*W3~'.!| #3փ^X)+=˯0Y-%ˆ6`mjy sbXXEn2_9z6{~οMwW/mm8/hfV?Br qpg(;=vxӴ(sF>ѿkw/L'J)DFzy.1GɹR?Lê|m*G]w)s]E ELׁ/b, ?.I?uүS=hWK_f&W ~? y.З3|^Zt(jIZtIعSUa'#WWahBpaO3Ȏ;S>Hݎ W6vZcnk&5] ?!jy+'d5>/o9z2U )g2mZ1"[)<_v2Kgla? ?z<ѡ+E\Ia;b ݜk ܍ۺY<9%TCvJdGSgA}Q~X䕉)Nrá; sIl1)uRhy-E%-NkqQUzfVRj۸]l(ٍeonWnFҷd& Ap2_JdŅ4۸yT(k(Y M'a;@8D)uOt(_;\n!^W&e"B*>Z `o<ɗ; WJYFq9 oFÄCϜ(UF!:=1>Dxdny 8gmF_+}$»7ًϟK8S ?nZsU4 F¯x(ѣkGB~ G$*J;q&_u2p=@ЅWqQǻyyv_EΔ> "yos̹ |AٴS 21v; nukSv2D oAIΩ3^&ndX5@*:WGӉf#CK$/d2APwO4Vށ`Րq2#͸qUzo ǂ3peBq=G\Ao9ޡ6 ֪$=z1Hƪkz[ҵp*$ŁCeoTP}_}=`*51)uI/EkE!ݼႬk 4HX(h٬bEU'>%vHUϥS7 hECU+?__ {Y |SX^(j bqI_Xm7O@y5O.\gb-hAbSn Ww >h7j*X 1S>W8FP$#(}!b'bX8;iiUfB^r 1.uĊDIXIċZPyy3^N48j~n$8 &0hf u@Eb$@쩸d{ޝu}ͪMX'Ebo/Hn? {f߾Xy˰Ua 6Z0`3r5e+O-=j"RwLɖ>*ggXZ &[{߈OO Zq> Ѱ;b:FUD $[ky Ǵ1٤Qg$骠 ;#R6!q?y훙ϵF3LqCXwΌ/x=[^ 5Jb&^X<)(B3F6m?)_r;P'CV{Sa"h U‰V =*-lEcN 2|3ğ!1`Dy[gb̔qWHk+mYf'=d9YŴ &~L ܘip^?tPW>e[)C0G4@Lw2[A''wc}?>­SZrzr2k[ ,o+cϦo3r}ʊΐ/Zg UAMwY 5t.@Gmz7S]^ #j?]`@3 \Pѝ xqs!bpʫʥEq_ ?f O|ʴ8Pkk Br}nWrLeo㫯o.Jo+~D b_?ɯT"7W$fOFv"d LSS}?mN(IH"b̊$&JrݺzjPfLlV7&$Fzb;K)?/;k@3zn; k^OBAU> _F;T/Gx:޽āk#gxv2*ˢMnAwx;e61槖OJ9td/Q+JT:~N[ imwaOU@ӧlUv֕,S3X}HL7ڏ@3^7rgs5? C{/SaUncfonZ⌌Q1>yYABƲfB/->p: ;\ JwkǮHٟqZ瓯PĽӝm!#ʃѳʪ~`('ņ?8U}\hfh2{(YGTXFn2YB>0~_/)|v0 2:o!48EMnbvoU=0-`PО(C!*e4Ω2d::HYͯi5DLt.}B>gu+9oi9ÃRPAw6}e8Wg(@Jd>LUj~|WC 9tfSV Ijێ^V|UH-c։ m58goW>RzΫZo#wiV .TUuSܔyIENDB`nn*ޏui v+PNG  IHDR TgsBITw0PLTEqY tRNS@fbKGDH cmPPJCmp0712OmIDAT(]=0P*Չrwb܉lF'7V͎Lbێk)]$ŵ/l W #+[JbG`}4iRS?<_ Ɋ &WR4!aOaJX`43MD_^ka7tӍ̆+f YLs=AmnD"< :Ver/OuG܄ϯnE{i:Y IENDB`nWҖFZ0n/PNG  IHDRr+{gAMA|Q pHYs. . IDATx^G&z8i `O[Д˶`) FmHq--q,ުʪ̈GpwZ,?"W_pG` m /IGp'glGpfA{L#8c{ 8#0 سdtGkpYpƞ%S#8^#̂3,r?GppG`gɔ83׀#8 =KOGpGgY2~:#58,8cϒ)pglGpfA{L#8c{ 8#0 سdtGkpYpƞ%S#8^#̂3,r?GppG`^}G#1΄`{;#dppG`gɔ83׀#8 =KOGpGgY2~:#58,4#ej}Ɵ[)-WI{̸_@?e}ٲ3qG"58,8cϒ)pglGpfA{L#8c{ 8#0 سdtGkpYpƞ%S#8^#̂3,r?GppG`gɔ83׀#8 )SJZ S3^ }*J D|gllUf G\('mmHpO3+Tf>pDf]{Tx.{3v+;fx7Ԣ9Li h]\ gldvqz֤waK20x|$}T8e8gpk>}5:c?`l NR7m bL#%Dtc[lwŶмǖ*g3 ;:<. ߯Т.a);b:$wa*ٔ}fm:c7llbNK1g<<:/<%aWA*Qc3j)mʖ)md _gY|B=7xt\ƸQ VCw :A)DѩSr5c![24Z\S|e_׋t.{F5G릯pƦ1Z’m96 j)T$E4S$-ielUkU/Zʱ)ȇbTDyEcǸ9mV-q?ztpƞ?]g#g]I[MVC#b1ϱG 8 YnFb<~ݩϜD" HU;W*L..cwݍ}Ʋ[g4gl6d` wȜ8F'20V{8c?l8DjߒJ8c:>tȗ6|Kw$p8c. =x A,NY:d8cO0w7YuS펹#0 äQ!p"mCFdTNbG2ؕvT|QbdgkD8cwO;`SF\# gNYh鲎8cO4#O0)#rjcT;0@(PTC{x|'Rz5X虋8ngl# 0_Pg۷ة\dZ?wővFJE3|j-&Ͱb./ dyr.wq_qKVb^$*2vm ,zͤn?ǵ |݋a!s0mtƮkXH TG׹yL6HP29S-0ˁg=_T\X p7Dzc'IrѥF؅oކ} g'N̅HOE.7pV1/ͱ0'@=A^eZ§" $=@JSi7O)8=誫XvhpƶrvMO @%4MێO1O*A(M)# Y[p~!sRpݍ%{X3 8O&{ruY# =N.dRv5qԥ"0"Ľgu9n:*UuuD=$.r}R'Mݦ:]\ lGE{<_xKC3qJ}5EO#Pgz!d$R"eM'ia|Y;aPX>{@߇r'9r^|敚,_`Qd|*2qA­A cY )ocP&`.6b},6 __ېk+c"3 {k)L\.ke!_4h4df|<],t?7G7:_Ioln(F{qlW}N"VQ-G~'SqJE8`i"2 5A ̠Z7W[qrf[Ns&/&CI"U{U~%־Y;Q \\)rQtܔTdpg5a`>سd!1Iˈ!ID;aMa3-3kSCw`9%6awd? N8c@y@2| 5'ր+^ ;&I\}s9x7G۫B#tr4x s8c7y}IjIƙWY1B!؆`*d r.2عP!p~ȴ/B7*;\ R,=8c!Bξ;Xyg"^gl/w&WxIypg8c{(O{{RtQPt31zX|^|W<;^ #!doL},Bn'۬W;\|en|=Cq5UkD5ֆ.6ۻ'o[FCNd!"9xi "jトRǎFEL6\qTvnDXD EndY |&VY},2p.,:p6t$gB9((ɏ/DNIhK|"\|Etiqat15R..}fcZ9:}o'یz8'ގb`U;\]?~"_D"HXΏ3\grS6/F@ؑI:4%⌵i2- -BSvfQg\(\\p6GuiWgl]9ޤ{kh{޸?/ioӂA&dnB.;KO#h) @{lf"=6+D6WaAEZrwNvر7~'Nnv>c7۹ y뮖81Y#c #-c.ԢDZ"$z1r!N/3v=l'zCiSejb:N#Jt&LCTyoxmvEvgl/Mt"m&,ܸpBtw, /56X.*8cWuR fpB~ ݯUXc8^G8cw4D=j ɦo c?VE*\y XvŅ紱G9V#`3y6꘿v4G=Pwv$i~16D/o;\#`3-1{v2 !mv9cuu-N M#Mv$-\v(ݟXc8Tݙ ^"Pj#q0Bnώ3|P'Ɉ7ZRs=Gݽ՗+F=䆳 :e{{ܬD'Ӏw c )mw@"+;T||q;;>~{WkD8WD#e%q$0ſ樳MME170K#m=owo&B<˞ޑ.9G ]_=+سf~#1M?2;r+`fz_́;dl8q.voCi]ȧ"#e|*ro$wE 7M3*"w{'"):ifOEb k.n@sĉ4>i8cX՗ر[}w\.beZξ*0cڌ h]L=com z;vf.k"}`}^vzx.uQbi{%W' Ӗ&\3( ' g.5(c{ P{Qiizŋi(! fsQLOEF/8V%fn2Ar\.NDpE:NP~qfcܤeiʋ)p]*ggll4hH bP;BHrMk Ng&0 cv_3.Ɏݹv?: h.ur]=gl&`GDo¾`|k֍am61X Cb36C/4ѕw.e.T~R?FS猭xKuN#ZOJJe4{Zz\glx-bhqɈ  ^!`JA\$ިrC@%8c{E@-^:rvzHɖ{gM3^,ܔll(S. gfP! =N]fD;R:kD6xGWye s8c{)9:ʑ>\ר_F(\3JS34ix/MDEt|WDh/h9e3aRy@nO14<G@[Z%k76KjNvo낅 7p |DKҴ7!NE@]2Ut".L As cpwpzom؃&㋭'Eh#* Lu tF8c9+2sY)_,[, (5-""0s Sᄭ.TdXLE$yjg[㜩Ȯ "yP.0ED)AJ6>o3v? {n)4l@ w7?gi@t6ges"g$27EzBA]*ʫO&3Cogvgl9v+mpױ?#NR6f d̝1v>΀HV۴Fcw868=sͿ%oK!Ҷi!G.0f,fYJ &Ҷx5e}diCEE)+9~:A{0aqv*LE8SWeQ1DG23H)1v<*PZt鷖1vB@AT!K3{⌍cU_ҒosfXhsq0N"iؒa"u-~5>;? M;a,J)ж4e=.pҁTr L3$j%' džo+е$䚑}3 1pf6xf:klѮR6y TN\U.R|1ƀNOxRvٿka34 -?pD3vP{4낛$tm٥)[g`'Ӥ6B68c{\nTUr\v"O:Xz p6q-v C*VھN~6iTD^\&{i3%3:õSwvj!IvZ ι Rqyc5Q#ns .Ol'Ka" ] LSaRݮD3OMXQ61q}`ߵ3Hِ5~LɦgPvSݱi quBmp]˦;:;Y6u aARaP oɾKR'T;Im:l-R4HQ}#m[n;"Lիv x-U\Kr \s#wTP pWeMBj$Q0v͜\\-wg)yƏnʐ?Upu!fIJ54Ւ36L{.wDN1lT*s Qg쁒^OE+n}=&yg;wHFL3Y7Un˜Ǿ"Jt2=vO3H;Ǫyz- 2UKNS5萓9ovdž@YN}\$>BUYVɽr6)߮m;޷AWvRשGeচ.) ۍ{*[Rg3 36EKa4e'; nc?iAaˢ^8cb3i:gv$-#'dlo3d:8z)p$2{GpeԆQՃ0~'VV/g~k,Skt닥Lpԇvup<̓Lz=Ry 8Vj101:3]96(dg{l^H;co$ S#I6I/Ggw2634Qƒs)@'4]Gn Rq.Dݚm9fJU3H;Ǫd.2=U {ʦ<˜SؔTy@63@ɐW>E ۥ{J1O~sBϿp`_pFD3H;ǪM ™ᶌ8 r {ܰ`06'!+qz@g쑒bl//%[X2Q2}n V`l4#pvd p$}%$auA(1\S_xНtWL(1JfRoT8cSwgcl.fB-#CD@ql FR D @-N}ׅ]2w :,")$v]7.\6dl:8.4HpƮX%M@r7vVΨc ǖySnO $=T6'綌 AwjZ5Amu+MحF(z䄸ɳEuWW5-ذY\8c+x/M5l}vVC\3vs DFKYbj!`vjd("@gBBMAw2hb=,G8 L8EG8c0#g&r"}zH#pPXp jw4lKckͬ3Hmd *c奈QSIgp|#rW|G"gdحʆGJo3خXYpU~mjJ#q㖢D/vƮ1nᶉ5Qj:PÕ"KJ:c?0DG6aI'#͗)/=RMD,َE_#{/jw\؎kd8qKnZA0|m2S0 Jq[#mfjMјG*E}S3vOM0^sy"kg Qdp)goe1!qO8ҾM S2R +=R&$a9sH/ؕn$ T"I0EnE#%mmRbIhbDz+q8#dme=MS-9-gpamc!\)x{XЦ(őn+_[!~8[#iLLvZ2|)1Bg86Pΰ]H2k]K͠ Ma"|\)gr;6Is֊4f)* ?Rg296IRI }2^)`>gr86q^XX=p)Wlgfu1&kS1!g46IqOBjx=H)}N#mm gE2Jp)euj{bDk{t&{޺Cq B]KӘt)UuٯGJĀ8c>g!#͗YS#&b0GJHmH8n"F{l\iut=RSt봝- gvl٠qb$gqm)ΐA|t$7n6]{tݰ;:i߇#%60]_Ђ#9/7&f8]:;96ۄM(#8/A%i))igot_. 9|Y!."#ZplGJLm"~&V`\XBKGoG[x*"쯢!6@6qqZ |q#=Hɩ3<#;/Ёtf)}s)EնsuGxT_B!Ʈ>V`|*2K~FͻjXl?5?T˧#PGcA8~5lHQHR=OC=iQ{'j xŲs ya8cP'"7$·UG@ucڛvny#U녲I'MF{s$8L m,l3(Ez>kF8-ês65 Ǣ&K6 %{HO }m䡫 gay{M}mX F*؁pVi}.bLDE;6k cvU5荷6kSmkD&䌩{̼ڌE:E&;d}8rZ}욏lԯYo:+9HҊs6 سfnwE"䔭*$af8!Ui3H҄}lq!Y7يT{l|/lYU ^䜭x ϣ&\)tͣg[Q3vG L7딟NٺC{g4jgRp1_'I0PQ!j3Hggn{wXO GoLx>sNZH+r9gs5Bg2Ӕ>9eڊd{@ g(kWȲ#g'[N)[Q=}}u"W/7}w_ gnK |ԻlnqvWOgJ!^xL杵Ѡ"E M{zCɵ)U@if ;gk+L# Dn;e38a9ᾋGP:u3Nhg(G뎡}gA{, >t낋NH‘Ru'9N{$;}٥jʎDg/}42z=C޺ so1VcI9c7З$d;eU'n9iN{l}CS6awm'"썓0n-#eG(]ivǢvj`|}2ef&;wrt a~E=p#]vhYȞmWݎs'3dGIթ;cSj ˭}k%;[1=>~1VVF#j5j(>O=h3W|2/#uf2D}O%]VNR=b2oIΑpCf,;>ǶR)G`'Q|ʀbgOzT=RB=ކ.IETݣ#3E{cپ3vd: dG-5G J0#b[H+g=R7eBL6[펄T58Үm_yl7ZkMJwN䜱GMPWRm+KQSni-AkOE]6..>:ۚDtCX܈BվL3@Npl:F)Citi#4Q0!j*#l!Ȏk݌hV{l1vjtyE sdĒOC΃ ex %zw'1DW3bㄍ{έ|kñ&7o3 Yb;ndLP5g[\V,a'(z=0PI1u8c[9 9ڿ#P+H$R' H*.8c, dRdzAWl.9ʨ3r2k4سf.w=Rv|qObQkf"V}mq`MF$~^tj_&| "c"=f^D^0.do5~Uc*g#Ia X3:cϐ%ǖDpCH)̲MJDv7c vz(nP`Pf4t);|?0#5*"Ƅ-LT2ؕD\3Cɲ@ۼm_87&l;)u(/RM$"8MFU1x-,#e/$1. gn07 2Cno0bGxI!YScj18c4aX`RUO՘5 ##uBgA3[0t$BSvM+( g1B)pK[i 83X~tW1p.x (;1^Nvb/ PlzT,ܣJ8cWnNqvj]kD62e78'a#84/W7(D[LˀQ3};n xќn5Bϲ[,QC:_IN  Dh< ؕ" K0Dˍ5a(o[Mhu6B‚7(B;kb;&FA{LQ'.{b4y6 %PD[%4MIub 1t޶ծqWdΛufh8ůg!v!Ypd; lpƶF62H (wxZiN*B0|jKQ/#S#WEeHC(:sxI%AeIDV*@2<_g6dK(*7WF.o7I2T>@TM+GpFPVP6tD"Q+K~ڗ]+6O|ہHI%o~Mؙ`N+$/Ie66kD]8c";XGepYUOq$u!"Q|t0kֵRw{EA+P\}ENsfY+vG SN6)21+"O!=STt"S-6Z63 FSMterShx^nIvJ)E/w<&eįj:Cպ+>j ;˄b@Xdkb# f0 %iLf$VPRKxx5I)"xv^B@Q nFpybS6CazemQp#"=bVO袀cK dBt&½rD<'405mxHd9oƹi}䜙bY(Ex`I̲D6a36E"`؜دG,>i (tb`*AIcd3GP@v8cU0>"bT+d k#}Q"p-ݲCcvr"ς%!EGqap65znwB=PL!W{Q_|r䅀{!76CCϢWəlnJ_Qe[#Zq3aR $83<9vUgV&bq9N7Ȝ%hg|Q|QξK` r|e砒`&J00FG^{lΏڄ2^vY*fZLR./XlL,Բձ Ӿ\%@"YwQp53ZφK;gt3I& ] ]n JFWxD>6i$hTzԴ#λz8cöŎ ‹+ǘҴL)a^YZ3D ]vUMpnFѦJ+/xօy_G)DNp! >k(Awd4^3^ q8c9*Bg⧡2{ L)'ݫb]08c&@Yӱԁd 8vɀG\f}h(H|QsC`f&NjH~ +߭"){k䬰Zl7rgr#pImHU(2;AZ]ixBQLs6GAF8*O؇pX i5Êj߃Jpv*HWs^^]gl)r3+|eWy0R{)JTf7鲃GZf,x.'`$DjX#kڬrZQ >śJ4-Ei3)#(lUC.6Js.2 SL"bVӝC31&}ԮA3\r ,ˊ?lH%;Mm({{O;ያ|.2؞tqt DTyu_Q\.fFbԝd<tS=Dz:q=!} h''Rb&}<[)=.!38!"}IQ&& :ˆFG%ou]WЗpƖ6* p|؁nLo](fy"`p჌_A]#7kͿ:ySC\\M\DRM\pC-'D{¤e]f"LnX3{#v`ʵr+**͎0_6؃$Ѝ,;dh}ʙs''Az FtwE u;c eH ? P$*łnowD58"u Iu#a ~3:@*u8cwOq)YͶXdgѲUe؋ {JW1C>1Y#)r)8I(E,aB{Jߴ-({[t󡀖`9eSE43f-34ٲ>bIH쾋sdTVΎ5/rZlphGJU Pǀ -IꑊZlf =m;~+; &+nH%V8aGsSKsd&r i7qHӹ7rg!w jS7Hضc ;4J ."wo6*)s8c΀}L9-2qZS6) W8p8>8؃'sE=.(N>-`2ީ@t 3ذt`\>3I9cϔ-_/^1GGNe4o^f# om8/z&}QZlGaOKpfC6M-Ko#$8cT$2{b"rlxʗa57A΁4D!صL;dh}]Kq_a5XuƮks,6` p {;ח ujuZDu|UR N I6S/W/db[S+GhT!l@*t}glh-D'؃A(v,C"i6e;8/)1SS 7D!L6$A?; i*g t& pĂ]$ %a _BT|1e^9L\ng5NvLHe^vh#7Py]M`Ĕ1[{h\A 4$P3sVAX;) Bc77yұ@AI AxPi$5򹎰^ s{-)knrUL`J[?pUzM?wn'ļj}գPﱥUYY;w|Ѯ. _saLEE5Y{*@ HIG؋ϐ!8 0bUhfϊyQ4B1"K+ئ\㏯ =jk8 eJ9\ɾAA Ԃ 9dHBbdx)D$.B{l+$[Qej.%"B ENR&kUw]97EVCUѶ71!XUD9BJSJJy;qd;/BU[ (D(\ gl3(-EOWʎe-43X̖)SKbk'Y^} gl|֋bq؋C/M5m vs#._) z >LTFؽ"E:FdV# aIz9P ޢ&L`*K_کl֫w3<}wca^({uK9S?i0pZsc -v6qz eIglTv6f4 !1S;q,3)JZu¶::@k+b|ӀmRN P"*f )+quXF HC]./\m+;34攍36:ͨ:=7_ ,\r Z> $v;?l3t4aݦtB&@C¦$VnuɽzH3a9z/#7ӄdy&=4ǯwU /vƶ֒ n.' +^%2)[4gl>{6lԲ[y2!Cj)B) 8csC ["|]#C6ldUbET0fҒ|p8glf2t@ 4,0'ƞbW:07gl6Xr@H`e{o;%<ԻV/!OR!ČL e48W8z|2bE73\V"؉x68Mxf(CK5<<|pR.rn1՜"S~4WOm) aĀ" oMn61$yޖpJi{Ĥ k&2J4y $(Aicl(r!l;gV;[P6V6H֞Vi~7dDb_b6 ΦCOqTWc|#E2k~#@UpվNً Bё&&-5c#3x.(7@pr)}3&Cu"FRU]{ h,:CA+ vyMMzJJ9]pDۛR§"Q6,>-F7%^ 02¸ Ou  d5dp}w\ TጽiW VhE ZzLzjq)qeE*c*۰.e3vV$Z%T3 p z~]0Ԁ TԔe}czkZt1Ɔ[lx68'a Tip!u.Iڌ}HƮ{'ߦ@MX̏l>M6+4,c\ۺӣt"~݇Zs2aK}41) < cmwīK6S6VDw;ؙrIK,#DXR Ԇ^Av1_Z)S6hx<ݿ&~)~' XPLYji#l~VqH`>T9)o/SBёD#dv$cVt-`Tlq# Axmv?&H*+E.>djR 26rSm[SU2䙦SL9eSmTV(4'TEE24Y &b &CԿ73LIs rd`–-Rqe߂6W]ߖQU֔͛$j|r67g~VEE:q!&+K)P"f jm=c㇨__ 2&[⢄3S@ :>QK@yRw(3m|͇qn~iBuo2Mǔ¤pbjSP!W4Z"7:FBӤhHY{qVB"m3Aې*/ p #5_%WvF636)sv VeRS6;a-OtJ)CrjoZ4.gl݆iҦGE)& CU vnJVQí0 ;TΈzgl +ڀ);~jıj'R=rt[}¼cv͹/pj=Br23Mر ($ݖ(eВ^T9{r)Lͳe_o~Y3 ]:q މ*T-ma%K GQ"`K;sxiEj7فOb2՝Jaqm$a†3\חd@%l}6Pz IB2 QH_bA{421lvΗ18G4-uxUZcd0-2moa8?3QB C֋gٱr ApeF4a`ŢRLY0I9r!oI`gѬ)M+[=*-! rǵmusԅ0Q^>é &KJf o8UvPRK|qs[SXdw.ED`!glLA^[jz`$.(+ zlJ`tV77XH z53v䵭Chvt񿈴݊/ [p0d6s6m<0Drf9:c1{m"2?M^R5(.e(/Qb?c*չoU/rEJK,Ƥ͉8'/hҎ.T@ܻq0ZM\ʓ՝=*'~ĕ,]ˋI[,Y-"NrP9YQMѠ(mVwVe_b=*+ p`b܌s0ԦžrSJ؅AvY)6УI? c/);˃~BWh@6PrklFzx@6C^{3jy$[ RYiݵط:>Z4{^Y"-6eleo[ZT ef"wTe+]{]L~]aoWVq[]w}hkKs`)்!]dpJfvbs"l ZDGdbQӟM~K 1Y/&kD"5dxj7-Ǧ^4]:Hr:ܪlj4X|K!Gkk(P`,1#UW$$~'0B({\֓AC0Wւv94 i[RZM@k-|GPW'LI(0 A@pݾF#;-{H.fK޶C͞XHgyM՛)"@,w)Lk޷uܺ]Hi "^KQ4dOص^0T|:/տ }v #>,DBj]H Gs.eZfkq풥اv ښVӻ${;m(Duƀyծ`;mvudM[c߄ zr818IIғ6ci"BYEńC{LƖ@״lFj*&v+J3TLSHgٟFm90)#@ 2;ccLl"jgAO a9U1_QS*P@o0a_3@TEb.`x4ʜ(U"I8?>o+{| 7+ Zl( pp$kQ+`VY)8cpw~&=-Z5!G Q_#0g6ah5gu:'bG`}˟_~bB\hAz y R#Bx&8 ^!)ܾf][*!asq.s.je-m_!5lCIQL:uqc$gSt b]8x6q/0m(sNNV~hͨ V)[~n,2׎73 +g}3Ht*ƁBʃ36^I aiOJSRʶk''7M>S4N4]SK7[62gU]6nG)ecST^gMrv~^J Qry-R\]xKvʓ23 Ifܹe0jk`ApLb:){MAbEɍE-!eh͡ql'e)YRr~ň 9|Q1'-'l:kO5Ūlny$# 7[UF26P.ׁg ;W9oAs2;f_}M[ln ݍU1IN3}ŜwЂ;|m~+Z aJua&YlT l;&:>7gl[fmQʹx,VP7مsOweRB;=V5 ⲣVV;̊ rt`>fl5iPaWE\Ƭ<{!NR{5}Z[W  ;6flnN,&"S6K$F7KuQrKǭPddPUm`÷f..-ybU?Bֵ̞yH254L (HK29cd?VEMr"pMdp-~R+F)`RW[ mg݂'qoe3qJ͆"@cc؉)xOnd"dnqS8@m֜l`φbsc#P9DH~}ǪFY_Aqb$TnN4 h &}ȭ, ƾpjZdS'Tl9Q 65JY7BscRY%&> YO/H0DxqbeAlrg᲏@%W,vJn3~ 5 "YDjSL-aTXIo V<8xT9FhP3 ?| -IFO|\&gmHE~(_{$5]XjYٜMnV [f4BdF'+%ja/ sT*aa Zt;ޯ*0RWfod|d E;hb?D~ H::w (u uu `½_sOV]v*O"B_l$|-,Mp1[f,T|RbtD==W,6?Lc|9`Vr^$[l!~wW<[S: OIƾ3rJy=6J%j {4X$>l{~nq9"g \oD`i"댤GyM3vy)2ݚl^PM(4Z?7NL Y=LW0Yyz#93UvH5DET$MZRܜz lCŽtZ1vb̝!>3U4){EX޷m֐ DOj_Ji>a縈Ɉ8Qi ϒOmAⱵ8ڜ\B\owq߀Cf|0:8gO= *~>)5Ҝp MiQO`4I>c}PPLA -I"UCcAy~ #źobMMw1@=a]bUR>cLI}+GY0xL^wQx^!nm )-Wn15aagg3P$"^^>U^Jᾊ"@>vF =!^ ܵn.DcHY"Up0ʜ~[kWl ,bBdy-g7ݦX2:';LZu3VT_Ts,4{{H?H]&tRG| gKPE]S:"Y? bcJBM#"a8 2|Ohq{gl`orUSv\rܮǯ;&*nrCSBchOf$a:H-iJreqG{%gw&{׹It7٬1} gۂbRc+q$o:\^~dSO-o5h[숲m`44w 9/MXKTvxZYM,ϰ4EK[ LB@xcR-IG^p7{$%A6,J$8G%aR4u SF(0ý&!@8eXDҚHz+"}a8 [ yWUg9Mq |1d#fI6bKwla*5m3I(AU{eVF#vӚ4 S&V~>&k]kG9Y-8c$ 답p&{ ie&bfNʩuzUjqRUcu"x򺿆ms9&O#Һcŕ0OBZA8 ꌝH]HEen_M2aPc{:@)žήnȫTNm ʮׯ䝱Q;!p!Mo5)iR))Yl]25)0Y~ewAt0}_u#Oj_{\w;Ht>Dwk+_ة8L]u ʠթ~"G2'bKuq=S3v7z;l?#:M/ـ'Ϲ^' 9*FRV]łAr]錭L̖Mʃ6V ^`هf`;Deι;7^gx4]%xA1 VztTE"% ~@yZX!È9coR*"JyNSvHam^7ֱʇ" qNCX nͧU4i)D&2!NCƓ0 i_0%䌽M'$ѯ,5p#m"́HhIUg`Xm6y3pk֊,lzk\%9P-kU I!<9rms`I#mU -wt0"unaUZz8S*c }%:c2Sq@1<\^EmZlS.ʸUZʶU"=ShtΥIve.R#Ϯ.|}'lXDۘMC(A|;3>tM٬iQRn 7 ;ʆ] H6I"kߴf9Yc!!f"^n8%f"ƪ8}:2gD*UoWpց;,[hB^;D&3.RqvvU;ymV|S(b܅Ҳ4[ ̪R[i?o˽rv9,1oԎTmPUͻhb=clHx.EM/kzM3`_62b/ 0kWR4,Clly7!XKd6hd0bu@vQ#tZ`k`tPXIIfg[l 2gl >eNMn&5z;{UHg_䌝N1ɮV'6QEI[s6M[fUAIV7+ݠ/?Tf;lIdUoϠV\{|*= ɕ91Bקzb ؙɫ\ mkR}(\NV\s\/hjsTp {$ }Q.(d)([:) Zl9먩 XC)Nd5"ӱB0팝KJ $)& ݰWu&ۄᢊ n5:G.?[/F_ZG iR*.=W[!0mq"H]vdX,lvʓ)**g E(us*/D1LΈ,¶+/b#u錝GVHBBakHZ>V-ڣm1p98ch숋* [Z )H]"њQjIJVZޛ/bCpƆ`)6b)c\6vݹrsc+ƭc*#.x0£8cz-.^֦nMōԸɶAGث=23ni?pV%OxYfa>P; ft)WOϠ٥8\B@•MU##(6Nmbrk-D Q_O::Cd$$D8xd7AB rƶK'I/&ݱv{eKɌu0s):o&"ԗX"M 0բ$h_C14m)e+[wWX[87io!nB,H,-:0e/~P.X.2yMDE%sA6ePY>@Qx FJ6ş-vm* Z4S6g^b.feY)6 NP-lEH]1V~DA7.Yw ɣx} A`D#:Nq%2'lHL9 \^,Can+gɦV`h[Jss (r椼Y@NS8B(FB(P4 obsCLXטnRJM.B#+|MZ$J%//75hd^#+# \l.؉rgl!jfb]b~ol6,s%s*7jTv6xJ>קpF1kKkّnyTP0r6S [l3¶QtD{$kge&gl&z`L);Qc`{0F4A۹ A@Bpf7#4p2ܘ/hƪKvX$U4 x9cs3wsv?&eGX.RXgLn2.YQG<_ج#؀.rGkukH5JEmaқY5ev=F{?2楂+tƱDRɴ(clf7cݎK@P b361:kR:W2HH&$͌)ޑM~ߝ˸] )\j;)N@nԿ1%aZ0D(&1/m"R&`;s%d/>ڒ<†N.e:ǰ&Q-Q{uVEYtgVFYvp?†/$*g!ʳa}ކ㾥&e;_vT 0(r "j-k8EN]-#*/jb(]uӴA7 "1M{-Vl$3 %Y#vpPb,w}4ȩ{Y0LhsU2ȵ%w]/Wә,7.p`@iZ-^^)%Cdg-v [G_zr,Lglauvj񭧹9n쪋,u  /=Ta0cC5Ј~ I:c!Ek1aK)t LN$BGH;"ƧkxPRٻOj(/ewiwXйDxcCb>#`o:chQx7"ď.-q46{:޻u*{ l. ݣ]ddB[h8ScoH؈)`9#:c˳/7-sw$tzTQ_| #+7Hg"H"L:`2]j`-a[>Hs߃&[Od=ae@<0Kx( -팭HϡOrH{Qa4K0Y7"-CXd`(-I~5赘6V]{OZ&I:wM->ROI83(ͥMe3)x~Oylwm'!LIRSdH:c[f¦߃7;a1k[!d8b:D B[]n̪6LU4KP jYDo"0n,M*Ӯ1ey9c se1-3Y GЈ/>8`ޮUAJJy/';Hꜱ G٢.m۠·£iM)2HdUۏOw}*}Qͳ`T8c+32BC70B./~&"AS^F'PLS@LfOp38E)<ݶm@1(LNNv=OD,_w3x$nސ4"J rgluG(DơQWA)k͕(Wf l;l]wǓpƖ|m eoFR^(xaI|o4Ώ(ጭs Rv-ad+ ,KD`>[[ j5#\(Oꢲ#B9#`ϰWρxGE"jIZ%03 :ceͲ( \6,oܹw&HH^Mq-;^Q3eE'Ky4ÙOk[:2,Sv>]&"6 ag/;㰺Vጭoy*z{ٔ h28I:"Zxn4hp`*Dgi:%Y>2sߙG|hG>5:c!m3Sv*Q\닃0a")Ha: K8cԀ-egNjmy06q.I~*sh.2xq3vGyᚿ U@FyqaP:2l>"/dC|05 dǾ]#{ (:$l?%]}GȀP)9c ݆﮶a$jMMjXI|-[ B5_ =Q% ]vm0|J ]/;Z3 mlx.HMV6]jv6mʆ} F[gTX)x Xe^_=xrQ9e}HPOCة܄V lW3Thf5eƍņ($k@㨮u!4W]Xs QֿAJku[ZC6:33N{ ť3a;D:K'Bgl;sl0{Cjya/AH,."mXbZ-4D1  y\s7vDpQtFFi53 -6356bՒPe*_Xtdʨ-lPt^crdp@ߏBeL!ŀHMIؙXAU;cH5[(;f@O."f%Eĉ;pqE9cK.E>7ٮ?5G+DY3-ڜڈvnwfeyGIIk.:n10iuRؾ A(N"֘@ ?UJ~O ~ԤpƶH\;YӋ/}t;(}&"YAP dnra&#rP° 1O`*piR^{$tpc3 Y;'wS.G[ЋǗZdמѢj6⇒D>oJzsL䋙VjwK̵XT̰ =[M䝱+$db0m:GE4s0saa3YLwh*Z}#Pvn$i@||ېWqiXsR*10[źA;m}Ն\wGvEJ>b~a]6G.8GGع k!uBɞ8c Eݐڡ5u@twovvx93 ʵ9\$`WÝ5VSM@⸭3 F%r. h1} ,KQMp#eyEubb& ٤h-_Vzֆ$dׁ9cU!El:akZ,)BӃ>&;C8`(̲Gf4eI~T;`ѢF|$}E36xLadrG_>EEeuI3vllZ/@0 o3bE#6w^y5O״F>4ӂAlgU,J5E:Z ?3vL2;7)m`ӶPjODJu؉m3 2Tb~V-H ER"G?[ ВsxvB&Cz 6a1`p1?[nnLM'_Ou[ZK{ uЛA p6S܀(Q"jQ}bhCx Fj·"\-ARs}Ͻǯg,Ϗ I$Ի/s * fU>j';G^ጭn6x|od}.{6[V@kLJwlŷHYbXͱ9c4KmB)15laa%ɭN&B VؕN\Oq[\!qwiNY`s ;sҭuE.qsYjpm|x%Q( םC\B(Q`¸<㫵qC z-N'oٔ[FهYG`PleS7FPwglufAcKQ_W c@Pyb)eWNU=3<}դApCG:L l;Y'"'ϟsN}ԓuV`JbIыk#ڈjڱ_a߶s(vA:c$%8#ʮv>lp4$zq]l| GgzEuot+*Rgl h60;~l}ڻFfiƂ 1y̵y-o7aGg~tTͫF40T PZ&"L?w&0$D ]Kíwҷm[lXy$ ]Y/!J{E ͙cu)S-`N8S9Lz W?CEnsH.T[B-ieN. - 3@C;E9c5طu5.l1FϱR^0 #eG3Aͫm&$8rzPs_^)"|QﱵѮl g݋3w%3eJp·+ l4%4CGL"tz\ܹHP6M&{Sls|AN8˴[U|Fy45>1~dvl.&O紱oN3i2yҽ);7͹_%B4{`řÃ+[`~w&^ !j]GIkh_C#l⩣4:jy.+]&v6H.YM@QTDֶ-?6쪢n 2ٱ멮h4[hZoДEt,7h=Jc?7(9;mƚ3F)K;c[%YdSoR~}"1#-2ZSp>{ Ҕg{aT=7!m(;E˿1mJ{7Wb?)'ly\m`љ97%͞-Ol9;i+Ӥi#o)!mX"{-tjl ;vߣsPٍͦFsW&T3EMpf&wFB){[#QmV"^dg6X96\M1P6ьXP6AƜ>!ͥﰁDeVeJ4N,.'wlR4:yl,WYYzoNزl"2e.3ynk H5<q5=z/2&N؂@8cHr)n *.H:[:!6\}6oa)aZMp6'o®sU˝3XF]אrE6BeԺړT$] k8aC%rfg y!L 6Ulk0/\J a'v$jq#]%ƦWg8 o-a%ͱ}X ;BrqН* ]t9:M(۽k[4{!WmcYGQ8j65 G aɽ-4P[r.Fd, $lkzZH8c[с9]v~swؤ|}sXأj[3v$b-!lu.sGlT[ׇ\]1MTFeW?ۧ^߁W{2U-e{M Z!jcX`-˖>D.k1M%qℝ*qev}ygj`fWsfeE# ygsdUN;y4N'h@+صKaO\\GR6'|br {%Tdㄝ~1*4YQ6BاQTlZϝ{w;l\SQ6(O6Q: Eu5lA͑b3 q~3v@٫`W"0@ Y4+]3'mA Nئ%jЌVJt&dm/Gwv.*RԲJ?-vs6\L)q=Tq}xV[Qe%MA lfOi{VC,dqDD yfZpOQ*JJ6;iMږ9 6Vu|m!U/l|lgpwș-<5pQOF,ZĆY&% p])KFA 'jRC1T@5 N MF6kC">5&;?H[>K mc]-me@j^I.*2l,0vܨ*K/!-í*xEFHr CpdOƻHjx)aE p6*3 @]EXEa\ah&=`A˫J/2@*k {2.ôk4cw&Қ +"]\S%cl 09Q2-_ )=Škp6"GhH&{Gj>Ԣ.Sgl15c &9j"2kٺݻ%ڻXyaaa 6E_e,3B0HXdOؙʝ{ζ34!X?F2 {߷ 2cjx.]zE8ĄvTwؕ ZgZ`S 7y8[i9Mw86+ VHlL&"J*h$qlv *H.+['FPiƒ6~bߠ7X 3"SϓƁZ7KEJ!nFh0 ~c360t[Pp**t,Jk%`sPE+mx$vI4M8cP #ȡlDZlSޑ?ժD{{P,1zE8c`뻈PH1*^"4N;l&> gN=l]gl9vVgK4 `|lB$4|!≯`\2ؕlcs; TiҕT-N2}q@:Э`hJJ (z$d+(]=6шn>F1 Y-Ljbo{“EAR}a{1m 3v vT,ysmʨ7;I ͶHGʆef,9CY]JSc)Qv!6|__g74 hX-~(02^[aT! Q9$̹/[#8g^+0H-{%8~P =H"` s[&{9`9R~7n0 SAs\_['Ē< WPKcW >rg:IﱧK0o2fKT CS@uY͏T8(4`Kkp6r 5-0.{pT dQz)(;bl8V`^8cB]0;9},Sֆ#2GОU {FoEaKtN؂i3Lق}-nOE$Wcj#IK1P8jGgIFV<GB Gw<S|_g>W S68PT@gf"yokpsWD~Ec&"wf@@bͬTȸwS2|-L+gWaE̤ @XI۽>;ec3}HBȱ{f5`638|#DAX\2iYv}Cӛv*X-{[:Qrc DDbߒЊc35B9U:ʅ(q:c?F cCt>Cb}{aŻro:?^i."t)[ATm&~76j/s,G4:giRe( D"0 ~SyDshR0/*6[N/_DxW37\"y U 8"w;͆U I;NY)+Jlc̞bqp/'u=yٸB~Me9> | uK̵WD"9pry1qSDLyy0n.P*6 jby1[Cu5٬@~LV(/-`R9%T6g_y26} \x6g˘(&m@$Ӈ !vZacǣ}p#j53(7OKPAЌuMU8YsgCɖ8cD{8[VL@qZ90Q2y`؁{8]6ń3A) ÆI6@fمtait3A ۘTuwtL:# h SRA>H"a7goLnoNSVi,^_"t$d D3ex1!bC{7KcPr1935x/t)0yOONB!݉ DagԺ+ﱇLKk`;l;ݰ="pl+Kx È:c?Lˁ޹xeАxOTΜ ag0/ z]}"c]$C=iFؾ&C6ٖ-6\pƿq޵^|)"Z{gXC7]LuMZ%ukC{r#s)v)%2J>S^N*x 6ﱇLKmfzR} ٥0q\P\H ]8c11qH+Dz;Ӄ2gGu!}%t`7`HNPV_ ,.>cC\ B{|I$p\? Wl=kۜMl[-n-P,q3`f6ٙ6;8Ñaq pƞ I=]df=iÈ)H|2Q/1@{$R /G)J2384!dKs#} Ǥgzt!vO>BJѧ\ 8c$U2K"l#BZ5Ů|'ITg7ѥņ>RN o)6@{<a;{L%V@U R=uAz16DdDD+-(K3]Rh6e;_?fS }z"ۡx::Vt+ 26Q6]0x}T =)ea7]^Э-~mrVB{dw0AIxV,yl>Khp!@I Sd.XŭEn8c1SqϮcFAd,A*`\8c<7 yFVCZ /_pJ" u8vĨL#=} `8z;9|=E鸓^mU?X,mV@@UCDN̂@[r0k!] Yכ@`z>/pƞ<{P5Mn̾EʭUC8ķ}cap>L*' d:ቊ]e!͂˅v6K+R#H2)R|]zeo uBX?~w?;]_=Ǐ9/81_v8cDmghI-my*|qEi+ar3C{`++* mw'HCXUu_~|,ypn#`ϭBG36-@aB 78c?nf^=*G8"G̪8DyG8c1#gcգr#"}ĬzL#pLWp3191p>f^=*G8"G̪8DyG8c1#gcգr#"}ĬzL#pLWp3191p>f^=*G8"G̪8DyG8c1#gcգr#"}ĬzL#pLWp3191p>f^=*G8"G̪8DyG8c1#gcգr#"}ĬzL#pLWp3191p>f^=*G8"G̪8DyG8c1#gcգr#"}ĬzL#pLWp3191p>f^=*G8"G̪8DyG8c1#gcգr#"}ĬzL#pLWp3191p>f^=*G8"G̪8DyG8c1#gcգr#"}ĬzL#pL^}=f\#GUj>H&xqv4;cZ\WS {y|e|vƞ y\CD:t/ρ1ʺ_"^&+Sƴ52-/`vja;ܾ45MN3HZ2x"!lWe:JrlѫG!G6L5U&_\/*MBsgc-umpS;{\y*t!l v=|t}gvEj^oۣ-lL F{&"In%Im}6Tc jymV"=DTax^} $@!]S\j[3NEN1/-;R?*_q&+HzKc脎"lU֣eFVk[-e"7Ht>RgT$t\o9;fU)䗐^`Ke\>ɞ~uqOZ D/"NEe3+ gR:r',/)ۮH*T w8snr*6L Ѵ<%%Pv%C}{&JP?i$bΞt*RފScEc: Mn'G\lPgt,/]qx9 8Y$fDE! Ѥtmִ]HEdͣEI-6 {gc#ZoƼ5Qњ6}@Ma{kީH/*Y:+Zܒ& 1Ho7().ڨin˦x0.Eeo69ց-3 ejmmmҠ(.5ecxŹ{nʶz6F"%LHx{D%;)}rfƞ̣(SkK(R:9RݧS3ԔnB&]"K, D^ӗ;DxGgnvkܹk M&'T;¾Ô4F1479cOL"MOb\;Mv&`۲ ;Ԃ3ĔmYT9]yE[bеb=0mNUmNNFm{^n~~o,tH`bm,(f-v}gy)&<9ct-60}nU0ABUڔs:YNm Ku].*B(G`NQJ~ʑS,J*VT5#T,57{>1D'Q%:DҬktziش ~-R.'sDeuQ18WD1\^mc hi3kWE e촧5'Uݺ]6sF! 0߂ؑmH.V*ssƞA3CpHX4ٍͥމ ;w=x#m9ƃyWCh<EuB>{6#e+{(F@d[pȔ]T.48l{Ȝ}h6:gܽ0Z!,3)c6MTW^\brnެu=Fw4KH~:B@UD h02)i;CNk̤V]I x&2PݺɞCt}BUIgJj[{Gݎ6I}|6tdcjZHS3v&M]GmGw\ ~s3vx޸PcT-&)6Q},n{qn>mٳ}H0OŀEQ LOǠl2?|m{ NʃTʉaX8J|Ըu4=cۊQqMcC2=Z3!(۶zZ![js,vPf=LLR=:-@of6>Ѭ}>[ĄCeb4;e+)q:cGEa*6}Bsw 1[ZwGl"tܮqn ; ̹էtFcr-rٍyIh =?eĂE{Xؗ Gh޻MvȨjQ{~ʮYC؅#svX&0eh6BaQ-\kw1 a?8p52׾Ů\:سSvw[IED^ydw-[1mCw Jݭٷ*Dp=tlG{-Gb)#+Cpc$坳 34 kŪx0Շb)Ja#qξd&-vBX=7e[4ǽ"RUX D|yR1nc{nUc,J5@ tUh'R DNGꌶ;Z</4ɽюp :XjBfe䀌=3eO^{ "#]9D%z>S6H[f9yu{b6+3EciprhGrv$oC2Ĕ-` (|T,]{OIsFDsQ /Mzf{M%.9}`;n=(cOKٚk|Nl]e>$QWɊ5əQ 7Gei)ۼWX`8m1=&awR{n<^|_l$tan K7k7]Bo6"Ls'k_e5alO2SUd[a޹,x[qoNWek [:Rx v Mܵ_OSAɑ?4q aMɪ&#>r}R)r>d&2n@yl0>=?2cG~-]s'3E1phƞ1(ԱZh{vLA@،='eoS$4|Iv,耍Pmhu:8cOI+(|G<&"ptƞEMY?eӍS xn4g>*K螞ayWYX| >QP4gl!'l{&ҘW#}yޝ8!?cphӑC(9=e3 3)5X& 1{>ʞ}m\קAA{mbGwv)[}qx>ē4t2)nNݠwe6HسQ6>=b']fx'ivݱqXU{Sqzw&$naa#1v.icr!|u)04s@RtoV=+;>3kg}?/tSQ_{_C5:D7Gdd`*ƶa"𻞧aIq"y(ԓ{$u&&{{Tt\C-3Q6[qFُI&=󜈲6/0ew(7L"ЎzEZOE!O<8zqGͱ C)Comi5lح{J?~){ZbmG챳@͗N٢}}Ez-cpr(_m@a /FHۺba~ndI" ᡃoIƵј$W F(=cl6Qqwa3oμ=׭w^Su+lj$/w%97uDnUM\Y)cU&l8MLj(y @CWj.];Y#宿rr Q˧E=aKhO"-{=$ ┑9Ҏ@ Z2v U: U;e=D&㎗ۚ"}c^uZx;JF3N0[Z31(cbVCo^ŭ~^۽0`=o>=gLXݠEF!oOP@3*Kr{!Aq 2_syH87Ma+IfCu6gN X iˡ>"dJQHXB!픧EvQdftٴ$VEGXVZӌfaZ%.93 oqƝP2Sˉ$tc7G3|=NS+)Td8ysF5x)}Qbs5YXתl*ɲ"Va,RI36Ið d(pF}4!cJ4 *@6ֵ*r󃕑!ӫ(WHlZv,VΣH &;9i׳JԦwxY&*漚}NL/JiŀꨶhWAՂ~WTW%1EP",5^M9K22iķԕGrNLeeEٰه iHJ Rrޅ*"`:#$r+tDIziwz(1 ^ f+jΠ a]:*^c$U36~r%@6!8j'iRH7j&^5RbugPh]Y7>Y̱105ܔvD:=SM=k h;c7>T -J=6۱RNK}u!\Lu*"bDKֺ% EN!'،!D ۝Nədlf983UQ%eT:$Ä1.2`hf;c/'̒zɱ0&gg"a;)&arbη;961l"}oaAIbws6^1o߸J؇S@,ㄭ豱u[pW=j7B=MEЊ26&Dڅj0؀"SDoɂW5P mLblL=֏ Μ;=jC-džB\1Pu&L1;M+oUtPi5pI-WXVaRh> Њ1XZ!Z=hWZFWNմ=cEPHIL8, 8+u -NAړ8V-象eNXGuh A Vs>E&K`A@*lZ `&;+&A9FSR(l *ȱet1Tm;D&r]X p眧\&!ѴMP Z$~B:dq 2DI,@de x,2te^@T fF?MӇOAiiU^,Ʀ8ucEU]" Ԯʵk.8͏d?y/9Mais&DXa]P-"6.DkmAvشnP}rXA$!+ik{шX P Y sGX Pc ]jgakZqL+vJQMGв[\4&+rH6m5RF/"\M26- ;kmͷJq-9 q f kUcl '-;6A9-`mBaAvU-zD#{فA9@*bk0,DiS @O!EkB}}I({Qh|n4ts۽U(?u`lzu$cd U$zGx$$ * a_Qk m2 o*8I)ʣz1_UIRC;I7ɍOb@jhdI=ch7,ؠFF0A1>qumʇ.UG165ijZA^PQU@OU"I[c>TQ{'{%Ý^WB {cXӼ4s斺H=gE;z jL\T&15A{EhW,..-AuIf B2KŒ(9̀E\*ME#gΤ 8vqk@CSͥήy 1 H)M\8^{+DtnS/S6%l.SCqƴJg"96AUFDR|$ c^Sy dv<=6+@٩#;mA;XsI˘+z 찡6 Y_uR(8^9$c\<%LX5:sMb5t@%DŠ=(d q"ʗ ѫ^|@٣8fl{'a\3{ xDۆV) MJ8~P9RU5J싽EANؤ@A*~#Aφc%* *; Y"lHЏPHlԵز|ծP.~oSm{DPG*4N<78tl [l? !tD+t0X$8Rǂi|7;6Nؤsn]FtA|) A5mv=Y <E Mcagɉ˄&n6 ,~Ph<,~L!Yk83J\,!t'M1UMGoh#CJ^+rUFaÁbEkwv{6*qP'$[.YP6GKǞS>Y0hdS{Wˎ.|4<㇮'BOZ{lq“ #y k#mUZӨ=tֽhmhx(0` zl'V3x<0YPU)$|b DP,E6?,x`WnlXqR@`t%$8D-J3"kLd '?1.5 )|qNvo;n`Ǧk{zA @dz<H1Q2{*nQ[+O~N~dV=zȥ4H[+Y_]$rHhh] {WhȰ>a(EI%3IϊUKP\Rp&`~B|\xd0[Tc ٨`*AQïdg۟y6JGZz%MA@1*\iFd%RcE0 ӁC;8(a^EUw. 4[?u <*Pd"YU"5(-OE* {flZi7xDL(q#`/MVٝO>yM'%O ̀U]Dv^&lckaw؛Pg [ȕ#PmۻV#1wr6#Mۼǵ.%vG56l1?fT . rbtW$c7(V78z([h~3v-@73E5h跠rښRmeL`M ׽t]uW;cdPQGwU4W_8>0PBmZelel vhlVgU6-AzO{d*mq;R)*ʠ36IR}46˵GU!#D֐->aa2G2<;#]W9R1>Om$ oH0HM0?R#7lZuFGfƹ1_+Ƙ^}o76r;&oyoVKRB5mjÂ*~2㖐ٻxGE:eǤ_H t4KܻTXDŽP57}F` _0͝#lI>JEu|tkq%^C{2$jFk7>Ήhʰ%Kʗ\s4hӃZ+]#!AkOc'a]iCJe&F@W26]ZR% &[}&{>cG@*A{-zI kF@ӵ;<<3 "YZо?bOpl=Ʊ{lj "F N(3Y%*!8cJ}Vɝh3"G!0.vƦ Q5t`.1=`1Ou{TZ=4.7b ̭:{*zI"#ո#D=5zK/il75QB,g XjYFh+l1|?wƶɤFP9fA7 +WqI^- O둤k!?FoL$c밎!vw{8MSԣ˴F^Q m~QAC1B6BjՐڝB%7_ fˎl F__ jKlJ*Сq13L ;KlCd\JAIz;c dH>ɭ] g+EUW!9:2AxCW)c3^%"JcBGD=)"XV;6@E}pf3 ε1",ֈ?^+4B}";eFh[w%T nL>wgȕВ>ƴЦOPq3Q-͖mYZFn. : !a`AX =a4mL e c :l QV=vOE2h*Zz9IwYG@ff0><\8+w[G&XMП2E/8r3&d,W@`$dS fJt>#2T1 5> %jGL3;J@B̏ʛd"A["\.P]?2۴@g$=c0SMocDN&]5 cee5Hc]|T`Bd[ h*q.nس<#PvԌalǪip1izi%! =jй:0ڷ \;>Gx@8\ NضtAx)ԕH].` ,WtGK0~ G>qya 16}r} `"WE]*`٫r,N%! {%)1*ĽB0F][7Ʀqzh$\2 aC60ζG#~e7 =2Hv眉!WRglgʷ \pø†qyM 84>~J33Le">l(UCCSf>*:\A iX M `_}[[\O^Dƚ@!3 do0n8#(H!0F0”{-7|0R>y̏5zl\ 6YP -#MPҿGR8̡ J";FJcYE*M* g"(ԈiP[-9PA͐rC9ܢnrY#_O[ o6&\> > xcc\޶Id؏P;lSWW+G$Dg,!G͒YUy#bCD z 06!*!#^-QhL(2sf(f؏UHlBW* UH)I()82!z`{6ٝ*4;PǏh!u1d>#g5O0:0 P=69n#EHnE"3pt`*2?:u,AYC/($[#qʌ=Lv]sRzOAj^~=D c<:M fk&]C6kN opm jr!Ix&g-A'.( Fn;PBvF֔x GNhyAm23n6Ϣ|*2+:3=R} ٨TY_PCFѠ?v6"HnM|ϚYFrzl` {$PP\W)9=fkv*spX D; ’TͤAoB J8>˗fd%oB0M%5TXzYPdT:E*½"HRGAG=P9“z$HU"@RB8-Y>1 { 5#ɴ!k!x?6L2cd6I"L.J@MiЅGdNjQ"_dJ2cϰ^9=vE< q[˜Jh[D=>_gR/j WsP`6P &c !! 5!'sdtBT#SAn4ICCn`wҶb㧀Ok M坏rT?㺏Avx | rT˿Z4az À36<|Vt GEf7ls(c [_X F)ZS , E,Os 2Q˳l-o]Lˬ~r\a pSkɥ)|:c^A0Lh5=^<-&c3ԦiRCxP6yP79VP@E G`t&Je3y1 c 6Etb4IǃK36DҸtvӸZygIJ3^h.<e0^P-Z! ScM.)aU 'Byl+Q@ e.ݍ%5μPDo AjVgʕEpنǙX[ncl%cw*hή-O`YUz8٭an)m4BBؗ.i Y;Dh\QiOuvؕdHc7m.z/ҥߦ͵O |76BB87xPmUmC !( M~W#HHcoE;)q_Lq'y&k)1QKėA5)ˮ2Fc]q'1=D|ly#C3&ٴDžb'hrfW+TJkt/bھo[S2U[^ŵv~0y0#x-ꆀMM{yu˥"P/h&aJLSS+4^\W6㖛]dڲˀk@ƾEVeF)š?@SvGpݧpė:#8c{8#0 سdtGkpYpƞ%S#8^#̂3,r?GppG`gɔ83׀#8 =KOGpGgY2~:#58,8cϒ)pglGpfA{L#8c{ 8#0 سdtGkpYpƞ%S#8^#̂3,r?GppG`^}闿?O_>}Ow/Rǖk/鯊)KOחE=W/VTzNT?u<'d,E7D>~瀫C_˛1Ҩ/r)|?~w1D"[&? yQQө? }*aox:*$nGNjW/3c攮wMSIdwԷ^JUzO1d\V'A|;{\f}R<8/?&~{ϖ;Hۿf0|{Wol ӏR-~>ߛK:YhKϧϟc_>~ ߸dUXUy?ѷ?e̾ ƳzM9gC3O?^E\3wE *6n_,qH]ei^-S._Sl.cF|_zpFp.?sd?~|Bu=%R%c\#7G⧖,g{~.߾K^J2 #ojs3Jr=m_ .ϧ~XRLJM|tGGRO4!۪>?. 6L?S^~'ӐZǿ|qJ>N~s>}n@Ļ_g{7П{E;ZOOx|d'4ĊO7wF`4٤/dpMۙ4M ܢNzdߜ>U?ixEk4U_2 !bķqtL?}:M%1vv4asKγp' ŗ mA9c( YoAާbBzI|ؼbbY: c39kD)|ay߄ov kUeجD[ٌ^JW[e:}_~ 9^x܃7;kqܽwOSՏW/7&WB3O{(>5r~Iw$L o }P(I|Tk~y-U6%b:}$nZw*ϿMN %"!"k}jpO| /(^0 g[8CJIyÎ]?7\ۤA}Kag^*=0E0D`M: >LI`dB\Ÿ ) P,y7ЪVG_ {-|Qc('Vzoɨx=Mz Z *݅}pqS3WĆAlj%+[q+wV>- ! 8g׃ㅘyr5\F-sJ ߟ7BbFx7؋f$>I~ ϗ F5 h;[{b/\ Pd-|J5nD,W}y3ƙsCY>BX |t{S9>>vς<|ډ/@cQ矁뾃P9n)[RD@:YS^a^g`S:W?]*w~p0|ug.>~:[~eQ ߽aUrUKzBt:\+o (*jg셚/ D֐(j.++p!IJR=K Scx5マI(;#MV WB4QHCx[TbP.Me} 7[lEHIׄ' CIDATW:Tߝ-ƀ7yr5ll(\D~%,NyؾrHSEStm\BjaPn)RYe]ܳyu&L!_Oh_rʶOwޟ~#-<_ Ha1Sk^^FNFѻYLj'Ȭ3WsϪ/R?d+f+ kxj^ict!_+*jKؗ q{Wͦ7lT( ߁/(4R*`?/qnj{SW`^H&3v zZ!w!̂=t^p\;!twIoO`a}wC~|{UY5d$C셿7 .ˎ*bHOЩy4sZ9 ~6YO}s3eH/o#w ":$c_ƹ/ ?opeǓ(9\|Sew& - =?]Js굏2;eWk%Z؎Uߠ?~:N0%hD!Ldt *d$q&3dlIˎ% xb$3T ]{/hk CmB򭔲"kIE_?Hܟ?>!6I'؋K8?G1`4r eO/$\Y)f{j\(XwJIaO RDh~)ERM7NV\^ϗ˟7r:&7n?e/I{A1AI3)c|淗pT8cM3EoD =@k|O`m0Au6z$c60e/07rx-Օ־eY0ޝL)՗;fM5^jMGLݫryo?N#o_e?=h7/ݫWD5fXc2- O(" wNw}Yf>RR #dCO}޺?cP5N~yi2{K @+"KRˈ#/s+*w`˟3>ms)O?Le~E݇?[Oߐ7 ^uو2V]*ԳKy܁"\:|WB}S%1SHs /߯*WT?/xLJ"woEћc5?>\~?HBԭ}K|A_3*i*netBFwB\u1r'Ǩӟcs͛"2dD?-W^W ^/} ӉK7BS4EARP9nyƞצFS+f;ʖuwݩ7W1vۏLuks1~ gWz}\LoO|δakj˷׿_ ℯ=rqye. # "G7|ZwQL~ Go˫'~0Lw:,薖?w@c>SpQkm|^L:b~o|^րS\5OSvcV&(g9:JVaE!ToѻwvsbOX YƏ ~2E gG5. zg =6ʋ,\83ml`Yc_f:vZMa*}-c| fO۷E8ETxS HU 滕͛:uٲpDf:o~N2CSשUۇP9]s0?Ҥ潭M{ϲMvv#\9[QUIНlOm 8;ܾ֯!/Kt4`?G%;_]U)̿ĸwT USt{Uhy[)=43/ǔ^6r+nhZ3.x>ÞaERW^($>D[3K[1)/R瘶$]}<[yؿ7eqԅgg7Y}|xzXF46JM} p{ݟ,n?yșE>Gsx(yVQ@es~bTa+D32zvۻL"nOy,aD(r#J ,ead*0Ţ#ȨOȣNu0¹ǂHqlwv_6T"?`Z7}ώMvaz[qY⌝B_1X| 9zuS?`;E@ DO4auc_[lwϙ^2P p'|b E?/Y$5#neuL*Kp E./աNp+ìB0SZV} Ѯ0tetSwa!Joع^GvS-(cM @ƾx vѡN `q3 O'F?&.ʌ}e]ِ37E0?:B뻸y]ɥ>X0L&HaT߾Nk]}|APaD?ND Ok$2 ^{}!w6yZ$ J NPZ)WI:itNxwbi#ȫ^Bzjú}=D=UҁkU"ՄOMُeT.nM)l_݁ڬ 9eR>ޠmاo犺cFerSS`-l\ [7am[ KPּ\WTA $J.UuGW32/fE奻rQ4]]́CxO0vuL+~{{wQlUx(;cb\3z")qء}2h w:}+h0aFi5a ֥\$AoU ŏ|zOji_i^jq>JI"JЩ[t`MPZ))6)=/ ?/U/Œݗ5\J]yt;|[ @i<(u6<x7|BHߧӒw,FY-g]Mƾ}Sx4&֏q¥ehzH|k4dOU*UNiG#VEHrFb'H#r^&c_Pdo2} ?la {|-+9U9<ˊ'p:8uM>74I߿DFBR"c߾j"d|.__-6|Sdz\)"]p|zyvw7NX\}\|FϫS62|Ei^o#6eta/Ϗ<tؼ䷙jtd^e5)l_F}-/lI雨W_}Cu;lAB꿖񔂷a^vo K1w$B*a7wDW Tq ?7xH_K_yuJ@uv#zola{{<_.6nÛxJ/A޶&S>a ;d?/ZLMSQ]#Apf(MaSVŬ ZQ-tiMUG"UccҚwck&;:^qӷ63-4-fDiWG]I ك`N4PHuгOɝu柟H SQ6ib~t%^-}t+9xMTX(SAclQo S쟤)8RJ/d/?^%Tg<~$|>}(bP7U~PoOq},SQˑ;EevpTTѭ?Wrw鏸㻼9XrGlD/ѧb/ ٧,C09'd{g_x@>uffe&3WYm6AUqwqC1xäBBdnY6Hz:}6."K_}&}, ])Ц }u]|7?S5!/uk溫풎?~z'?n=u5M,x^5T*="|N$jO"~]{@[3.qQ{ ma>Ql|y_KvrSϕZOU(ߙء'5/1·38)/AQ+` /ρ~G@%߶?-_k@|~+XE7 q/\T۸*S'mp S_ ')_7xnӟҘ(lV}?z`޶]C} PFO)k*ڳ)*gwyf0eJ/) oֿ]kDﴌk{Jxfok0JЉR:;NSDz/+L=z4WkȬȢ뇨ѼQ"܇c{[R.;C>O{-5.W|ÇA3z*ZBP{ )*uYn dV͝}ħwb61f%[tz (fu xU}FMihS_/c p:+-׳!S ~M0U^E~rO~aͫ>^J2_7@I(Rv&cl JZb{_6})hk8/qlPG:q?5;7_< 1Y1v-XN"p8忣 | ?2ze_t5zO/F>>mȣ'_Z-4%?,~]5A'/<'˛Ч/??^>>}."U훿33_S˗w̕[OOkgfZ} JS\\^vT˳oߞO2_>}~}U]&:ú>~Dz^T|z36h>}׍n=Nj&y)Oo^/ѐǟS$7$sa.sZ[ꀌN.2 Z_8zw߸g#̊3sGp~{Ď#0+سfvC$TIENDB`n,UF|K_('>і˜6^GH:Lf7-_wmԳ[m~}.ZN%6x;I=>#|] ʤO~B[ J 3Mo:>a {Rǵ-2OzmF1tAȥLWH;5^(~ӛބ~otm6=ȇ# ?׿/~NLl}E(RAN+D]zWgC]n;zS>g?O{XesF+>A:C M9xGS8q8x Vc S,-oyKFB3avWk_ew÷-N|;gUi\׽Nvb؜S?8_?e[!U0<VsO=ߠ|ޖ2aiysP a[outiqk +7ؐ 7@-X=(LYPQ;=|i!5!vm Ʒx ձ}{p`yqHu|E"%\Wg=؜zD=lS?3,_jTs JQJFDw4 X>:d.w  im{#'g!mmQ~ 'gx<ghD{lp0=g9o|A~s7`_W}QlI Wua({XqYH͍I1p^a WDs"nw;y)V66Ɨ5L=Px= 098e]fWwb u78kbD 1o.=G-'t#H#}^yDƃ8wa@!Ł_.Z =# 91.?Ow68E3VtQl||ҠDxnJDd<`;\ن/*2nFd0H햿>~%&1 9XH`=Ɩ;ˌyE[y~&S,1DAʅ@F,g%FIKuw+L-lb:DL,GaJs*CrDoŕ̜麸Qp$ 8 0WВEK AK$Z)n9&aўk-p+/O8.@I|SR2jD^{p*ǣyMCRʘg'JΈ- D{s~uKD[~08L2V#}]PU(aG8(% ^?dv!%cnuб)Z2[}{)P;$v (~xUA'rrZuk֬Hى?~)ef*"ḫC?%.-|q2)OqmY*5Nm0!MU;:tdUSu?AzFJ~m|JwƪLpeЏ /@MB@5f.q4݌{/{C\J-!BtV|p"}!ym:a^>SU$B} {8 uYKRܡ86 NvNv꘥6da]4G'mz ?y96*tM2KR1X׽*w_bKU0%]ZX]kC*ppYYoRcBXܖ7uPۚᖫep%2$/“O~ \fr)Bu=nYRlR&agqAZf ֲbYg%qy#DrDt9Q~CΩq%?n%,7˖҉ pLǀ]tj{s,ɾ,L zF[QUKbtwzo(h.!j@?mj h"88*Pj =XT3NҶ-ыۼDx1 HؼAiA)pm8?Nc7f>hZAlϭ,Vrw㓹PsҭD(ۏX YȠեJ^m+7&emԧ>5|]ƒeYhI慯N5Sg=ȁe>qs$u2&(! ! Lg1Lok2"K΢0YBKbP n>~,oXu><"BG wiTanGgj9@\%v|[g-()uRҧjA)yc!XfrDB]  cR맻ݭcwvgZ)PMEKeuQ҉5Gu+I`hU6=*˚ `Ȉ>>&(m\$(u3"X7jZ%1nsHr0qQH%IHdPTvPoLP*Zq-oEEgiY F1EOUAg!8+9!%i2(mC N] 7J7-QR3Ch P(S6Hz% ! d3nf06:ZqT0Gp $Э&ibg. s&AϬ:g#e^fwW;xGOSMUлxFGW /代 bEX5gV/]'䟕ͣ43^$lg l^?&C_) C-? r|z/ lL%˙%^G:"Dr"4dFb4P"#͞ 2FIsJ=h Dq+o\6/iBX9ȡdkfqҵI\,G=2<%1K4S}1ZH`# 6G^͙tz ";qJ9_S9($FD_BreDQJ͏_B1 h.M.#J TQ=+4{)qA.;3v 5j4 jP&6J_1.I0ꦻ2_O|Zz)FsJg=+u*Ke^)3V(T,6V_YmzDyȻ ![ JU)Kp XefaP2f -u{ǜh3WewJPR_FYY%D89)9OuШ/C_,6=YG֜^$]͐_Z99u_ԧţ(;6[ŔޥѶ i-%ځEQLdwAǻdtzቱr'eE b/X*inJ%˝tK&;BcƳ~zKEKb89~rNq`xh &!m<:7g7Z(qnd/M EUo5yis }RJ-6Z;,b(!mfdYA9g&Nͽn_JYqĵ Ddh򑷿vorlDW1W/\!G')iޗ# Zi>'>ZFau2[ =R-}ZꋈƓ,@ 4iJx!E D/P} </R84¬P&v9 bMLĊVxAsn:EpGBD*?佌. Joc;N "N7"C&#Dv8z#f\^q-Aᶕ'R,+ikrtaۀK9iKzDRPpa>]bЄx$B_y38]J\|KacE'⅖NE`vo%Z0s\ qHHj_tRmԃ`={ӀESZBT54k]Za>#D.G DK'pVі20=de(8m(98% utۂbI>R S΍X/w*@%.^e|\@qb2{<}7 Nuz@CHaryn:@(s;!4b!*.?40g {![JUʚb=9W*!Vnk`0Jي:NWhTvC}ɺ%퓠9ѐ$-8AgF` R;`ýlUZ˗fZM8O x棍]>]``݂ @)?"R_{ A!*P: D:L qn:fɦĘXre12.E  ;!>oF0AvlfI(" a .%b^r> ]Y+SY.̢U2!{hNL@ q>\]/eK۶q.Q"iu#p]Ԁ2ZV֮]HUY΋YxN%`F']]VʼF"B Jc,Sf‰H*+ %9<YX)z$@!|r  TmsdRSZe0Ek#Zm㍠l1agFWo{y-h}@?u.\B|y#+MbDVCӣ0t *Ĭ^`%SPu%,+Fp/JKe$9-E!ʥ^OˁiNőog^у 9Xzq̦ ˏbck>%:ȭ= ř)F43n14A z V@@!N ?Z!4Ǻn72jv45ri Z}>;GpLʨ߻? G?[GvHuEd٤<|+.II%~ IX´B-X3w/g~(F& *Gj\u9X=5"d:էC՗INQ祻ѭ܏B"1^ފ/mL_z(u!$D2ioHԃ8nL'c'[dH@j _6(6ߘ nW`m`Ĉ۬||Gay! f*Gx@eј{8CWCNjI]rnJb3<RTqOH;<;1ZM(0"ЇIoHM?m):4'jTAiYZ* /盨9bUoڸ %$|ݭY!O<>KqFD=XZ+S )a+DUxuJ\څ p8d5]&l] {0Tlu@ S(QȜ~iP8Qi8DKr.Iـ bz?]@ϒĨDx41iФO֏C J!KtD+[ÍR,S"C A-X'E>䓝WL+lfG'#l+o>OTUbC'rZ nؐu#kRCAFG@ rH'n}"6Q 4C_B˯aN:vm,kI5ވ $m͚5Ƣʥ;koFkfYb兲.۩G[qŎ\+%$S9RdO ^u;dž(İ5 okt!g||xXVm@aN<M|# tH7X(l(BR/ԁf觊`U~A#v >\FрB  BSlvoj,DSW9U7bf_BIP'x&j0q$ c8,9kËNpqbc0]uY V'WHavq/'1mZnEdZ^>SP }Ãr8B?_Q.S v ÐW` &*6`OY(YN߸A|56`"aWJr9 ɅpT_t1QA T\Z Spdx@Ne7/~9&@k29)4V }{OKem)/]81v|OFp>"\7b|\0rq%pxS7bOfÞ#3%S»Ɠ#S%@ɂ!.C)zXdTX!:5Cwx6z`=:HYR\FPjzRpY qƺBVSߖ!\y6dq@I.C(C5|]A$Ji=)I+%x]l[BOq@9*VRaemA)tͧɋPxQcWuG#y!n֪,wP+yxOqtmcowΛ_t] w,A9G,KE(r=URPANxOe4S#}G,wΤceľFbZJy[(WH{(,q+e—2o pC/2; 2g>d@dKAJGorI3?3fYB| >vj H7gM?:R:˩ ~.bHп袋~%\~z 3]~aW!oֲ YddN%v#"(,bAh<@kmZY|G4SYTK<]TI"tFUr",E^rt=jHua`$w fmKIO 1Ҷ-\pjn`#sAm_oOAC=>碷!RԴRt;4Yg}C'I!S1G|A ]nۓro(^y#{5q7f$%7B4؅4]rWXP8A\=`l:kva4(ڀMVT."G|6_c8NO#I<=#JȳR/\<86~-)f9]PRW:#a)"h.HYtpտ뮻r+$KYNAʏ][lanH8޴',/1m5):ϙuuK⣮P+;df@M}Vx$.zhfE/!/upfS%ez_vbѕS ՒO@F?Yv؁hsʀa)#%'8򗿴[a;ZNկ~5nwaLt8%1!Ys]3\ܤ ¡Jd(o "YdB…ۀV2*g-⸔#{klM T@ A˹KwP.LkLaB&VֹDoTCbm%~Β5wMXQiX/R,[Dn*ʱhѫ J$)YV$@"iDjur a}8πEY&^Q:mZث/)w\/$@ޝ(F<9@H".6bvBz{(PdAiAI@tcI^+ۤ7Khx")ETPB;L];%b!|:z\>, !婔m2 E=w}(ܖ[n9"oq߭C0,J\g.h|Qb-tu3ԟEƈ Jb'ҩ\\R؞'p+cDB`^Z?"M+^-i"0V|;NI>HWu񠞓@,1wԈFAuXwo?*c FQP; M3wMP9d?9BH)WCREMkPW5{G]AiɃYO8<4T;od7d hJM3^ixqlC&QW-:6[{*Jɕ؛ܯcVN>d'(Ų9y#OTc=74 p2=|Qu"%+fXWDbϩ/Z~!J(hd8p[f[p Pǐͬvmtu;=3xatp|z!K@ EU5k S&uտD܉:q\XJ@9cC ;R]M(`eX0GsSDU^H)dDQ&YJK*+F .m?-*WȣKP6'gm J(qEDu1P7lի9(d- KRgysJ BSTbȚhQBHZlx2DgK;bۛqL4ʛ9 6 冉=3/rB٥R,FkR7504K܄\VvZ {a|fKQKe6PE%!4TPJV[mEmfP⒲R;r7r !!'ir !KW\qd^nʕ+"t>`!HŶ=Ω ]n %4t}LcUv$Jhٸj,tKgSF*ƃ^ 2z3hp 9YNἔ]J1L pU 5˱- "6T.P>ncWE}jLNqc b5=yNPTKXN JWoÁPt-"/:&Z0EleHgW V EH2ZTl8Z7Q>RHȳ I!2(7]+)ݴD:}?:z$i!. N'8?`jb mmm ---`2F#444@}}=Amm-7@uu5TUUAee%TTT`rPVVPRR PTTPPP:!++ 233!##!-- RSS!%% !)) !!!!.._7h_—/_  >}?‡;' o›7o ^/_BHHx!((?3x)>>pQ+8r>|СCpA˿K8p߿{={ݻ=ڵ v ;v۷ömয়~wuVزe l޼~Gشilܸ/6lׯuڵka͚5zjXj\VX˗/e˖o[Xt),Y/^ - ‚ `0o<;w.̙3fϞ  f͂3gŒ3`0m4:u*ɟ L2&O &M'„ `0n8`ر0f=z45 F #FÇða`С Aaп }B>}wЫW/ٳ'W=z@ݡ[nеkW.]'xxxVFjT*(JP( A;zuS2R3Rru q8Pd)t̬4]rjfz~ZvzVNfNnr">WG^V~JZvFz$JJ t٠(Rgq~VvIQ^j>~~œ₌4]n"dJ|*.*ԥҳwElyE|KivQNvA~IAbW+)gɢP䁲R{uEEņr@l꼂"u/.(+.+N/+a@iP*(0!\s2 J r J yR s K rrʊpy%J>ۣ8? /Ai4P_ZL!"A!rbCeiQ!r~/ %eeeREPPX^hyJJeuyYIE5(*p~=+ Uj}iPm͠;MP+]ӧlw]Naq[+ڎdy=).a#Z㴬8EJ!aomlKn:l EmY<V+ "( MHJxtJvfHOQHO%#, )?_dxÁB͉ic>NIJX|scN^T`t&*5n[x2@sFeƉJDF#P9AC`G=b]Sv%Zs$8`u8X] ضɮȚ5458BqeKvO鐶|thm)#= ު>Fˆ*BԲioJg4EF;%+ܥ7Kn6A_RUV^]PVP65Aa- ƪ`^166W7Vk+нXWQkkQԁhTԃX[ZcMclo7T6~[Sj+ՍƆڲPBcCM]uM~4ԔW+NE#ú P׈!zV7UusZcu5U ZcEm% eMusʚښ*PVBjCm]S+,/(-/.)c\V]n(-/+/./ܠ<ՕUUu8+RQD2ƺJWm J#2g]Xo! ]P߼eNzVcjnjlnT4:^aUu𨭩EWj?hȓzW!?_Un~/ʿq_m߱$e:*gIkzʿnZ(Zcދ| O~OIPFOe_(NBT|%&fA=hQ+tgQ3[L[h=&C}],sގ>'F-{r6ܬ%;V 9K\Mƶ?$2vMkX/VSh:^K3j;(?0E" #o|EWUW_U1N5D\6lЀ ( 7$10o2>ipƙd4ǃǩF ێ6{ж{%lFJՇ GΖЙx+~Vìlmynhǫ| YAYuTkeO1#ӗA(%dk3LTv3[Ab牑s 02]gnPf; O*L.p0G(w<9~{%?^.K0/w~Cng϶65P,b'Kg|g)߂yy}d֟a^>VZQR\,ܯK[g+@p;dҵ%O6tnU/r \}D4+Gđ.=2' /OK=}*P;k:S`e$Mp!-0 K+◑ͯU ?|fQF:QxVu:RX/O;I3zHytmN\3 zݱIGxanF 'ϓdZ'ELo\Ƴ; aݙ<S317~pd೔`">\wFeCàǏ70Ͳɮv |[a >88s^|J6(N [@sRW>d&!]fqmCw7>_SF:%X}E3/zYζv4<'8}o?2u9MuI u\bx\~x Q3|f2S@lHSf |jp\ƛ*v`<7Vҽ 'JA(]yBS=Du[R_BmW|Lܚa䙎g;?:p}LwfTh)sW1q4n܍1[dCOpny|}ѓ>̾aF6#[ {4W8~ bG520thQH۞@~QP֋fBKp*ssXqa(f@CybSB}TEi87}x.=͛HqUSY$B|@(![~'sCLF LkiUJD#zpAXUN!)\BϠ4{i*tǻnٛ}z~ a`HꈪM(8U~ux8E%#EVXKx0nvXgA[7ْUKOs|nht RC&wxsG s//yg; _[5 )a^>r=U2uE[g@a0Qc5.[)([\OOA-Pvdw1` QJgH0&oS9YKHGmqe; }Oc{S 6wR7<o+CIŪh˪^- )kysGBV]!y 7e9ϨQ-̻'Dku"@ f-guI_\ɿer$;R"4tȪcٿyMb{h_qշòfIw1Y@9y}uc.SK϶`~ q:8G@mSz8Ssd[}AZFYO@/2u:e}SLSi G'|^hf33bR1+k/:#ZO/)NT,&a _?3s}c#U%2$h:^A"5vl@D` eK"'ؒti}ܺ xZ+C(?K -7ŠPkIwp wW x@#&Gd#3xP/0[YԨS](d 'S{Bt䲐~ Sށ;-Zs#l?S\ađ+w{?WWkgH4U>fu4_CGԖDCߢ0'Z:L3@ ˭HZwk?.N?ucDZǗ?JkzvNX/o9ܾD1d3:Z4唔CZ~\Mҍ+OP^=A5 ޝ6ǴɔAkzyrm3\['}1 z1ݜ1bLcFzzpmSDښ,y's=̓طwf a%N3![8AJh6>ƙ(m$<.z֞ēbwVz4: RLF۷϶מ]d VGzg;t4FGmXSkqe^_QԘ܂36$5c4͖W@dUlWJҡ dM''0^p:;NgϽsY&"#^H;0fuηz:K=}xptL{V⹔Dm3Kh.tlcX=g$g5/]ao-CK]m, '̥".~$"9y;/ʓ:{>Fɪ^5ѮWc'?@ck3^j_Evӭs\3Ǎq 4W˝~ Ȱ*4I `VrX<< )Oνq?q6ywj^THhe41?5jsӹ>=P,w8e6CsɟOH5D'OS~O:5wNxOyG@dXcvGxw˗\H9is UM&&)d=|̂3T4E踽Krd'PG|Q~ _kcڵ~#cIC۾DŽbŬ&Pi=} Z\c^U|:x0Jo2 -er^oԩ`,WKԀ:IyEc_déjN0EB(IT#]>G,# y+[25:TU5u;Q~ u3!ԖZJx= CnyK.2q9޻-ϰ DRm9QRS&ޫ]v:3?ϛh s޹Qg3YŢK3eT|Xy2o=)Z*4IK)R ~zuϯ АwhkLY݇g]?45q&ҴT?ui29 lKGUooquSAM&{ǜV֤>6k&OI4L"\6niz[B}ʦ̈́ʋ2vY١_(FSi1߇"ٵroF^f߫]wj6#jy&+p5+Pqar6MrZjMupUhz;f{n?'|+ri#; y3HgdQWXTv5x&)P.(;*ՅQ|4' MF]9utlJ~F]k2rDghFmHFn/g&*6ށYRD͉?jM܏"?Nhb4d\lda=*XHa֩Ј%pOuG;}^^f3LڎRQ @o?Jg 9(+Yfq?-zw!qBV!e{,%IOMYȔ)GUm]=.w@E[fPT{mMEn\?9:UE&.ՎdL|pqfBIw2 ?'fUhNq/VSMCڟQV 1rH0)Qtv9; AwPD$86D?s|T4qbTI6ўʯQLYQ2 Odw}+w(RIz.>!:D+SZR`qN<¿;u8 wWƃ:rUuT;{v&yO0\(qR;NFe^7RŶn<]LoCˉu BBYX֊ yzp#FZX%Pd\䞺o BS4zݖYe^f1O'U5Za&~=pă["}h \z| ̻/y֪voKlw4%cy,]@y#Gŭ0L{!V@ uʯQvlcOi/u݁!:_+5DG/պ{V<^#WUeq_B\gvJGsƲU86huz%w{6r{+XS&:N8*נu60䦿.db63oQmvZ[Yd}0Y#"!dpkaWeQ&=$=]ސӊྏc+h^ފQZY>r~Tkzסhѹ]W*5~L  } b+%;m 8Z]vZqt:$Z=‰I*]5%G-s+ExrQ:MَKdCvly~Q[%# m<*;Y-dd D( } 6Baoe 4&C!Y qO%ke" Z-\wv}G-AnHI&%xߍfi_?7M D{ D"-2&Վrk&sOWԌ_ʅG:5(VRvMH.''?oRBwWYKhp]B,מ;xcGK VM!(8tS Bԡ7 -so |9,gc*y5L|GЉKW RRj*ijbG;D~Y+E4F z|/ \g>%&q^{+|2hwct['pN+=ՠf؁m.Zkv&B>kRL 8m@{*a'Y؝GڕG=ēWW5R ٳ؃N<(& Y+0^󩿻uL[mhm[}{y)ce.\k p|* w~]ԽVs:2kuJfȆS,!khD`>wV#ݓ7D5fN_ '+7D ~FraGߏZj;rTƣS&6!<_y)O3rIK&xbv dՠ$GI.S4ˮ_t%+Mys\|q̉<Ɯ@FѨBmKuxSWyRuG5ģ1-&į&g+#*ќ 0 WɮmR۽ 妬q# ݽIho=rTK yKތ/\4 MUl<]EsiFXMGR;.17#hA9jUفQ6atb؇Z(̂I]cT[W녎dE[CܰA\j?{ZoYun\'UBܵ at5}{?_* ?jwj}!d_k 0I\wyBo<暽h#n0NJ@˘4TZY#~x!o:R3++gUB@Bk/eT#tt\*ڄOݹ6G`BU *P:UdɷMk'+*l!5(SRV(F6eVĜZ9_jO'2&\Jz!F$Bt?!Ԥ(vh|Z ᮕT3TS RѻiY152Z+}狷c`MƵ sQ^@yT<^H4$I.nr,Jej;ޚMxzahDϕiSl[ϴTl#sԂR0!48iy,l1ٷXydM HڡfSrvx ny@!%@>TK֮ZA[U^OeDH(Y@%c+ɦi*/ Jy,^1V zׂNy*8,IVq\$BqrwH!^ԉ֤C6(ZLCFo^y.!dF a仕%zA%a IM}JpvxXPe4X%' Uww]܏V?~{#szp|&R@^IJD첪o h^6X]JM \'w}[}DO`Ɵ$m%Wl}Lc \jhX<_U e2qCzƷ8iV%g2 i[3W2?e?ΕIg@4R!ex.\5 ;FGoY[`L$`F-);]m.g?&*Xi T(@A_&Ňbc82P(0LYǿfK)MCGukd7%|n#i' G>dɄx~ WJՠTÛ1nWrw|PBPHzUql FzWF8c]$7.hUG.Nzɷiy*ē^UX&\AJ5 e6YX9ŏ?D{vɎspt^/$<ݫc QXnuShUBxI \<`IxkwYJty~<IHiIi6:e4_<:`;::z@mJL]|B]SQ^q_Q:Mܩ DA;p,QVv& |QE/:}(K&L$wz㐼dz !8-REof|'"Av8.ia۳LdU2!: t2沁WҨA=@d|uIDYM]3Lm7ĠV#+.Sr];rZ, '/b\̮W! z֞jD똞 iZd6x-vZr*g-&}=oa ҴyPbBML:?s9>zCiěꢱr V5y~iR\~6ҺJ'uEѐAqwxEk?<-.3WzS=*Ci(,Cysm>ڞSwy5$.Q7)/K?쏮OdBV4Pl^51E )k˿zw,-3ٯv鿬/z?!{cQgPz s0;5%Whu`ʬM;P1 Dj@7\Ujn8I6`i$(|Sy1h&[hGxl ˪o&rYvF᭄Q\]״F0iQ$dMD|<䐝yࣣ3.bB\&Mf‘e`n=l }ƸLZZR?J+fFx ! |<8TӅ3׺/7į27Z,zr,s6Y"~y4QS+\_k6bQ:|>dm]voL{*ڛz5{YXїz av=$e,O`94j "?xwTJkcV]{yBazm|Vғ# (}OE ¢XAtJuw+ rg, ݐYKRVĕL>ӘsVvF 2шȻe+),=k̵;t3+ު>=|vugW$km0;dѯT[K+1c ŌC;U%7D'>%yx"d/jZ8=~i:tSr)ks5Z݈mI쭩{dۭs_ ډJ'"א;k1G\['-n)wp>e)Pj_Ѻ*rpBzfYɰăxݣہ'!~oi6UoQA"o)p]@4Q4VOaA"++}eCh`%y{1c??=MPq.6mgCGt.p>Ay,x:^ÿ6m#eE6nOb$$7dUQȪI#iw׶r7>Vmci'O~۳ً^] lMlOK(+ڻFo{̛4oʼnۢ+g/i9tta$ޡq7D -[!S zN:m Tkx&Vn{C=l5u_Ȳj :bof>;Gh<d5iq'[bόa5uds(ZO2 Tk#VtyZޡ;Kb;E@m2RJcr݂Ȱ-&LpE+EVZMc6Yd$*^s`9hJa?$0YT*y'Ip0kvVx VtZoqcDZPn[}zPl$nϚ9w2(Ә_"/TD=$25fJ$Լ=[Q7֡돹fgՖW/|$>R.|m_\[sƊ,~oͼ+dH}69n_PquOpz!;qU2ﺗpϦ{@p@{EynnÕ ʡ"ܔ.HD}V~]¾b)0"~Rnzޢ'5&q?E|Zȇ-ه.=o1/oC3S**caKbΜ;co`w93e%~DNATE|R Qݔ צUMs; lqÀW6a+e[O)/8 y!W s%:Yɯ7þYхټ^3Bx]; ܲo 99)fRg?ZVR5gLZKn-a"^xɾ][jәՉ[/egMn8r.ŕP6Pы9!_`ĊM)y+u4?[vt(KC yu:W"74%S#`ű!t{/TΉEbiO<֑%p~v|dqNJh&6S[. eP[4{]l$>kvq,O: =tRe[CD󔲈gOZmGkd^o)]UpXpZy/{ɔxma0Qd|j_ 6L,a׳{m3ݠ0\u_%vD#5K&v}zF#ࣥG͔N\MԿva, =hѻƂ89O+>3KZC> sZ\kjWߛso f&#: a6/VMű8C،"~l8)VR$Π˙"D蛚EYp/./~ߍ2QUlYÑkIzJ\ׄ υȞǬ.gjcm}? ε+洃; ϋڽ1XFد!J/8v|>: :y_ "*hfmHoHîiV݃i*_6IMe.{KsH&W,[!%`R<;3OE. {,>`;NBt)Hu$бԕxo U<84|8<^[kUC\*5v=({iyqҏQ+YJki>=ūR't2S gO!".(_xNr]}e(/R:q'Z_ m >4#&:I@v3o._|0{ӹ Gz{DPTB(*. ?WnEbfW0?XQrɎR7 lF!U2}pRJ;Ӽ6C fUK[Y[}/ǐWl5c-q4~gp6sypJtU^y_"mjqGOg =V.lrF y}&^;*y.{"rr9/>+~_}PdcVB+#jΞKJN&DՌfh4 X}%z78êwq{K$swgwZ'zsA⵾[(=YȯHd{U5sRs@*\ìR'G K8GNח3E4Џ+(/CSj.{`sELĶƞJu:0~YM;Oԛ[46թK(9hAidi̺;VF ,3~WDERFs:P\>"V9mPRo]rsI -:qU2>ɟU9o:ACy5]y@§Y¹6;'J֓PJ`M]`Rů+Mr)>6u^i.~ꮭ+w-Ν m"y_Ĩ2QgөFxqX!o^ nd_r995[\UfN  ^BuNQ[XNb 5efs~A ol MzT6F炩A|mkr_-9qں j/xo>1iGOrk@VA 4]e]kq^9~epf^.:>#͑ DΥܼMp]; g͖!B/3L@E~/i]ޜW_B4Ho}aYjSL}03)"ߔ8bz,j={%U%!U'nFʠ^rfLu3kNMWٜ{Hz}{3UR9Yb/Ivѹ 4(bN)ML2ms{xcH)C*ܩ^Nss}ێܫ]_}6a]QRVq+fY_g=߯mjn:7a vUɳ廸Z,t(!|.ޘR>zs~ׇ/(u3-$2#H5k:uhT9Cu"}5\n 5a@E_:yb wa.S2y$?W_,2NW/ѹ>s66)~c"߽z)7mUN;* կW(*9\` VV4/')\h@|a5I"˳87-p›-䙆3IJ]JСRڏʑ+bw^VC!+<ཥ}ԉ'Y<vw>lߡu+I!Xaoާk>4@:A:^Ԧ3~^ò-⇤{E_9R~6,Nwh&OXff(b >b{xa`' #뉃8f4Tk_;u-_YgVY[](٪;J-c!a5|7On9MqzP~ϫfXI78ms0ײ-A?R§$)Ii5oSb"{";SśҽvEvRpQ@UuK'‡7W e3Whݹ5-TɎ<\ǪsWi$pU=)^g,::wR}cG"]A8uЗP.xgpEȥLl'俬tZ2(at{)#\Bֵ51ځMDuD<¿L[K9x3 my[Q VAs8!f,.[/xj.Z9u7 :{=v:Gش(>9iؓ "O7fX1=p!t :? [H)Frce[m*uNܯ:C+>B=~%Ĵ]՗@Oloe3mh2ƻhReQ[֒6ᘰƫۚ6!һPVU74EJOAI<&$y>Tx7N|; 3?V.1aLzjr7{V<w ,>Zl/#Q!Tb,dIcMB"T3)e? z$XYRJ2yq>ފTsPsvj'4.|Qh|fײsM5Ϧ㚚rء VR}X0#U|šExxf >x$oQ1r7}{^2\(y 47ָk w=neiNM 4ݟq<`ۧŞ+%b;Lb8:n/C]Lgj ZfL̳n *+N}7joyB2a.4?}Fq]1$1suKQShZ.%V~oTaew?90M'=>,н{J\ͫ}lxIn̍yrZ0B`'Ӏ%X#NOV'f!;Qx=Oa8kMTAz? `/zb08ҹp˰[#_Uuwm$tA:C?Q<:ƕZ}:_ƿ`&-K֯4Lcā˘3'^dgO=ngO&HTїMX˩f<6VҭNKҜvHoQ8j)>!zƵ7lm5dp;i4 WV4޽&iI?)%_ZJ+f}a'*qlHHlρ$TU-t=q6RiXMZ(mS8~&Z1y89e/kr7bޛOyӏK$-S٧xz'iG 9^>|7XtCR43{ihvɿw|uM-PC_ ,sn)jG?U7np8ڐ/8R=nύa)۱;XڊXyZ50R_LC`:ޔшOT~~w'ɼ95B|{B荛nQ8LQ|oyJ.Al|J$[ųu.mFG 1tbyO<a90*Y0w@R\J'(Ky_˴?`uɽɛBx祈h?w KES8.X:ޔcc7đ(*C[_HQ nXfMٿ d!OVaݺpԧTqF+ 'c:{ y[ 6g ~xw9?][Aqm?80(>sMLs RγúP銿5qr縖3]f8/ڧ5XBqҋ0&;,ϠȏXS[sd7rSy5lf[GlM;Ltdɽ\O;:?62)yc\̪ةJ#Y[}9݌Y3`m5άXskqZc_;s&VTNl:UoHM΄'13OOM #rTN1[O~cfG fdya DFI>wwDxm/bfQ7nm{~*>s܉'ȫ CNl3Ba#0'䄋w;,gu_Bfm z"~$Et@c/p)r׬Үm0ׂ'g7<ٶ3DɎ{poImrցؙnhIVJubH$&| KkP*/gk]Lϡ ̮+)Si 셍cej&p2|t!&l>g]k[h_0׍(dUyы&87giUUbf"@3RO+e[{fݧE/Ư&ȍV͜W,`rnndG1'ߐǶL3-U)(WXEU5Z{r Vq'~{6[D|ۋ|5\z P:kqC|r~IxOc+?Շ"Z:GZsX »ޖa vڐ_Shu_謺/f_]:Iy9:m^2:uh'rug!!3:虎{ C8VKOվ1xfHF>*#%q[DM9YnγAK{C`Nx8J-~OKD_V~6tK 8cuvJEzh~~+4;0 Ƒֻs܎ ?x.R"Q&zq/|8\WqjրO\=j|kꨚ8>gêވQs$oΦqKܻb',m<|j#({Qd£`AP qH-eܛ8><_?^@} kpVqIlsl!rFaO=̡Ss\ m|ð~Le'?ztU2z^F󰿔t&4<>P"7U34kU2̂~w#xx3GLppy(!zS(Ks_{ZO0ۍTꂣFܡÜ ]s)6#[#n.% mby#^QO~페bk- ԰.Bǫz]xs?L3m 9dsf^ĭҩ;d8r6`r˔56=2x?7Faޤj–ݦ'@JrO1b<=>::;?zuc@0MJ|x8t9b'r\@n!QęA<"qI#\;\.^ ؄osS ؽAjѺYx\u%Wx'{7`"?]<䀨ȯΘ1V{m۱z^VEh;mQ#3U) KQ#u,\w&LN\=xFo>roxFMidSI m6顝ćocj#h {b}艕GKO`ńn5 SSŠ{p8oQ,>XrFR4pެX`D(Uxϩ5U'R!XX {xx^L}E rC<ǃPUq̟hCX8S"/ni4K{` '|:uo_ ca*<66I_<:0ZnYW봕|Nlg 6Uޫ#^%`Po9%c|hH1 XgQ(PmӞ=3w"n..>qJm. bc}A9ćPV$QNv;vm_F:{tE.p+U=ee 3\^qmh{n~]|"cz~Fh?FGOu7/cĵ;uI-t kAkw>U=akz Hͳi5!^]gO\̯Int N@0CpOs~r6.GB6=])Ph>σq{"TT!jiYM ?79hx;7P΄ ?bAuI 1EzeIڊ31,[ZZ'YioK*tknKx [1OW suVꨔ5Ӯo!|"6uq3g56aW?y"ԁ Ft|R-9<">\zeNPAuAS"1w8\JJ.(XUyD'2lI(.;jnEm xk.BI!NVyŮVg@, }װ3^+͏(+`>Pgaǽ mA|1tu!ԉXbkݾ9ɜCq獔. ֑u9S=7:\^ڇr;Z%.)Ht2JV'+(:UνZ|G;7c^Ϙp+Z׃&Yփn-*~X΋ʚOXŨT5MkDҾW~)mTMW%R;mrITG`W#m"@8WXyV 3eԒ53mitVV{c8Z$}B9S&d`ϵ 8夏\ZYjE%CN>yʤ1G{ :cPN +}?]t[x$$:Z8?cEWبv$mEYƩ 8U6uڤ-$ ˚TZ/~*;PodcGEg=9.x@Bp^xc9)j3"ǘ0ws6l/`w r"|zۡ܇&R\d'}v.sgż wyN.j؁;dM3T ~ x}|+6=8<%w٩D}7!K!fY}␄ZG6:֚3f"8ow󓖀Nw47;fe+̥ͶB̰[}3_q|"ַu,wIv=rcyac ff(0}Wrqem톸n+҉1uMٸ1 gKJU ,O-ru˶7%[O/YM}&~q}V#&V}Fl>Ym]#3GUy +;@YSWl_;)sYGFo%K,{@0[{.1˃Lu@;z3=Ϲ?{a,wD##rW@٦e\PDQ'nzߴf{):98;#L[szIVawF[ಬJLѠ@EvtS׺sPGJL/}7)^#̭E(I1 hx/Ǹ$z\2Vt`-u#K7|bECm6>S8%OGCE>}|xI h0\̫lLet}@X]GMCX W8I{Vm=q;d71^6w[K۹3g LNQ .A\gkG׬tJs'h/KV p4ϬNA/ CMј?>(znJJoeK៎˯Hy!a,OKGz!hzglh3( eInюU{e7_nhSoe`X |>ڱ[ԩ?v2rŖ:n*)r+_̞H64{]{G3οj,;g}daL2aubKVhA_UQ_9D%2)X> `'Pi(?7k N!/9M λUO[,*ו4_sk t +ʡ F`/>GmWz7kHa4 !gV|aa:(1.R28Mʾ^@3HI^[QU;WH"ckIp(1^us6lІ}Y-8T;Q J'yza {~R;<})]^G\C@Si;!V6)\X Cpbl^eٲG8JsnUF?\n^uxB"#V*[ fv<.7%Er;W.5_e0=egXރgX*wķαK6᭵r !ɻ?f`e0p&^H"oETb!x5biGU?֫!\a0^U_סOĞY8N`o-g [{`vs<o>v<XQ;4mURE"up=Ll*X& ^lˤ9[.>cpݮ '7N33{X7e_1}94CQi…4 ~<;հûF/ g;ks;?&<}g kG2p*~mZzz9 @m]t@MQV^>g# M֖ss= &>?͠ޤQ>ׯQ9Li޻ \WdŞ dX ~IZz,W_)ţ, #[>p7ksyMEώ$9;_ZO´Ay|M⹔J:~; c0w|^ ]K7Ǯ*fVH{9%oϓTwn+ɠ2aw]W,r'Z+`lJPqc8hNgW{~i'-c G:?f\λgH(kte?|$5lyNZ<7ΆcOcÂ6E_<{y<`S*3ɺ!r($DgXBz Z9V[Y>yɾPMlYq>.:']GQtD)2;?{aٓFn=|G?, rIVegZCֿxz꡸$"QgHtiL{m";0ڲ>א`,NW ]됢鿸.6~:mݻ .K/ji"{uϭt۾7htnD(j V:7f|鎌禜"eFV`4wW[5I4HoC[k=#CLfK1d:N?j~ԽvZ_]lU AUC_=x|D?UfQ= õ}z>^t=I#eݻ}' yVp7A3b!u9zCaPpT26w鄫^n縘pߒ%(exyj8?=SYg!74F2d3N3Uwm!*r@)bܳ!ltjzA3QݗϯNϭ;_3ہ#fTӋ7tMOS2EhkrwxJ1^TΞOYݧzR`Qr7@N!>0O#F5"`UV4)@ Ģ)sЈ)_礰E*9~O"= qW4R+m;I^I;ͨ@Q|N OG$ع,bW֪[n4 {\Ķż`D2Y/,m6,a7P1:USۢ3S0{T: Iw7i'<6k9(@{99˨\IJ*iŜ垜+bd~E2F:OɧΝ]9dW>a[4+c|wG0?qդ l >y̥XLs;omșyM+sS⨅s)fpc} &zR/݀x1$1n(9l!`~SW?ޙOJҬgSU#k"8F*Q).B[[ kh;E(ΆuP7lƨ;dv3=SQ:`C ذTPn (*[G6iڐQoc+%teі[ p<[F ۜ ;hhelc%V̳Z2~bg7i=\\EkK'Ue3Ya<ŧVl%߯JUSf=pecaxcM*jzhAL9t< nj.C~|Jqa,kZiovNg.4A=I}mMCR@E}:elGK+tkƱ&ָQ(֥VbZ~vZAyW;[ba2`=V눂O2UFu''zb1kɸbX#;B#ߤJZ=e'B=!62 ņ=n\<eRr_ gQֽ̍!gSx8ιC]&n-@~)9zCZZՉէGJ>!ƥny;DT .c%9UH왌-jC]TUۢJ,}p4;:Ճq>Ь҅Lb%.X2o:+82Ъ(o(u]P/8*X}ئSO9;\n"<}4;ǭcev{c J~3&.Aѓ{LˆܸUE7eo(^4޹urzoV/ح1K8$N|~+UJ.Xo4`OTS ivy9?v\ax=GN9KU&:Uwл>bVνLx3 0 *P &LƄM(]Áw6S]IvǢ&KW}3 ͟>z@>4~yq~J<Μ{ڍ{7=yVF7\OοF<{58{]yFvJ~edŏ6_vxm-ڹ]DNZ&HZܝ{lx@5bhB{vDt7}FpzتR&wtS즣+K?>%ʍj%A)O%_[:1bi0`~;x>=PnM6ոo.x橎Q%`{]TՕh<2o`ˑjs0)ǜSfͼULlN+␝x ZwO[uvQ}jڏ»wXJuՍ]fjj.?26J;r~^$ ƭM*z[K)$D_Υ/*װ1ؒ`F6z&x޾HְQK c{Pm{9-ajDc.џ{{X0D`d랥 Rcg\DoȮ=ksnk.yl=aKϖ7;vsWb÷Wx14. e)bx{{TEǧwK)"uO#2V~uzچNzH66:G|`S~__G߷?" 8{OًSBFG?:`8QQo.xjXU-`ħyTɣNaL؊#2Eՠͯ^MA>_Z4/I{H~A:0"mWꧨ^. OUF14H%b_vX]N&(gJ#KdGL~X{*,'1XCM)a, pӥt:>MfIgRLe(ʅqw%uj7ݛN_enൄiQ `_^|%1J8mH%(F}KQ% WUγ#܃ǻ]R '~aaQЊ.$ŸNU:pR)LL\9WSnzLX8]qX^G{5n?G8sjwf㻮ϩP`;|AP\(jEx cyq򌢼 <qWw&@I;}Oq|I9Ag <NobWutf6\1|U9FvpukPt<]2A:^I;˝|ͿzޔTZK+ϜaN  χN8ԥ3qiUDѻb`?[]ϙR.0a;I40u'aKO+u%ު!璬Zz#t  K- 3C|&y5)CV-HP ˨o|C..<Td[( nlΒv@PZ#ϷfHE&ӳr:EotgD-Ƥ2l `:]Ç7L5K** 6Y;/8/.1 VDѷqz^+]<|堷w_bMOy <-0 ɲ ;g3[J'~Š/d>*{Qj]ݮ<]}; Q- 3󶷷Lw-<0JRlxV߮&ߙpZz͚[!C>j}W& #L7e~y@si#[h3"5zi_WY2va9#Uy4ܫIQPN{9Ft+t M$UT*Êd2<~)Kae%^7R{/s4H@ _RmDC1h N㩔utnLLx$K_)7rǓa&= 7*d+*'"&YԕWHAZ*9V*Fzzɟm9~2RW>[V^ 6s|} G5Ul;/sW(g<8p&֝OQzw,9!RDNS^UXq&;=a 5byYjc`2LG5KcZ|oQoIm{'VJ0%I-6X+@ X'h[CGZ`z ldE^k6΂t3jFI<\k#X.[lZ;o&ʻ .}.O`[[ ~ޔ?jȠ綂fՙ| e:=K}1f>ufv<~zdYI'?$>j}_X|$Q?g/ޯ(sꮢdǸ&}?Ƃ9vjTd^(+9Tm#zwx͞&gs6l!Xv¿o-#$̩Ǒil2?z,eYzXcҹ~*E.\n._A_Ci:'vaA4L{~ K1._mtB%v}$OtQbHJOڻ6 Ps ۹j1e6wOxo}=j?wSh[ c mrD(='TF4(ߓִh%m0y{_*iKNRU Q ztLv>2!Ytj_DkjLxFV1ةQxdfxh)۰@X5)2=M{x0dՙw֐PB5!tO̥}OXG/ʟ>.y\TR慦Txy?,}ZrgEoPGهo^)ÊO*5oAr<}S }o,MOԓ?釴ZkT(%͔ϪڕbD칭=}uzV9 7$t3Ey^RMv%هů2YdΫa֋UlVx0rvbKaE]ΐ!,v{+(hx5ϋҮ3m%[e{a>J ݮ.]L6zt)<ʫ:x[5~ߺ =p: *68_4 { <%~bWAN.fyF\mwlԅG2j+x_Lm14کGnU>Hd];U.)zR@EPCӓף05mrOhUNoTIeLػ+ޚ0_• _|guy83s wQ3mK{ytZuv'|t۳T/D7GL-O't{D̛sigfjNV Ώ>iOOJ%ұ k.  0< 7-Mpd)K,,g%<]V:s)./yUPϪ?K.XJ}*Tx\4<ԍx)ف_?<_䄼}Ν,xkE7kF~,ԕ?Qw|t^/䆅~̈́u/~hU^;EBYyfz7h'Xw: 3;{v Al:t~]T{5FYdlYnJ=$CY[,u.sKj:΀DG9o[.l`'{ Œ:2$ `{u{XV6yc/M$o*F;Dy_lƧb+;A-a̓lN ' R^vjGL&7؄vIVzc+'%Hȷݎ=Lw{=VS'MulSb?J걛#u"9>y 978lp#8]@"*hkֈHb^3J9kdukBKN cLPOUo돱O/}IPT{??.HmIKSDw=a:\;H\e ~5=8tYSy؏#$Uvj׋ҩecYabIdL\?~H}Cd[W=[5)j9hfF\᧏:"I_$^aeNޠh-LJUhRa71L!-IPj?dl22F%+Ycp*uQ:;ݩnp{ދfW~@#6t3߰ST7!7 }M:2(q%+=wΦJ6W1^eSZ߃/i#XfWENEoX)*Jg(ɋGm^xKgq?Q]Il?;9ޝv[оCA :4RҵX'mQe'}]s /]IOL?XDj(fR)x5V|һ[(nUT7 >ףh}<zwH$%1N/4ECFf7'']ӷ)m0v"D]{gժՍEMd(UsijSf[Ss~*aDwQ-*\DzOriyw(Q5Wk}9g2lwTgTֈvY1ӻ>Ol%>kϯ\ȝq}"s_~N}_T.~.(].%D7]W^Ӿy^\/)E[իػeڃ~{wo_ac?o=yk6.^jyٸf]~ivw 8w&{}|tgnpݑAot= ?p)C2~?,2DHpHF8^|1|Lr& L8r!Ԩ𸐸3ia1IAcSCD'FLɎ IL΋-NԤ1cBbl\'KIOVp;#%rܳ9>:"-rlXjR:?!41-#8$9#.#)1)2<-1:0.-=)4)xptTZx|VthXxlVj|RZT̔Ќq) !)y)T6=>."*:ll`ldxRFR|ltRBZdJj|Xv茤䬘褬̼kw u%"!-3#9>$%-=3VrVrlbBRJr\RSQY16(;rbT|jRJNԔLa~Iy®&^MI K JMJsz7 p\̸]Jꍬkw̽ λ4lB֥D)>Kqa1Ά&F&F_<3rCg+l>oӁ;5k؁;s]G[`Mkۺmъsgz-Y3{xɋ1cI/3kE 8na3gv2yaШlCMаAn#\gwFx{L5mOO=i 6|Ƞәf&icf9s؄a^b-Ow^͚1{(YfMZ0\bKf߲uYaR?4d(iԻ첂z 2l*v)A)AAe;a,1zܬt2+ hxV_u[pQf]]R˵X]X'el=4uʨ8`x’# Y!dޮj-@k%k AgId?IEB[;8!$`F!u2Bb,hPAX6n#v(Kv.!\"\ıa,W$\@E ߡdrߣ'$:3."Hf46v$ g,VK+$QJ ]/Z޲`dDwo&-6x^dF j6+3эon5Ypb4n[ *ln3[lxK4! cl"ULh% naEm`xfZhլ0,l ~e1lYFEDPEa TiLcYӬ@cj2d/d0 Xa$KtLnY-33vuL=fw1sWKOwgO7 o4u?̭d- \aVi(e`bBp@$ d I'6t}ohH`%],cIwV3[rZK;I@zIh73e (EaLV}ߌXɪ؀8X#63"6L]7Hծ2;&1Jj ~נādX$TL##g7qtîOP P@' `r{eE_.S=Vp|>Q8&Sj"ybx`-:qU7LF6-V 2wیB'K!w8qƱ -}}a:O TΪbpʶ -pg\.xpȯu}mz}Eg݀\V<.r<.|<$QGr\a ӓ؎Bccͫe:q\޶-2GY: ꘆesdZG1Ie;j=rsݹ6o. vǰcmZGYI4 j. 7G2Gsc\t@WH^j۾a{+L±k+rWzy zp+Ү"0 {Ck#!X.!fH%o| K IX; #rB={-1"HGG&R^_mssGW<_?gW*ݵխL=a<8~rzG߾q?2jo.NcV}{uvG[|b`gwNNwpw[{g1tt}pݯ~rr8P;4h9Р7hp)Rsa9߾@F@#8/8Шht!s18اh41P_hC4rM@q}MO4ǁf@oq979?@sǁ]@qW9+/sE@/q%9 hY.ZÁO6Z<ZŁV@krg8?@@NqhS:|s-ihk*ږ'sI_9_s8Юx;@{c8@ƁEq t0 @8:H:z;ʁŽp=́?~E@'p(jP9P^@8P;9Pp(y;JƁRr-́7q:t8Йtn5ZŁί@YY΁rq K9%bE?r+ 9|t}\t89lt{ʛɁ@94?ݟL@'qȁ=*@Oqc9г1ǁ Gs8Ћ9PHrpo9ax(*Js78r @s8Їco8Ч^sOTу}΁kTՕUw@59Pm'Tב+О5p S;dnˁ,m8Џ+ԚZq {KhA8+8ǟ~H@_H@f e~vɴq̀m?ujҭOת]{{iԲa#MknA;iӲN& ۿgSR-&Ec᣺ul מ|DF6Ԧ[@BCj$ho_0j#Jzt ԽWdҵWn=7c}wݭOwhƿuN;1Q'wΘ1~F9dlb-Kn[DEDY= \nE(zDYQ4q$z$S$.*It1It;TehjrV"vDGt^]vTE#m6x7ekr4Y٥ڻ8mjYlFd65Y6g`UcUd3՛-fsC`jh3L7u U5U5:Xjj f-SɄjꬦF42f25fSl\_:fl2-Vbpi19pj1i lڜjnm,6 jC<xhj+`͵Z 'S[_P`il 5U}Eu]m4jj+RTW][SWoZ`mMMO_V/j*?jkjMscu}m5Z `2UWTWTfQWUo7ՙF@C82MsSkfn23uMN]''jbw:\7,z`nnr8DɮPN'nowy<.IщnKaY08˓$/3hѩzlݒ-UOa0sx\n(]QGu˲~hȒˣ dBTvM#'Tͨj ]&d ~:p0UUY|MS5#ETEԯ`2^֚}iQ@F v[}q,+*nQ%Ln^4Ub( Wk)n x%aܰ"bR%Y&{WݕK@?*"ˈ 2CYbt'J*e*i2cq!dXPRT sZ(½ =bU"B B\x4*ǥE5r>hqL;9/A/O4SI_ԈkVWX[E0a0x!5xcqJf+\M2Pdij?-iXeMrùb0DTDkTnYt"sRWݎנu͙RfGq_0 3 >s27Ƥ04HĘt$3YkIKqsmL؉< #p^5f̆%0v;PMaqK G.{̞"7Dѣ!ƒ7=pl0;,n.57RGFYBseK!˺ npB^F i )ra%Ȍ.NFWa<qE:7XFh,1%| d!yN+SrxHqPxǀ@FEp! ^v8 |U4Gݢ"r7";qt؝ iYYw95MAgߎ;MVmXxDb#`cn7Cخz]uAb̓¨5KK]W};Μ쇵f޴"tڍM7u߼nξ5lY凉cg͟8ycfN59VؼjUK6o4yɚ% lYdۗشwldO薥 6p`ͦBcB#9=ǎ ;z4DBĦ'~;qhrDrdڱC$G8pb{RRO%eDąŅ%D=~"1LLґC)a{r&6"6&1LvTd|3Iii q"bb&'NK:q<:1&)=')LzL|K)GbbO OM: ҏ%ǥ'%&EF%FƥL:XtTZD|f)'LI;w"*Ȉ褣 i)g"'F'e$gD'e>wԩ̌S'2ғRNf$]LLMLHJIK ݷ;*Dzbjrt|ɔ3IGSRf_:qlRvӱI&K ?p:!1>1>&h\̹r}&ʵ97/;{ԹKJjq1OM??)2Ca GGDw8|W\b{~mnu۱r5VΝf1 ]9kfغrnX7u fYxiSG:io∡þѷG}:ks'Nӽ]C:2K@~m;2PpP!!-ڴm;{ 9k}ztrb.}S a`!]ӾW]81#߳hS 7/Q&?iEL9l;f8_+d 13/zd\Qi>n/h۟ Q^ןj/oQ4HP~q}#B+Muv&K5>|1'5~9R?ali 녚)nEl/q}8_띑9%~*^^?_@BmO7vz.~Jv/"Z\߹RAl7Btq0kW$#zo+)r>6 U2l6|kՋЭxa(8i m~ 29^o$/Zo( )[ҩ!#G':aL͓(l=fIXC :xw$xaoKSo4hUfZdM"ޥ)xl<sfjM k#V$ t0Ƥ.]NGUV Ա@}o󖄤EN.[#$tukpW:T @Ia^fI˶wߣ ~/`~G=vێ1xPR~A]ܢ5?qE!cRBP|d5Qm6,]K ?6~&2lg#n1Q:8IHY ,e/XgVePD)$U8t/uYK2Rf^}m!k9*rk*7S wRZhA.Y~Ey]*T hj4utC]GfoF#Z2M>aANB5;+>ofz2r_3k 5k]Q\otw\!yuF$ r$L~RBXQ~0</q1RGY>׋}J"Pe(JOŚ[O_4-('C.@h-3RǛF~av2M"j\[B~ϗj=U{]poN2Y 5^$t^<:2 /Ry!,a#"n-HɸT"3gM/e yU }ɫ3'+wy5k>%wߌzI@XeE$Mo0E;;LqrZl5hAVkf*W;j\?7$S O!œIdZQ6c.jovB5=;=,^!③,\o5k u܎| r-&9i0+0Du' =W>ēl&s;w3e V6pU{=O-إ&8 a.T2Lzt Ҥz/qd9ץP0J-cط^9K4j2kh'asÞvʞ4%J꫚گV8VI ) YƮM v?sS\vb$ !&aPl?c7m9~ ސEt2vk'Dy`3ח4 nHt~.e?H'Bs[D~X PA!(S{4J%|a՟@r\n0JUjlDgs.'kƢQ-"TЩs[AocɷQoQQST~^ʴ&]jpTM>d'3nUm uK0Y4>e|ױXxD5MYi/J =P ~4yܺG޽([O=+CmJTP^<}nzYTTeiiyu}iP@Զ Ӧ=7QͦRM~M즰'}vȓ!g h+yȮEA \''F:9ʚڨ{gMs* ݒ9_Z J}D} &R6yD/@eC0ǔhm%85zEZCC-_( k՞P_: T@1"?j5:5^72SV+1Z"+ZXFB & 9xeK_)LD.gx$K'2<Q&%M$,MBݻݡMb>d),vcHcp)/j!j$ Gg =ƁZAaڼjVTp4VWw[yl :Y- !BisFR"]8D;lwgiey(n4^T4nB`Ei|o5tikE:QJ -M}, l07ua]NӍ=dj쀹ɚsE_7a\ȯ4Vij܅tcb}ݗÄ'.]Wʝ]ϕYyW({4dH{$p9://W,OBfIyCe6pڢ{aΚd$.^;G"|#=+bMֽ4 [Աq4q4ekk=^zGE;KzM>"y7d|+jj;XJ}9$U󟱟dО$m8Cݢ[ː7&MXs8Rܦ@}78Q30YuzH/fHxx'vi7яv"7V~UQD‰9z*bhE2Ջu Њ#kU]+ \PB ʡowt+mV~R~BI$[({D] ` dؓě@$ꈱ@,hV"ü@{/j`†6"x1Su {K$*A}r[ukgL@&p/opf%QqQۮ䊙NxVC&g $ʫ!7-QVwO!Nq7Ӏ3MGln4V4pWѶ0H#}!sTD񴯾 Q(ư-fv"B7W64nNL`G{dHxrp\6;<埦c (ݕMcg)Dfn‘w~I&m"{onHBrW&SAue](v&́l6< _&9_>;Ymmuu͛[2N{2 {cJ[#WNy/1 oo7[,m@n:C~Z(H sAwLBV6V@˫3G OݖOdFĢQxm^Yr f hУ8Vޓfz:mxhC6Q4 ܇f*nBRV7͙Cc MMo< Y,8IXuQ4ջs]oHltź0|;BF=.{7v \ {e⎘ .uȚɐ70NwDw4dKTK.=0@ 'VF8=ϠVΨ͂݁|BM^= !7fP#5N1Ul[rI(# syFJAD+Ri -ۍ$Zs ZG^foI^$˲xMfaVa.|EqZ@+a^@%T}ۤPr]OZD DGi5 e'{crgM2zm._FFrׄ ҽ哫P#}Z t0Ўj AZWfMdMH4*tr3:ȴxFgf#\|#[M@BY|,J:dߐ>^ 4AcKFC]9`;M敡+5@Y?TeMa?yea+))D?1@G]1jDh1?vPI$"S0!WU`_xyw+L&LZjBq ac.ıapDc*1~{QE؃>؋)r)Ʌva2A%-O֦'p8߆D6UJ ;oFpaPȽܯ~>1[ם^1}_Nœ!9!kKsj`i&V`'G2ơ`ED&>5`'aJ`$> KcuT(R0ѩ -( WE G?_Ad2 `ăXý+ty7 8R]PD,YLeێ2T|s)q&V;`2+N^#:7knc(/ ڲI ]s{جw D/T#^.*ulEuB9\M沲NRS_zw\ɿvwr._xUk̊>{\ n_8}1Ō^'sOO9qNr'7fpJ;.`h*¬hv}N(`]E {nN-$e'/+tŭ3DSgI:M +"[74kYt6"<ѷM;fi5T"p"sj1nQh|;dYNT]ٺgs&Oީ}%X|M@s^^iMh\BИ}£_}3YY>+SNQy55 f" ŴQB_B@sHo* jSP_%W_Y GZ7RSX-$Sm!9LTp8V.#M,+a?aFo=Au\rw~2lmâOܸp7R`M.Ehhq+Olw׏`R0#-0\/~YlAeכ ;{Ao<&4עUYeF>y@TM7ETnFJ 7j25h/mnʅ Z,1@Ш_K[\+M@숖S_fzGq1,6)W$z?+$ Q3?J;eMA.Ib:N.F_EZ`aǼz&T#xwjdnz @_[= rm#mnv8lzFQ v]99 2374-[{ FlOQ[ mPw<{fՓ W GmGM)tR!m2w)l]+J#{vXgً@\ޘۆz+lZ >]  0* -C..nĝ-sf"UH{*QɬU+6 vi*B e𚋱U=iSdL@.G%wVH sZN\J A]tItj4h${.LjE*'1:7rNG 󻩰$cSC=\x7B%.2{ ftQk7YcIE|țê\6%('LL4k/lAY"va|NHMξH $9wPg%Im J-a&G#Qs w=ZSvjt˻ͳIf^a'Zfj0$k;:!L֭4㢈 `WQn3UGj"<@ ܤ E[1/QmɧVgI7 :yBwH _D&'?h䗟.:ぇpt`p+#ݺB & ,j5-_:\55G{Uܯ̳Շ&+D8S K{>Diw {h{%*u:f :hi꘩S+EFql9~Je?T~)Sy;`;wYxSd^zn4i!E2.RٴǽYR0# 1e*,VYdU|6?TN'lǎ}ںNDpuK-L#xo /ꈎӼΆ{ȼEW"?Hc&]eMRC'Q5) BV洎= NOV mA<4֜{lTi9hAA;bA}udLAK6$VϜyP=V[=[!zoTd=`i q,=m@,@-jz}ު*'c(`ʜnǰv2C3?gK}^cKyHX 1L䕭XKa [}'o\ sH0FU i1a@FwM h@6ᜠ< {/X4VH$aJ__M# j]'v-L⯎ [@/g!ZpvpX˖,+6$ݻtѥV~W.!= Xx7OdUt l4NWj9.h-Hndu,N֏̪0fXO4Ƌ9:(ދt#KhVRf:G>skduj}V쌢j)IBv{.ܼI?Zd~!㞭4m<"3^aEj0aLiZ(?Bȶ~+ǴCUPA:PIS D΢/s|*ݮcD朿J#!m1r諐j%DސEaeCO/|tqo_n%!7싈I2xSG ';J|2|ƽ [/μ~j֩ǏzĬxт-$u1 Re.wQ~a+(4U?҈.{jb|ft+_;JQB8EԗB"3K՟ɖvq~K ofx.^X+Z]|R)_v'28= xh:[Q57xSØsqi5(!(z!a9N afkU}vEDq,}?hc*g*Ә~A(2ؕ.DX[z.)^0r-xG֠|2/k.uD3ID(@ ;m_=(xEӼBLZ ]mh@!]]o9kҞ8H} Ub&;i>xA4pƻJH5 fOyhJ%n9P1Fvd:-@M65CEc9=!ܾqj-e~,K(Q>o54K%Z9WeV!?8 0XMmf J$!)3H&6dzزtUU9 :˾arMȇ~߳!2m`>T7RE;^\6؇exaPU*tZх7jbg~CtTIC<( QY;eщv`+Jn Z;ܧc{;ƚ.g[ A l47[/C QB+`-.u^b܏BcnvCE` `W;@ vzm[ %lU7jy1ϩ79x ~$V5!*j"ч6/9Utt !/2-knr/MG06Ş{6/[fv@\~-v.2`d[} *ÎD]̉h A!Am+;LѢsg`h|=d0RtV`[Myi5DI0\!|1p9fGW`Ⱦw5_?Zjveh`c kBKghP!4 @X#R`c)r%e2Q*o{<_\ΒE~>/Bd7 oгZ`n'Ͽ1^31ED;yc>b5"Hc[@SФ! ^ p e[֬hYYYA}RŢR ;js\_@2#* M&1Rb׬Їޥhr7g1CcK *Za&C)cn=R7]*qB"ߢVmY= &1#p,[dԐ:X 4 Vi:&wTxf2F]E6smԒsIQzXIzS T)L+_  abjJ_[@b1 h ÐX8Fw|kũ73΍GQug!^}Qԏb98A5BYU?"PsЫdX>J"Rj/JVN: d@&d>Ȫ?Л\АȰ"R 1> yS y#7]=u3FSŞ?-bl_ɟbVÁF\-a[3h s[iG@f%8<4nr?!޶l`ڕ\PvY^7Ҭ d mk9(';2bNh [zAnq z΅wހcMBX! 5d`؃|Al[b;|lbVX'6ȣ{#ɷ՚Bơ^#1w.:'$5? 5TFcr4#_p7+҃q̹`P1Y & C" B5,Wta4B5NhR! 13z С-k elIiH{`fq04rfp Ov="}[u3$`iH%.4̔hnig>Ƙ9Ncy$1aأ2/ANƎ|ͯ>n/5,Q㏧+HtfP< K{Umq,Ʊ?sRx:ֿൊ(U냯GxO8gѐŒ|H!?B{LA0CX Nȝpxs dDKJQ %񶪩&!$&?b{SӼtuG1h(^0#h$IY=}EoR:]@A *Ᾱlژ $h4 >O adwawdtm Mt>N4=GK!WM[z2^l[hbۡ -|OFyNY~>dCU3^3 Yn?aQ_3D@AgV_3ln26^^w,FˤQ4Ex4ypJ'1[0XU2`ڲكu?y*Ea@(詷1+Dyj_-gC< H@'n&!v3P%a N ? {ˍRo5[Ogl1`nœ蘆;B.u[l}>> A؁|UmӵR7TE m|7H) % 45艩 )/+~\ˬ{3šzP9f1T|GI,+9s퉢\B|t=uL~5W; ’?, GL~\4;9jd/d(qUr{lDKغdۋmV킯Y=9vgBӏ(Ϛ[:=W# >`g2@Uz={6$x  #~(^=.T8Y:̆SCoV|Rp7BX. *Tv$|F{̣})4]0haWeIeHΥAOi5H"tr4% >⑥ McNٻdc@'\rhZ"yi%0OAuK7~&hʨTЯq]v1G[ޓu};D^FyhP"SKIvk؅Rϥ>x$=Ndɒ)KN*p׏=A: Vo[N'Wp=g 3Il7#ՏH+G`沷1q^/րwI<s@z;7]s+'՘~>=#Cy̡+ywnVb_=$| ,DdzώYלag0[V 0w{/)hmG ZbwU%='G 婫k0RceHiMg(pQC+#q+ڳCEL.=02{p&UwXX2I!DdDD1Òmye8KrrrD䒉|/ m;K? ;f@D9%G@ NyRe I/<0vq+U6=BOvw6QMRى菙BV˻2K'UӚ!]_DDFk̭D I `mP l8EY/bK2`GHo)fōʞ-*wV^pa1sY})V}V~7&̟,Wnojff,$O੬>/C,,x}Wg!"\ :,v $};QLܰ2̌`l]휍loZTB8:s:[ .[fIph*z"'sY-$pӯC&at-I#[i|nM>;PLʉ+ y7J n{GEY.ڪU/k/$]M%_M >Ndvԫ{݄[  lf:AZڒoW ۱{1!g 9Pl'?ubD{6taOyw!wF1-aj)ue Qנ1Q[G?sn+%޹ %Sgy9}(M(>-y|gԞZ)y<'ˢ73[>RXSa-"H`*OTMJ4!.*{Fd-m5 r\᲎; Y!k)Z7uaA)턅=3HܹK YRqvۑ:KQt]r-5!GPD(?;ֿt%έvDVy.Ĭ8K:ݡN# 㵪*+OQ:C*+#.t7P`@>l(rI} #";j3|XgP}ѓjɸt[|/ma-ة((첳6U5Ѽ)}D/`.f~?p3yk;W/^j0nv2X.oxGOǁ)`$/CP>*pmaސ eql=?oӼn\ZI/&Yk u$7Pp/nnF& cȈ9yOρv^l HN΁y0\ȷ|U-;Etґi:r||onK1G:ohb9~&T"ALsWu iA䓑A>='$5.<\wT[/:+1^5 5^3=00 Pa*pUMlRؤ&nv%{Us4-Uk5 \sX.Ran>tJ$I݈<\',o ~eQ$=~ن5LC>D|dVmpHj>7M^Ų:3h9pw^o2r7KlrP5rx-2^\(s~#i$vrb` 3\~85{3K] o3>qR'nSHO[cf+sh䂩ǧT|qk,<6 슶x.&Y @)5ǿ "ϊ9HxN GfnQLlQ,āwwixز&m~Ndڧqq-p^:.cV5MV] 'f$-LO|ԌG4lC4Ure;qJc2r3PAޙXgK'0K!ufN5E1)Xǻ:?F#C.Vsspk4blw DTZ`)˸x^}k+c*Y߱- nܮk$A#WÌf }'$gW[^|u?0<z)Z٩X(B +.2"~L9-++_7 1D $k&V!{Yc04V62ƤC/XOI~oMӒl[ .isx1sr(dц`*ưkohMh4Ⲡ]3f%a՛:1ɢ *0\8 r8˿±k;i+1$z􉚤B/>KO[\zXc%wK"DdCf?YLvCv- Vg'ú 4ߡqun0<3 D^2slmgcc֙a/@;Q "| :΂(9qN+תW p(I$< uzށɛ%l߱~IŽ6[ 6 &>wbwQK|]4Ȉ ~|PjgNm.w_y5e" aGʍFq|v@[>9yA +$߁.㭭bHRz[_#8t#(HI-|_[eU|%+|!AcmKo$98$ #),CV:FimZ23ֿz s -; >Wz[\SKƅCFa G`0a37Cso;uї㼇0Ӷ/ +iץy++$t^GjW]FyoVs]dhrw\'WGx \c:jɱ9oOᷓXe* ls<0yj ˥nWpVNO\# lOӡJ**ޞ%M2z]p?j^F{skAk@bO|hChW =h~z?&;![:{[e 궋O c[2 t8*Ȅgy>\7rx9bX|ZV1@r'&Aft/-L_M|8|f.W"nc_p880 `9YN!-+lPdmE%TL?aC F6:}xS^h)o/*3G'xӒpi0`೙az_YV$+9h a5<:)AIT! d//r M`3',+mtp3`B䒵])c`4JS\'5;:H21ϱ/[[H`9.rey_yP`zBfux襶\Z^Z3݁_B sv?m wm|g05 . "X$ d#Uof)>fղ(l}¯(o1=4sI݈ݼl86@WWj=pk(*o涶OQ1V S N]]rx=c yerշM8w9¾U-f|#\_8Pg7`c, m-,!JZvz$AĎRH5l1Y"eDe4MKiksv\o&"/pfdL!kg0X9QM':Y>3 ;Zp eUtV:d=D/& `4pΓo),Ҏ ެ :dzYGXU0{jn훳H柕j]pn/iC]AYf<3wx{w@"!*؅]Ҋo00"<.+k|!+.HϚpNC-$Z#9;*@ JpH:|#kdx'V97-F|MϓbmS1 8Im4АլE Xq8nXko!+0:r`baY>hAOʬ0K 8vvDTӈ1Z L?ȍ!S}rK|T| @LڔywBуZ]VYI1Ke?7l4gm\ւTz2w*vHxiMz7 z햫Q"c)[]:GXLet xtnj+!G#_1W͂,Z8z l$Hhک˱fGK֌d)>D9qS4U$iPd72l.ԖC5X>VOxY?5P_m']Z -Cۯ$ok PE?r`iǍ1>0=~K@d,6_#iep1Ǎ!$LJ9&0V81bWcPNsc `&dy8Ԁ {qK(Z͏7FZ=9Uƻj[%ٰtν[l37o"9lďqӇӤ b#0i1nݟ`x@4i|WF@Zp?oCNIhw7f eFHKjfц8)25r?Z q;*ѐl̿d G$J/A;w ̛,g/$}AOWHǑD.PmxeWd4dMRxpΝij~M()(*̈NHLKH29=5+#9C|JV^bl\hǸ2ssJ*+ Tꎡh`ݞ|m VjJh恾tŽ" v4(VA-6~uA|I2DhdVK /bwRK:þWӿq_ٺލ~$=WBuCMN{d3_$:eҌciv"Fxne$tėyyƢqȚPIX7ipM&T5rf;bVPi L@Ҭh"rڮ%%U lDsٗA}]>`M,S@=-Sl}{6 K[ZL# 1]$˂3~Ҏ, q'iD3|rf<\׎ ilw] /46Y[Vԁ}ED_!jn[7ˢU <6 Qzdmʐݡ:U&+.PMh$7`^LՐZW7$F|`ƐaWYP}("/8lqq$ `Jl$Z5 !L,< Y1l3 #Bvك [u4j xu*#QN@NlfuHB{?2c#^\.!ecK$߸T.i/9,elG&aY*XUyNO@ C'Ons}X5ǁ܁IjXVE'W#n瀈θ0 Nn=pp*g?pѸ7gmA-$3,dw\vh 7(K !Stt*uw,|3K _Nۅ"!7\0p_8Z(~՝X= ɒ7[-|_e9V PС01XJ"~eX 㗊U^ϸ?/!u|JfkzAON/-D v57. qW/aBބy_y9e5ߘyzb]i%^ XY~¹Nq$/SU%'k`rpF,-sxoU:;A,M9@X3n'+3yߕ8$B1-Z(0 'L$nJquK/WAGnOך00ZME[&geX/n!^,.2hR 3(eS'yy\WvKS#œ)H :khAEO~ǔ#*`lyj.# Srͤt>rw?LT—>3\ձ#82Wȉ9 0?Z*lO.?7)}z^O#9j#gXZ- 'Rᾑ|ްfی F>p'ݢܾcTQ'X3H"HX4+`5rEnHVAWqSV6px?[T') Jm(|UR>xnO&!7VfJCZ>3VO{u2yA0(ƙ ~aSz>@ErߣXE./(0ÕcٿbD h}渙Y%S^B_IO${Prdt50{EO\r -I\}V9L;B{nװx9XZn(-&&]Q FD&q5{}$I9H< _7?FAO}${$$xZϧgoKAZm.-}HO.:q.ޭtӡCzaHgxmW$3\* Vri/aIOu{Wj`S~&r*X2o)_nX| cc?Jy $9Ս Z}DTMW# UH/K|6o-vÝ ƀcy7Ŭ?Fy"_Q*  E!:UmdnWԍLu$*TyHmU=-33xDŘ Q|wA l0{q*] ]miIrͯ']I7~F &~3mO9Qҽ&ˋ2|U4ߢ[qfhRn|*c)fąH"OoIf4lx'H|9J=:/1Ԓ,p(6~@VҰ5tG\f.PwI9|)sTK wR98fM!gzNrI<6,րx}Cn3ڔOE/Cn)&:z5R1. a1dSiչS+]T:#=y EV^f[? gD!sdfv|dl\'GNݾ K:8o%\,"Wk:naESo|}ݖSDݶtj2c8Q7[wE ժL4Jmw"|C4{B3R5pˬ#鼩S|M:JhT?Adꍩ|; |>7'41WPxf߾@|iȨqiK8,ao<&Tč!D~?)_V*qnFiͺ|\'Mmyd%$IڪE2ZoLȢlIYKfiG'O_:zAR>2$d^&ΫA]_2ZSO"+J2|랢Aqt&T0]Rw _>Э#E}ίԻ5x+H/w繨ZKǨ^$ZoM,V&=7;?IR"7O86תk$'# DV+{&=?}\fUhOLMm364f=ߕ a6MVYup<8cOa/>uŞW |w_.Fn?kP!!a5) bPO(|蚺g)eP@+X p+ rw 뭢^Ȝ_2UGF1gFvfU_ۢͯ\$H%VݤqSmDCcuNZJXTzd-sO+Axҗn}@Pٯ9mhw6"hTky[bNnQ8ڠh$ɪr ƊOPZJtY'8b(!/#B.BH f=f֠? ib%+kIjQRk=[p*R'~6WZdŸFvR> WiӠFJj.d侲pV_WQPhkݓ-?WĞnq!a_;I7T=$_UEWOBR/$ωK`lN#KG~C8׈Wש Xk҂@@Őn/b!逅[uj_\m1ў{.!IU*"sOD'|I܀I>5Ʌga1ftՅhI+ϲC ُV(R%֍!N+8. zY)GE#T(adIwamVBks!'Prw Y9z`wohބL ΕO Wr Ud,3us?NxN0{C:%~RoE&ޔ@3U9D5';˹U?ۼ2-vUwFi;}!}RMڜYE0A0hCGІŜ'"-H۞EJ zvn;wOąVS) (l@fԵ+;m\5ߠHF$^!:x*N4A|dnjp׸Ų@mLp5o8IT'~\Cϥ[ T V]nr#XMt؝7 ţ Uj08c;)v? NAEm=_ؙv77dɽi$C9 }!'46\}QY!&B}Ht׼"nyˋ C)0miAhò. `ýLD"p\|fO$z#jCxAz[oFY%`ESA|3GؒIn\0/ ?c#lkЮc57 `"e`c`,L ځ-zyxgA:6ԝKS7% Ӭ!r(f.dBM7Ai;^Yd6JWOI A[IJn|}oڟ1nA$κv}'yN0$4< /OqJ\sl5) ڡbʙ:@oql̬[pHBz7"υץ%yQЮ\P5 స1h{u',SᢱÛ]S;\=#c+:w=IA]& چuAF4qqj\%&,4H֋wX4Sp}=iCx ^V~!i{:m]E<*ߤ>f!H6טL Y5!iDSAtuIM2q]CIӊ3N]lNIk2rZWp%Ő||}CiBW JS0"ڨ|P]^*vժ!y2M] 1W~li$X֟f[h2;|tZZSCF^Vۗa 4? cdL6+MIA>L4ljFAol0oIi!{Pk4X*Od1%Iwd#?,mZJtJm/@rw6RLbwi%L#2` deZo(]C K\z4%ɠ ФBKtp2f\ m'ێ$7b~UlG-@T2j-h}D_Ƽ_W z(r_ds^jMgc>JǶ1d0 Cm])5g&P;?ߥǎ;iKzGH(ͣ p6#\BCP&?\jw3喙6 |⩠l>w-qڣ r_b }OD=h,Y `}Y#Xo5,T׫Q9/INsJurg= G!nZ ?lĿz{.leNUIizŽZ3j+@8 4G!N@D1|MÅ^%#Uw@|"L7lf$놊j,(ԚBEw\lO O 4zl7dK#s}IfQd]m3-L-Zm쳳P>3MڴA:l\"$?ʮDY-4_o`I) T=n\c#4YouַoQɕ &CsV7ֹBvӮ_TxڕN 8,/`Q i~Rzt&&MRޗ;=ձ 1ZjOk-k-@< "zٻx4X#^jIVyhe:xۥGtYW0^oJ$~D6qPoU#$ec]cixVlm̺g@N~/D{ I,tsl@FA~Iz*H!M6u: } =DԍQ+gr\4$.gML-I6Aߝ=D:m0 aܿT }E fp _z:~"c8*N?\mLs_rQUCrppd.ߏ6f"C53<`ȭ4(6DBAwI}`!;ل=طz1ѺlsX6:>1'n[n-)C%Ÿ ^ 1+oH>E#0NQa^:% /'u&VYN {7Im/ Zr .O*C{7Oûg7ų] D'=&#UXxخ3?2"=rD/rñP~d800@_LJ+m>̏+~LÿEdeuZA0k"E ea`Ǡ 4ZQqQy&:,㶵ޅ waH!5\ S ϠmݢAz6?83r{w= V$H֩fGl/K"e^Qb&byr:oq4gz>XhD8a.`DHK=퍉_+/IWq;y>%չA'P٤3;-+x#L2=Ts5dHz5Dy4~;Suތ:ia )L6[l]@ qU9wb2dЩVqIIp"ӂd~qXifBd^j0iҎg xmj_~2% ƹSU."9˷,G4rOAO woq'/Sؔ1- %-Cu5[ktNn;s &KַgV.JdI;=AFU2( 5$IX!^d =: &{Pz_yL.5ګr`Lf*&ȕRfs}DVF1IZd#\롇juFcQ쯈T0eD' ka Lu}dOxO܆G$IVB[$wZJ!La,J Y0I}/?@ah>KLӃ${l5Lzu8UVI M\LƯ$e4oMDnSzߙd[n%>|8pj;8ޮXS5FM,&jnmd!c5;?20ykiU%J=@0/@"?ai02WMf*UC@PJNSp{#sXĜuQf{ ʏr#ѐK>~>ofگSu$7"iss~c]W ODQMM,/qi23@Խ~6$4 3hW~kBM!1<V|țťfz* Xzc5[Px9goZ W¹x#kDvO짲W2'_$}oH{nP#ekz 4%Z8WI<3k*s#jyI#(;YgoEzs:`mJ3l..>> Lt׏fj[ z[r!a4^ZfWBҵaFR RcҗAwߘөHA҄xc_'ب\uAA'Xk FMoc4B>q{pV[wݾDcA9`yВd!dk&iH!Ç@=dDt?╙НFyѼtFYK;Sϩe y!dXGX-k󔊲*^ k 43KN ^M$ haһ^EZ7ɘeކ!r,&M.7]U#[97ffkuoC/AL[$Yn5n\)=.^wX&I#d%iKjxJ(9|T6Img 6ʲ,3׸IH,%J tC$r['(h=3&#l̝ױxszz7)t&DMt3KHyUtPl@f[We2;HzN,Q5Lɗw.Uw-:Jneo&Ь6&H2f fo[OՕoOv迀Y[l^IO436+ӉcE/zab*lQ_2n'僢>5poX}3~z"Y%:/ +~%L"ϒip4WEw2 Z) Y~QCyW'q瘉b9FFoDhaeUs$n4X6}K'fբSg dכZ*b_y JAxGxzezD/]9:=}}bwkQfȾy景//j9OTf#v\.LF*AƕY*nI(/MyysЏk0H1;Gՙ9 5qKE+ޒHqbyPo$bǏawi@ě$U|}Cx x'WW8 ' Ɛ!sJKݯrZ+(v$;^c%Nn SxO4en+Rq[u? #Ә}v&tRW7 I*Du |}&՜mggs:;tO{-t\1ϋ܄^|$ot 5"zũe)'e>;`csF/rkGK!tf~8=]c ; bo?ܽ"hL-i]5~\$Fq٩_=\5r;)\_t>|A.SHjk{$m̋1> o%?\U_z:(ؗE$ٓY(0+ϧۏQyFY{]*,y56C0Ƴ<=A_ 23^a+$]Z/UKCtiy}T1_Q2err&c,T#yOc8Đ̩2þէw m*!ɑt&LCG?tвݏH8$|aAf(f0R@> kcLDroVSGf$T7.$CH93sl=sP3N6`O`[zWuruΗ$cb/29fϯCFyU)bNQӷIV1bK%I&S8)6$e^m=?Gn*˪r #نC}H_KTˑB=KGHrx>EMN/n9XI\I5$U$燕aybtl^z ѳ ! $Zt<4_~Uc?rɦux-/xK)w.IP-)6< NNˎ9AI` ۉ1`Hߒ691Vtn(<6\}wƼiw1-Z&H85irC)-6Ͽ)f-2ٍaS3yaS/Q0.~`gRk|8$Yva,Gbgc-|ME^MIkgWk;2f9eϡy$*!n P,EƊ#MliB6{Ϫo*]I0?M17Jz{`FH#ڮ*Nn=;3|s `t|&C;! ӌ0OCa ?QAnK^[Pɱ2۷ow}m|*뙅28j\وAp# ĝ([UT*y'/8ުt~vJ*9*' ]S>W_#{l-.Gw#k'W%?D{V~ F ^-k j} _+nӏ iw~$1xK?`7]Uco!sk59wK#P͐}-w 럸0$&+B ^_bl%AQa\vp ppR?CM Zcpsu@O!솷7yvq,\%U#?ǐƋ2iUAUV̂geeUygI,I'eE^ 㾻Qn=iJuDө29CCzVr2U+} Eą#Eff0=SiC Q1# ۏ "ߢXS5ے2v;E6ͰRt;s/DF#_"qאHiG | -¼w_$JfnAIc)nf׻f p w6[k:JTkd&P@}.v[0lQx7|$ƣB'MseX6t67lCX]MP"0 YG[toFSol~yTlO>8{8_LOfGEE:}dʇ(I\4Ӆ6NSm\VNA[V5MQTQ;,fmsYU4uąmij.(h=g5H%ˢ$Nluᩢhes\ĩipDLiaiFBga ]u%ȺNTMDea̺i1_U6%oT5S7w,5Lˉ\f ݆>vΚ%4eCL暫cTmݲMC욲a{!3M42]jq-QLs,MՔ&4 R &:YpȳlqEu|wϴEAGy$^>)B(A_E>zVt1|czyx n9XE =Ş:qAN`k>9=XdPlIϵ]ET׿fl8jx颦ښ*S\&$*s|ɃSQBL~2?'ӉNggy&MϧNsQ7e*Ӊ닙btv:Q梭"O9Lh eLfl8?ˋ3CLN'VPZ5Le~.^jٚ")5Si<l߶={J?%$$If.!vh5@ 5@ 5@ #v@ :V l0!5@ / / / / 4a.$$If.!vh5@ 5@ 5@ #v@ :V l 0!5@ /  / / / 4a.$$If.!vh5@ 5@ 5@ #v@ :V l0!5@ /  / / 4a.$$If.!vh5@ 5@ 5@ #v@ :V l?0!5@ /  / / 4a.$$If.!vh5@ 5@ 5@ #v@ :V l)0!5@ /  / / 4a.$$If.!vh5@ 5@ 5@ #v@ :V l0!5@ /  / / 4a.$$If.!vh5@ 5@ 5@ #v@ :V lZ0!5@ /  / / 4a.$$If.!vh5@ 5@ 5@ #v@ :V l0!5@ /  / / 4a.$$If!vh5p#vp:V l  0p65p4ap $$If!vh552 5~ 5$ #v#v2 #v~ #v$ :V l%552 5~ 5$ 4$$If!vh552 5~ 5$ #v#v2 #v~ #v$ :V l%552 5~ 5$ 4$$If!vh552 5~ 5$ #v#v2 #v~ #v$ :V l%552 5~ 5$ 4#$$If!vh5 55Y5!#v #v#vY#v!:V l05 55Y5!/ / / / /  / / 4a$$If!vh5 55Y5!#v #v#vY#v!:V l05 55Y5!/ / / / 4a$$If!vh5 55Y5!#v #v#vY#v!:V l05 55Y5!/ / / 4a$$If!vh5 55Y5!#v #v#vY#v!:V lL05 55Y5!/ / / 4a$$If!vh5 55Y5!#v #v#vY#v!:V lC05 55Y5!/ / / 4a$$If!vh5 55Y5!#v #v#vY#v!:V l105 55Y5!/ / /  / 4aӄDd 01<  C A2C=HBæiᥔu`!=HBæiᥔھnL6 *>Bx}\qs!pիQFF%5jhUUX55BB* E(  HB (P P@B}gv Ox?Mrpvv;;;?vyLtNK!cJ-eYʾ٨j4/EV:km)lۡ&DX܋_U@?XkC 0??annfggaffajj &''abb`ll FGGadd?ahh??```z{{~Aww7tuuAgg'ۿttt@{{;Bkk+@ss3˿ 455Acc#:g7PUUPQQOPVVPRRPTTPPPww!==>|iii_ RSS!%%ᗿ%$%%Abb"8{g QQQ 7޽k0 o߾7o__App0~//!00//իW~~~|}}˗ ?sx9gOOӧ ''nnn ?GÇG?}N:'Oo|p 8~8;v ѣGȑ#pa׾WU077+_ ۷ {/˰{nصkܹ/;`/~m[n-[ؼy3lڴ 6naÆ ~zXn|skš5kO?իWêU`ʕ' X t:hZH+{y ў օ~[o'&}X4$x|ub5g/()1?XjusqQn8,t"HR3 j @*&F0@M#'/d7 /ߴd hmu-yf?SCg+ca8Zx:۟ZƷoGmZ^Jucxi Ⱥ;Y|)) ?+yh^!v1 q:|j47/졲6~*Fo ںmb\>_!D*WB8\̈~ٞbl$:i2ˈ2F#Vܣ"DMTe)hp{ $S;3{K=.11\,;,-% Se@a%{*kruC|\!G`^iNRb JzF__>a"E$ԛZa+B9#"h3rFU/8O9 oXOO&kE*X^d1 "^IbT1Iu4l둾`5xڢj+Hn/Ҭ3ǸFOK ? ?0kɮgD{el` z? ^H)Ӹ[Ip ZȜFDVx]kIj{4zT)>H}osoxIz d` fܥ\p-u^gBAb #M+" 1q/>SD\[({X澥 j4!EK\}%R&K7+lAb04'ԯ;HfuBSedw2dE]1w#@X RBZ0SQ ^|Cʺ*RxFQ ֳº:Ki4C!Ih_;"IOMXTsAɱhۆ{BZُ옔#advDs>ޑztݑ%2tkF^n#$o8լou\Q7Y z 뭪Ȗ'u-rh Z魽O^DýM5M8I*ч`[ޑa"%~P`Id\Sg:t9P&?}_)g#guaWQ.@Kϳ/ &ǾT /h 37 Aa=.4#9ڑ+-^uյZ2IԶT\4CۿZjKAѽ&tç]=uoK;|7+?ni_IzÑ?y=XuE^֗~_+ߏcK(:_Տd y-Mi(4#E}{-ИMvu),7Nhw;M0(Љ0ޮ"4&&RF hpwVB爦KQ.r*>MeMH$ oD7T>$ˌ|HgEDiBDzOf'ͽ8en$P/P0&B:.R%U#{ձI'=p GZJ:qDq-pVZ@~Q1¹#CH$> Ͱ̰QޕfX#ҷAJVRAFsEڪkHxI?3R" ϝ}u4zcRUp>IqNEN"6v1G!#Z7 'HM Z-e?KC΀ZtJJ$F{`/=~ߟ[> H}glZTv OӋJ?$EfVuv5dgF~H~|%#/&%()707=:0/>(8%CnuevqKGwwc[sW@_{gMsc[]KseUNi|`MmKmqU`WhXgkKow}{]XG`{K@GO[SkGw@_kphGyG,Ȏ{X]RSQ\Y[YWYQ.6-1"-4W\vϻ &W#bcb2dFhO[ummCM-mvж҄ͨ]g2,>92uonYiNjJ렽 _y<&]hTȘ/${{?OS]ӣƮQm/o./NKN/ϯlij(+klnhlnK:փiQfv^xj~QU6WmC!]lljh.N(.M+nҖ5-MO@_}Q{?1PPU1;(j *:+jKsJj+[J+Jsk22 s"‚"#⺆1wr=;6󪅍wzw9^t,e!_nbqڧ`2:56m6>MOHx_?8㟐7438}bWqQAnO^{ߴy綃M;k:E-^/xCϻ|.ۻsvpak=;6N>~@{>>͕f۸8\>X_@W!=-d%aZ~V'RUC]LC--v\~_VGxlUb*Qƈr˟+N5LE#(gEҎ,In!F?fR%k8yUN9i}J)@^Z #2\2dI+pr) 23+J9u$D 0,gZev s%1BƭCHQ%[d~rfm`0Dqn=Wm0*7oΒۦ̩1$Xm%vt߬|Ov#yC"Ǭ{ `ȭǪu+>:j&FiF} {{fmpl[C2UBRy[tgJY`KH@7ҁ6 kh#غVbyqz')$l+}&E٢=@!CFZsf|,eh v[ȼgxp52f5C6!׏ǀ26#,GkΗcau[ǰ2Dԑ;#šrVrQ40s7>%nS~QƝ-GȲ71"_L/FWy֝ -]NZD̽f]햕F,m&A͔F~P{_~$/o,{F+wgf5Gl؍+fl>WJM SRE7B}:+ҼSY0ൄPLkh7&!wX)F/d yԪVqrH# ճll޿M{b k{{:zZ1h/l+jkw&ӦDgt^u;o9-]MuMmݵ]Vu54u wu7 t6uC֖ٹq176504+'}`4;79 8ٹɩ Ўډ޶ёAm'|mpj{n\L6T5u4W5wvNU.s}m=]}Mm]V\fEAq+(jlVjʫZZ{{z)hG Q0h}M_@cp@wO$hhhp|{f)Wu LP^{wrotK[ ZG#WuyI}AfemYimHsyH_F+1qlkhniinD٦ah{kDwCgW7ɵedj|b|rf|xzf|zrpotvgxf~htj9Wucv 'f秧U)='u{Y>|5ۧO_(u< Vُ u6]l;|gmzwܼs1׽~Sn=imyŹG^ !Vys\-w'EevaFgFh6#uu[v˝&quWh%Ms9ndqMׂ֖#[מ}qDΥ)8uj׀[k77[)nm4f+֝U&[D~=98^U;y|ZX_?0|Y#kȏڛO,N;8grzVAi4P5f(:Ь Mg2nͶ P*/M= Z Dd 1JZaB}@]%gڍC cIDzNث>_ =Sb([%Go;s&QjyZ =kUR'RSz@cR=(:=& Vre9# Pd%F\zIjÉ zQRxveQ.*m &(PB>Y(=  QMVOWɂY3ؔv{0E jeH3,NqQ?dtV;=Pʚh\P`F(bBf&o Oor< eBُ^PBʘ)"|zI(e32'!B٥PP?PNgRsE!S9=[I,*4gA$#m8܅{=&vJ2|(Ƨ1XrH KmETjb tfQ Զ057<>#b*Uv7 iMq0TkU'.%M,Na-ɣϓdT&v`^NQ-@-6he)Fno*zXR &F$G~L딳Q%ӭ+L)8/9>_0+_Yw'1`g?/e?Wimc:*z_73_gYؕJtlFzn?/%9^0+6bj5qESђٻnyPd (6LV[JU#_In- bQ:s("]No48V -4'y#ˌ4ס[^8cJ'gN 40Σ AZF95"Q,YX'Ja@7 %QNudF#QDud(9)KK17n/Q|KZqF’cC#G,f?lOHi#[ e&Q?;p)tkxq8tfnRROZ!aN(an 5HD؊^Fwu0y@=<%Y-ORar@֯}f՗BV(SbveaF'( ,Pu5>GYyS\039E#hte̹y8BR&SAէryKuy N}ZPXӧibhПFGXPȜ7G3Z,d;M\ף(ZVs`n?^gAjAzyFiob3y&=SW}@uE&.hB)U*՘d,'qHI+/KQZ|Fӭ--4Eƍh'K/&wB-^#c$NU`d\E?S`/nJ sh=骓|HXBZ4ckFG p}gjVswE{%Âq5sl>tʳq }?5X]y:ҦZhȞQaOg`O_҇zӉXpnz<&U|j q8Rnqgm.{Nw.-\(dLd-5tӯ*d_4J<؟i(Mf&fiZ '|3S6-Y#w"hSiYmlWMNgTu㶃o;&FGx aF~;oXpY:$n\ZKs)6%a>!U"wy=y>QA&]DccA3R,Pjը Le-XwCg;s*+{ jqt.ab(7Ec5hGݮn sze<4E0kl-EߢS(t*ӭ 󶰖0%)CIVq۰eP:|YkgOK}\S5 *ul 2.~fI^5y wamfjSɌ[l p:d#4ۄ ݥSSj$WkDkaa{oQvQy3J(4w2o#2veh#VV$Ggchh  (4V-x 0dh%1Qsܘ9#rKW \R#mnS2ˈ|oe%#]Μ3rI*i(M)ۥ$ʮ1*}~gRS)RW_ Bqx1ԣ|P(l%ʮYO". Yoڭ1b t1 '{ϳynMZ"rGYlB2| yO5\Ҋ6Ly(xFw.+BSVcB☊Y\"hiRwόsޖwV}FH"*6ق̹TZ<$Y{Ru3ڸ=\0sPFvSʝ6b&֠l*Qy۬MS^]R2B]YBK5FD'Nqlלu]D]}$ZB{"U1vB'uo"YW Ϛƒ{&RWA/34WF'O.(g sq,O^p4M; .}w̳(fI|%Ty*kh퓬e =LJ*9n0:h}ǕήkB)ksS: %Wm&U5 Kl_}7& 2,Zót6$é#҂xJ孑3{B<]dYk5t@@?NVk#TL]ϭ#Յ*;|Hw&Ho%J:siS{T؞V#ϗ# ƓiKjy$[ɖVҸւƖ'x~@aY'VEB,,T*c|0^-&eKFťMdΌwN=[09 RGV_ %Z䩜lZ<[sZڏ;br_iq/6E^Q̻ށj㮾7 8tGExoZy뒉e&:~h$ҳ4Usk Y*!h$kDaMrI[#O}#H6Miz8SG瀒ϗ]Xʎj(xv !坦Utj.ZU\sl:~.:O\y(Nl71rvʽe'̙K(\y7~^ZCCsބGKA|sr b'MCT=ĸW sc{Mse[ B y*+Qۛ-DN `׶KG47Cm cL}- Cou,,r$J0P^E9s,DH[v %e+OE3@(G0(B#J_,_!dn3NǦP<60$ yeUd\r0 Wf^i3OƵF3=\L󏝍 zŗxtyMP~^gy`C7koT7[ eŘ AlCRWMQWU9"G|>)ޫrI |? KkY~ JdbxC K>sx Pet9@oKޭ|sw_YjuDOysҟ|Ǻ>ʻu ϫ!A{y_)cֲnZG@JT26Rf4H짯JSzi4tH眿~K!Y@ ~#<\_3 .*h1fJ{lhk^J7c˭hl vgKSʏVI_IvU>r#O]t=UEZk'~hbgΠ78rמygYoKG8wI[^ߑV枭罩}dg礁 r~'|W3M{mκ-k{1?vZR;7\296~k=+H^zCף9F3Ɵ}Š~Bw*\ 2`3YwK5F@ v4Ժ=bgu>p'@~\K\ U!*op_C =+Sym;r0#QƀseZPZnIu+"k EaM0 YZ [On",䙻၄0+匶87|poY7rD tz/5-džEg VߦvNkr 7rI;F'F\2s˾`yus ܯh=w?Qz1yB IO9oy5Zjtv[V#0aw9I󁡗E鼙E~7Bd[WjSBw8%qm$ߘ"KCRތxLJ0$Zl_CoeFV`k+WG緭J.yxI]6rhVhFiV*Zz6FPTII^wh3˘/*\Y}Ф&ر +(i 2"=< h"Yn<>$n3aUmS.'d'>z^ O 9RO qvރbuUγY|Y4H1Yv1 J>mWtSH^"wJu{ Yz!eU5`/`fZ zdxc`JIfz; PF^"5g+7}G'D_E7d~˟Rh ˇꝍ̐[V F_e95qN .j+^á|ZQ(5oOM~W"gr J.{k*x?/5f zη HBww-l~ظӇ9;9+9M!\\K.o/=s$1WۏCh,F/r%1WT3s5 \,y70e'q[S8ψaF"ʺ>h؏#|1/Wx?*/i]|*8qe*>ҋ7zj&S g:L| 5/'A9C\н[rSs>3˨L=q)uL!ۤ;.[CG5H(*Y-EVrM>n9JB'9[]ywHsz KM4z^#)>֣Fmj謹&*km#޴!||sdz^rkRƟiJ业Mn˱݆JFۜw\kvGI{ Wծ3>9Tu.פuN5IYZ# =-2*j~jPmRU q&K[f*蹮Z2'@=St~)u8|)\񚈝*Rs9ۣHnRZԫV|S#K3QKvSG*FvEݿZ0;RVԌiEfxRjSQRj T#1zEY,UнjE\F%Ac2@7QcT;:Uլ%ٹFo,]J}z1'c)Ά2B׊PRȸB02VE[J=]zPQ+*YݏT_f]n?Rnq) I onhle{6/4L^JeHԆvv>RgޱcJ{DRZ4AzuJ+xM/OI̥V3@7z6t9xzVU'TՙXZx \^_zh'zO-UNޛWoBEFH[wP_sҚޢo!weJY_ًU-Aw24sehtZs^_*[(YZoh\%գ7t+zdOq4aj Z:}-9GYvqa!ez`*csnq/Z~!QN.=ϼR^SqI}^UzE۰tƪAsE9cBx>?IIbm=}wL\Nuf*}A=˨ǙVQeL5S$*,wr;NRv/i_2SGݖQZ?LTBS0wgRCȅeX(e^PeԗL=-R2RRI=Ń)4[tzB؛7;N't},mūZ9\'Y_|sE^:umʮQ :W876$ZZ2E֘$y"e2,))F.>zk&ٛrU7$Gsڼ_ݲ=3 :N_(z"IQE5T Z>N~Hv"_FkIL]NeTCjwa-({=DMS*j SGQm0ԉw˨LtʸY"'I[QTμ eTO>g!M2>q2S3; JVRmi;WЭJ.$IF3-"QӤG_S䱶G1mhtFG+V1!BGLu4vk^6ֳx1Do Ul߇xO"$+S;j6)OCmzj;BI(23ADQɛal~tyFUk=.r=M_&^ԛnkLʲ=Cߝ?i O>n7WpppUX+̤r T ڋ-` vqD_b$?OMͧ2}yRU,YDI4ojך炎#3$Jrnaߤ_Q81=Q껊5aD =ՉOP T.Gk\l)qz6[Qh~ک$QrF\^Rp>ӿĀâ_=;z\` K0hՌ6oUO\fB_߰#hqVt .K5>ްC̍ 'ua窇v(y?] 3 [7;nWkzİĂبgmAo_{hr↥VAƔ@ yLEI{^j`=Oۏܽ*<䵏_JRvrDXh`K]SGEu{GkqQK`K{_oOw{SD7v疥6dO{䁷=^nq/8 |8W_]_QXVQ^\W]!%=">%,$Cl^ĴԌꦒm|,,*3;&3+7092) . /91;)axһ0Խp䕻-Nx]fq^'l? ራ1?}O8}sm&0ԭBm^zUk繽gpܱ'<}}\86VgNZm=32?~𢝋MgK;K7o?:|n_8M Nv\|{M`whd\ZvfIMJjSeUMOS}UswsOo[MP_k}WmeE3h+m#CMͽ]5M 5 eYCƅz0z/\t`]nq :P'o9[YX=}~m6[o8lnF+^:cl{:Ý`F_SG8~cGO3ֻ@o#b2r ʲc"2C"_džGz$৏޸?zp󁕷'/?x:6"ކzv˧]zMgׇ^߽} NOa]<3!4 (%1!1)"UAlT³ؤ'>}y{wܼp%wȃwz^8GR޻/Ftx 4ܠ֡@XzulprGl_oS{Yy5;L42'%fA}s.$E})߈KB`TtV͔Y[)N&eJUFl7D¼!D=pA<5Mʤz a:`M 0~jF0ٮa6u )G: K*H_zĭUGXWϢtAgfkԣ(!*#hZBTicZi#̶V**XQH=LÔFph0REz3cxX}[2iQY`Nm[l77x ??~` ?lHߐ+ 8bdNQJRIq =R+=_XcHBHp(@zmzm0XFpY0c=HtCSX=x|l?n4*i^ZKq>{ R+9]@tO/VI]Di ݇NHC;7zCDl-AZGFHO`@YvĴ&$ F]q@{._aϨOx=PF11ÚA *##aD@bgz3{O@ Hrث@r GA>:|ZAF EE]UNT' nd|) ]T՟fW{- ݊F$fVd6f$u%3IP ZAmj1gv5I@:{(PF{ȏk:UߧpꦱU^ [l^|x$NkA}M3=T*BegЂc_;J "m;S:Iլ pXK*<4ZY#4ΰFô:Kue+fx'h'Ţ(i?56GafN+Thx\Ip}|Oxy VxB ZM H2vC񜡓* [2 -e>A M{ygE1knd lP mL@0ӮjF Ie2"˲} c!Z90k.pȠ=& V"v^LB!OmKPpS L*<.i4 g<8WJ:-1$GbfI[pa16vtt3DsU_ӓdΙ6T\ϋ#tt ύ7`бV!Ր:|@:NN vAk&/.U|VYG*-G[bь؆j`չ3 ٦m:!:h!G|yiȝQ!LJç"֩hrmS1UVZpo30׮6gGs+VlÂ>c%,/Voy3h[xnaO0auap%Kk(c,B`qIL^O ږr&tD@l fP00dvqt6 Mؠ]pL@g Yk]ƣmD| e jV"C~I?1@0->J6 C QmꖺWXMeg߂DL8홟UU\CKpNmnU3"0Ma-M*%8\Md TT0T0ّT꫄J[ -0I,~Ë#?X $߃vz'n?9 H|cǻ7 h=d!4A j&$g^6SoU2 ڏR ǺB3 Y=#;̈́c2A4E;膉޷@=n. ]e r PEd1L@i;RŐTЎY_Sn0_Ϥ(yT1De =Bj8]2s=tuPڠ0 h|u=v5WOi&ύcS:yv=YkFxlPV:ct<Ԥc71@}^x:5 ɣ9JF{ե-B/zדz2@R, ^X(銑#1fSl`51ΔM7ma*~@7xxuYбju(/Ȭ 5N Nk|{ ݎ>_%/g?W *&(!2)Ap╌y=6*wIEThr;qc?p.ih+Cѓ$ydi1oNoog0mGlQ &ak 6 @ N2HTB  _X /{)BMa$SڙA!~Cڤ'7>nj-W'v@@DL8Na(z gM2#cʸJ&UXA6b+B*8=SWr:uQ  Fũ*I@1s [p-ǨkYAzj;EC A2R95܇i.3,ుv q!|el)l38p:ˈ9ƙ6q\L^z YiUyMt|9 n@wP^e6{Ύxg2b8̩ v=V%dsjí1+c7≬XG87P8iyo]mm_@lc88g5Dry8fXf l ;<#9dy47=8<,,/.JVmr.'/sJFtpe㴜|>l=m*m&b@ᡙ]^*8^Jwq򫜗 `' eEۻl;aF>OVs}T`O%7_P#[0"@8]-liNRD#Vʺ#P>ºM%)rL+Yg';>sIDD5 Jx5A63-0R͐H4[@p*3!=r{%|1È,[4x˷{xԒm~MV.iwɋ4ώP<R.^||OcU9aWXZUN%k[N^*zs;ui ;*U p\UZ|o|3-Hga=mQM}^#fDMC`e=Ы#+h5a˫xG^[.\z̬/Xu;`G0_xuEWfޢ8fõjyĊ(JJd-wC}fbH^A8w,g&@3ܸ:m5y#GD.]μR/1}uG)~@&5$j ..Y;_oC_J@ߙliN+'r5bŸФ)̯dY&Su/6hB .V^  ۝2jz `ds@?C}cPHCr^~Ջi_N [pX9||I=8idk 6%NxͧIh'ظqR~]Hix浔)&<j3gF;H=V HO6L5ϾaKݵFcvvҨƵ|O-}YrgLƔ od`1>ԏ$ϡ߻:/>qgTV!bQ>K>u_̜bKo[_BQ>>S-^DW58^ox!L5A:ŷĠ)Yy# u|4g-aJ51~O77>wr ᄔ(赊|̹N sgB=/'z1pNt)=xJSF~@8*(n#Jb+gR)w$RڂS-? H?-Fq2A541՝S9yb_}a $ |4k3@yueᯧL& |mNy wMPZ(IlR4CmլPq2ۥ{=5p'™%Ȳ)66Vz ȰƎZ2Q/^Bű 8K}MŔ6M_Y[Z4iIxX}3&V/5սzqǻr<\˔ 9Mf:(c$NU0.fRʴԁ,?G >qGJ+1t<}D\Ik2.&O.H.vL U(cfczj!_s dDwN*&:i0}~Ms%AgY7μ% pPNޝҴ*q{_ a7EK{hF^m`{@l!{VV15'S.VY`#[ 2 :(yd?Kڟ׼3,n by!NPQf٘:/ban5&q.bx*̠N^sǡG"ܮ'X-xơ~`3 -AU(9܉}.r1hƄ|`'F𑖓}}U#(Pn39HD:[~JRt@vN+8fz$ukǨ7 ߀9gљ6^-<" 33eGQsrG,&~SĦ)B&z=8#n-5Suffb9o11|=%bbfeG@S{ +ޘ`߼7ĽU7V=_IE|,Tg:,!MOS j [BW6ǏoeyH2 卝SXF9-1*H(l')@Ӯa/sp<}.rV'ЇH ي)rk)Gdn[Sxðf-#!!4CL\KhPODw5_%{!JUŴijԫ|S2Nkh/6Q?TIS+`8%ÁsIh/Κf,9#6֎e4MJpS-YTݹGjBK[KGžbUfΰKi6R>(ͪ]*^m5T">򸭸a)f5:}-4J:*mpN7_}w=E)v>Di!nmT*fn-<4/qQG+$Ɩc=gkjaęA٥95Z3{av隴c|tOs!m 6U.H[1Qtv8c|R\ *6~vMbAE-%T2W#m 61;ٕFp EA͸x"aLe(; ,fZOVʴWp߁lsk >)=Լ)c&GKI,9+Q06qgוL|o>S Ov~\Prgy4|߮1[bȣN{9? ȴV^* 9BSMCx=]'j_,0@Ly#hpld70)p?XO7ʛ<-%Cw*k2cՀz5a/}i1ԸB[I{-r=ޫTlXɡIV#߀S5L\Qx[aҟIADHriLolG^uɠbL &~Oљ \A׏|5gOԣIC43^;%JjY/WlhqGrk`r 5NY@>޽[n7#>ИG~sMH cHyWVYN~UG-F"sK3 $ TXܰ0{m+&lÚU;l$U[ nk5E3=Aqf;r{&\U9+#mm;A8J|/J$KZ\jxeR7ž*0_soSj0nQkfiI57"迃9BZUeYK&hV\}9qj:$ hii{a7rhc8GTp6ƽ?8z|%7|G$Y;{p^]G,26dzCqC.[8QOlH$o@νڥ,goÅ܁Pt.yaq<4U&HtO6.+^2qd1ܚ2:EnPs澪>!cS3乨U8G_%BjGtۈ6Ѯnp1-,o%4O 5lгގq>]{- (SIVI5nG2[hFM:Q Qp9OS]L2)b釥Wn 'X])4L6G3pbWԨ_/(5OpR(fѱ}”(~J“-f*" K`fn{DJ*,|SRKk[8RھT?.'ȡu)m>0Fߞa; >g{J|D5ݨdčdF:'K oA;N7(:*MF!5@GtrtFp8Vf5]2S2a "^5a#rɴ>7;fsg "0<ǡ1w\D̺6b;LC{a ~rPzÛSj޳"٪T~824įIs?MOt<J*F7B DŽ>5)[P8ke7n]nrcX%0HVK%[uđ{~]&g91q3u;8a,mr-ݳv޶w!P$$O7ɵ|23k-|[u.@4~9GOwV*8cSyW!oBfI^O:Q;[jO ~7}]4{QYnF4}3B#0mbm|3%DIĴƥœv\o5G^st-DR5Xw ,^zɒUsiϚG c3RXtmrŜr`]Km۰iߞ/;tË\vc'<4ˮ]=ׁ[6k UMh-ߞRJR'rz4YR);{:*FTmKe 1/sF?Tkeu3ӁގE@W1X1ѧQ (z;- ' 8U888>׎d05:Өը czӈFQFt#~ͨ_anh1Q< .RQ=ӧP{ց y]]^^MwseI{weCbs+{5C*f`P94Ы{AWnjJ~D944LNЀZ12iCZ~~G65_2[#殎^.AC[ kktum`Yiz::j٠SFtc&ب֠Ƭ#C:b[BՍ٠3LQlՍ'tb5M#cq26:6s7P4pUO]yCr˙nC^^0y"|*mXXI3B 7Nuh70|MNG~=#LUS0lx[aV%1 ,@m}6 &Zm2y5I }'Rxs7$|4IxL#6m1XV@Yd6-=58Xi-^xHv} A(bWTxn=݇YmM/THyƓQʰ^;>w(2T^2>.FqE?XB>w zwdc4sxKL +w]b +5]5f?C8&8Wqr O@v p}5, Jhp ="$=)QN(kɢI ɢI׋9,ׇfQ9.Yސ!n1Pmx-É>/.,oMa+H9<6Q$XSmVH~Fw `@9Ar:1O%RO|~ExǓ^XB,5s3 Eu|&nHZcsdl-LqH6:)nU15XⰆЎp{~6P퍙r$pj♡~.c WCb(Ėdhc (Ar`W%Lzbq =3|h3#<{>j k~.Dco8~́$p*+hN*Qcsgpa J R#Hk8?aixv"+Gjy nwd~nYƬ"K_gmXg95Ӭzl ʬ|+l,t')?mT {AU}QUv~&hP7k=^1'okn,*iijo+@Y^YY[*8!5&2/!i|r19"%0VT k^7.{822I==|Ooݸv%w3'8qCp{ܱ0ǁDDU$%EE%Eǥ)~UZS܎*-?;#A|\ZnTL̈́gqAB$u[~~}+V۲sǃv=z惸;c_=tI)q/ҳFUG熅#v*.+.(*xq)$ ez˴첨'i!O> r9/AOϺwJbsN^xx vAGS==/=sz}_  qw rڕY}众ǩÛ5OP@JNbQE|Ӏ{yUVUVf$W4tזV$T䦧%=Qߕ_\_XQ]YUW["o(S )hqPBvcqMZDSsWsUcfC1 TޡA}JKuOEAvg~WލKW7d6vZ{[* ꫋SrrS>H-*O|\_220%.8!{֛Aa&e$$W%?M+jɎ*YVVRW.XtG3ޮ47gռ V +ڻ]MU-MJ!&5NV_^\\iHImMqvVsN= NΈN~iZsMy7 Rb2tUfՕ5t(;WVJ{5ݚ.Bo)Z~hXg1i:ڞt(U+(Ȯ,(*.l,-)_)Ȳ&tnDj^f''MI8\|>.nj}Iqh;Ji#p@5zڤ){ʏ$G @+ǔ43>?ddA1Mi[` f3><[Bm+8p ,,ȶuAppcuLeZf3[;1U Y;8>YڃͿk @ q84#P Z❞vPlyÂ.x[~ij 0WxbzPֆ8|Nl8@D, O]pHrv[ $Qms\cP*A|n~:pH2f&t~;S>$х~ *)ǐtdiyS|c&6Y H@߃BQz"|[v WaNiAL_cbO"Z6+4=̛KU^C Ǝw zp~ @?lhdc 80rtTɗr%G#(야|aLMv\e7oƣT4.GLp*.ג>iWVXmG/s/%GglO謦8ykV KoC%UPFbj6U'BH4,jV9@[ j%Qu .¼FE*QgSPAtРi`LE9eragzQV4F +^ F]Cƭ(k⼶|ăeo] )'2^z0w\>,O6?$O[9Grx8ȣ;b`]}0"s*"}V_o$sA1FS > jSER[R+ ~ȖQvd䋕4|LƷ鹓,L @%9H/ K%ᑅa˕r ]'44ɩiʦRenxD0,,q< 0Xxn.Cx?N}WQ3;TooUMOvW{h<WSÕ\]mgSw7m%U+OV4 V䠭6zs C'#.|0noe |pG,.p)f?©+_[ # nA_+|SYqĽrhR8qdDz& Odas(X 7T'w O!f~jf4u+5I"`%S4bɑ͊zEiW:_kjhmE4W&V'vɻ5fZU186?^ 9ʉ~ljΆup^Iz|)W-pY͑f⎳=]8b07>{l1X̡<.}$,߂[5Lc z/)> _Z`$ۥzZ_5$jq$$If!vh5 5T#v #vT:V lh%,5 5T/ 4$$If!vh55#v:V l0@5/ / / 4a$$If!vh55#v:V l0@5/ / / 4a$$If!vh55#v:V l05/ / / 4a$$If!vh55#v:V l05/ / / 4a$$If!vh55#v#v:V l0N55/ / /  / 4a$$If!vh55#v#v:V lr0N55/  / / / 4a$$If!vh55#v#v:V l0N55/  / / /  4a$$If!vh5^5x 5x #v^#vx :V l0N5^5x / /  / 4a$$If!vh5^5x 5x #v^#vx :V l 0N5^5x / / / 4a$$If!vh5^5x 5x #v^#vx :V l 0N5^5x / / /  / 4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If!vh5#v:V l065/  4a$$If<!vh55b#v#vb:V l0,"55b4a<$$If<!vh55b#v#vb:V l0,"55b4a<$$If<!vh55b#v#vb:V l0,"55b/ 4a<$$If<!vh55b#v#vb:V l,"55b/ / / /  4a<$$If!vh55x 5x #v#vx :V l0!55x 4a$$If!vh55x 5x #v#vx :V l0!55x 4ak@`@ ut NormalOJQJ_HmH sH tH Z@Z Heading 1$<@&5CJ KH OJQJ\^JaJ R@R Heading 2&xx&d @&P ^V@V Heading 3"8x&d@&P^8CJ\X@X Heading 4"&d@&P^ 6CJ]N@N Heading 5$@&^5CJOJQJ\N@N Heading 6$@&^6CJOJQJ]V@V Heading 7$h@&^h`5OJQJ\^J:@: Heading 8$@&5\N @N ut Heading 9 <@&CJOJQJ^JaJDA`D ut Default Paragraph FontVi@V  Table Normal :V 44 la (k`(ut No List NB@N Body Text]^ CJOJQJDT@D Block Textx]^nOn PART:$ /7n J &]9!a$5;CJOJQJB'@!B Comment ReferenceCJaJtO2t UNIT= ,n J &]9!2x`25CJ$OJQJ^JTOBT SECTION"$d]^a$ 5;CJ0D@RD Header56CJOJQJ\]^J` @b` Footer$$ p!$d N a$5CJOJQJ\^J:)@q: Page Number OJQJ^J@@@ TOC 1 x5CJ OJQJ\L@LTOC 2  x^5]mHnHu.@. TOC 3 ^.@. TOC 4 ^.@. TOC 5 ^.@. TOC 6 ^.@. TOC 7 ^.@. TOC 8 ^.@. TOC 9 ^DU@D Hyperlink>*B*OJQJ\]phFV`!F FollowedHyperlink >*B* phFP@2F Body Text 2# *0]0^J0>@B0 Title$$a$CJ\C@R\ Body Text Indent%d] B*CJphLR@bL Body Text Indent 2 &^CJLS@rL Body Text Indent 3 '7^7CJ2/@2 List( & F@&J2@J List 2$) & F pp^p`B3@B List 3* & F^ B*phJOJ Body text outline + & F8@8  Comment Text,CJ:Q@: Body Text 3-]aJ: @: Index 1.^`: @: Index 2/^`: @: Index 30^`: @: Index 41^`:@: Index 52^`:@: Index 63^`:@: Index 74^`:@: Index 85^`:@: Index 96p^p`6!@6  Index Heading7R6@R List Bullet 2 8 & FOJQJaJmH sH <+@<  Endnote Text9CJaJ>*> Endnote ReferenceH*O Body textN; /7n J &]9!d]^%B*CJOJ QJ _HmH phsH tH FOF APA Reference< `$O1$ Read=@O@ Web Title >$xa$OJQJ:0@: List Bullet ? & FZOZ main@d]^5;B*CJ$OJQJphH@H H Balloon TextACJOJQJ^JaJ>O"> tableB]^\@j@@ ~$Comment SubjectC5\pM@Bp ut Body Text First IndentDx]^` CJOJQJ|N@QR| ut Body Text First Indent 2$Ehdx]^h` B*CJph0"@0 ut CaptionF5\2?@r2 ut Closing G^$L@$ ut DateHRY@R ut Document MapI-D M OJQJ^J<[@< ut E-mail SignatureJp$@p ut Envelope Address!K@ &+D/^@ CJOJQJ^JaJF%@F ut Envelope ReturnL OJQJ^J6@6 ut Footnote TextM:`@: ut HTML AddressN6]Je@J ut HTML PreformattedO OJ QJ ^J 84@8 ut List 4P^`85@8 ut List 5Q^`>7@"> ut List Bullet 3 R & F>8@2> ut List Bullet 4 S & F>9@B> ut List Bullet 5 T & FBD@RB ut List ContinueUhx^hFE@bF ut List Continue 2Vx^FF@rF ut List Continue 3W8x^8FG@F ut List Continue 4Xx^FH@F ut List Continue 5Yx^:1@: ut List Number Z & F>:@> ut List Number 2 [ & F >;@> ut List Number 3 \ & F!><@> ut List Number 4 ] & F">=@> ut List Number 5 ^ & F#l-@l ut Macro Text"_  ` @ OJ QJ ^J _HmH sH tH I@ ut Message Headerg`8$d%d&d'd-DM NOPQ^8`CJOJQJ^JaJD^@D ut Normal (Web)aCJOJQJaJ>@"> ut Normal Indent b^4O@4 ut Note Headingc<Z@B< ut Plain Textd OJ QJ ^J 0K@0 ut Salutatione6@@b6 ut Signature f^NJ@rN ut Subtitleg$<@&a$CJOJQJ^JaJT,@T ut Table of Authoritiesh8^`8<#@< ut Table of FiguresiP.@P ut TOA Headingjx5CJOJQJ\^JaJe Dean W. AllenEOKveDA=DA=DAס=DA=DA=DA=Vcv9we^8@z@z@z@z@z@z@z@z@ z@ z@ z@ z@ z@z@z@z@z@z@z@z@z@z@z@z@z@z@z@z@z@z@z@ z@!z@"z@#z@$z@%z@&z@'z@(z@)z@*z@+z@,z@-z@.z@/z@0z@1z@2z@3z@4z@5z@6z@7z@8zth#C (?/}6;@FWKgT~V1Z cfymu-{V7Ĉ5ע$nQ]}&i>#I&e0`  Y d   027 f*F !"#$*%&3'0()*R+,-./J0 1 2 3 456 7 9:;<=>?Ymijklm!,0<G:]hSgOPQV 9:;AHIJbcv} !!!+","-":"e$}$&&();*@*L+q+,!,,,--....//////v0w0x0000011E1F1G1f111111112G2H2I2J253N34}68_:t:;;== ? ??I?u?v??????@A-B9B:BDBEBOBPBUBkBlBtBBBBBBBBBBBBBCCC2C3C5Mg6v?pو1HRbckop‰Éĉȉɉډۉ;<=KLMNˊ̊݊ފߊ !"[+69() -.DӑԑabgLʔה&ZSxԗOʘ5™#$%-.7>RSTUVWXYi}՚P›Ûכ ()?JV`abpz{ɜʜ˜V01abl؞ٞ`f`akע956Tgϥ3$]qݧ^"jթWªST5Nw®5m¯/װvwױRS~ 0|ϴص6Hַ׷YĸJz{78HOlʻ/vw&8wx%ҿ34M !5&y>?W#$6&':{{bk_'(EF}~56IJnoX TBCPcwxy=>pq 67\]34;<EFIJ[Sl $v)*K12FG}~gh\];<`aB"#$%&;cHuQd|M/hiG[r\ X "8DZ[(,<=!9EM{(V !"#$%&'(3456789:;<yzDtVk,5oSWGVx4Eb{"1^  678FGKLMQRSTUdef  0 1 2 = R S T U V W X a o p q r s t u v { | } ~             t u v   d     3 4   % & N   #$'129:=>?PQcdstu~()@ANOP~()fgrstuQ5{|#f""""kZLLLZZRFRFRFRF""""$ """"RF"RF"RF"RF"RF""""""sRF""""""""> ""1"> "" " " " " " " " " " "0""""@M "RF"RF """"""""""  t# "t"t">  "t"t"  " "t"t"e "t"t"e "t"t"e "t"t"e""RF"" ""RF"RF"RF""RF"""""""RF"""(#(""("!"("!"("!("ٽO(""("!(""""y"""> """"RF""d"" "RF""ɳRF""  # " " " "e " " " ">  " " " " " " " "  " " " " " " " " " " "  " " " "  " " " " "e " " " "> RF"""" d"""d"RF "RF"RF"""""""""RF""""RF""""""RF""""""" """" d"ddd"""""""""d """"d""dd """"z&""h h h h #h "h "h "h "h "h " h "h "h "h "h "h "CLh "h "h "h "eh "h "h "h "h "h "h " h "h "h "h "h "eh "h "h "h "h "eh "h "h "h "h "d dd""1"d "dd"d"d"   dd"hd""""""""dZZ L#"Z ""L"!"Z ""L""dd"< < I#< """I"I"CL< """I"< """I"I"CL< """"I"CL< """I"I"CL" "< "< "< "< "< "< "< "< "< "|˾-""/""d""""""d "d""ddd ""d  "ddd  ""dd dd"""""d"d"" ""dd"" ""dd "d"d  "ddd" sddd"ddd""dd "d "d" "ddd "dddd"dd"d "d " RF"RF""   # " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " "Š7""    d""#"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""[jWdRF"""""d" """"""""""""""""""""""""""""""""""""""""""""""dd""""d""""""""""d"d  j """""""""""""d"""d"""""""""#""k""kj""   # " " " """"""""""""""""""""""""" """""""""""""Z""""""""""""""""""""RF#""""""""""""" ""'D #""""""""""""""""""""""""""""""dd""d "d"dd"ddV"    # " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " "Š7!-W " " """""""""" 9:;<=>?YmT3&v dm UD8U = L 3 &tfijklm!",0<G:]hBSgOPQV 9:;AHIJbcv}~ !!!+","-":"e$}$&&();*@*L+q+,!,,,--....>///////v0w0x0000011E1F1G1f111111112G2H2I2J253N34}68_:t:;;;== ? ??I?u?v??????@@A-B9B:BDBEBOBPBUBkBlBtBBBBBBBBBBBBBCCC2C3C56Mg6v?pÈو1HRbckop‰Éĉȉɉډۉ;<=KLMNˊ̊݊ފߊ !"[+69() -.DӑԑabgLʔה&ZSxԗOʘ5™#$%-.7>RSTUVWXYi}՚P›Ûכ ()?JV`abpz{ɜʜ˜V01abl؞ٞ`f`akע956Tgϥ3$]qݧ^"#jթWªST5Nw®5m¯/װvwױRS~ 0|ϴص6Hַ׷YĸJz{78HOlmʻ/vw&8wx%ҿ34M !5&y>?W#$6&':{P{bk_'(EF}~56IJnoX TBCPcwxy=>pq 67\]34;<EFIJ[\Sl $v)*K12FG}~gh\];<`aB"#$%&;cHuQd|M/hiG[r\ X "8DZ[(,<=!9EM{(=V !"#$%&'(3456789:;<yz Dtuvwxyz{|}~tVk",5oSWGHVx4Eb{"1^  678FGKLMQRSTUdef  0 1 2 = R S T U V W X a o p q r s t u v { | } ~             t u v   d     3 4   % & N   #$%'129:=>?PQcdstu~()@ANOP~()fgrstuQ5{| "#]^5{6]^_`abcf00000000000000000-0-0-0-0000000000000000000000000000000000000000000000000000000 )0 )0 )0 )000(0"0,(0"0(0"0<(0"00(00+0+0 +0+0 +0+0(00800800](080BH0SB0gB0g B0gB0g 0g B0g B0gB0g 0g B0g B0gB0g 0g B0g B0g 0g B0gH0SB0JB0JB0JB0JB0JB0JB0JB0JB0JB0J B0J 0J (00~ )0~ )0~)0~0~B0~ 0~ B0~(00-"(00e$80e$0&0&80e$H0)0;*H0)0L+H0)0,H0)0,H0)0-H0)0.H0)0.;0.B0.B0. B0. 0. B0. B0.B0. 0. B0. B0.B0. 0. B0.B0. B0.B0. 0. B0. B0.B0. 0. B0. B0.B0. 0. B0. B0.B0. 0. B0.0.(0053053053053(00_:0(0;0;(0;0=)0=(0;0 ? +0 ?+0 ? +0 ?+0 ? +0 ?+0 ?(0;0?(0;0@0@B0@B0@ B0@ 0@ B0@ 0@ B0@ B0@ 0@ B0@ B0@ 0@ B0@ B0@ 0@ B0@ B0@ 0@ B0@ B0@ 0@ B0@B0@ 0@ B0@ B0@ 0@ B0@ B0@ 0@ B0@ B0@ 0@ B0@B0@B0@B0@ 0@ B0@B0@B0@ 0@ 0@0@ +0@+0@ +0@(0;0oH80oH0I )0I )0I )0I )0 I )0 I )0 I )0 I )0 I )0I )0I)0I(0;0VK0VK(0;80eO0uO0uO0uO(0;0gT0gT0gTB0gTB0gT B0gT B0gT 0gT B0gTB0gT B0gTB0gT B0gTB0gT 0gT B0gT B0gTB0gT B0gTB0gT 0gT B0gT B0gTB0gT B0gTB0gT 0gT B0gT B0gTB0gT B0gTB0gT 0gT B0gTB0gT B0gTB0gT B0gTB0gTB0gTB0gT 0gT B0gTB0gTB0gT B0gTB0gTB0gT B0gTB0gT 0gT B0gTB0gT B0gTB0gT B0gTB0gT 0gT B0gT B0gTB0gTB0gT B0gTB0gT 0gT B0gT B0gTB0gT B0gTB0gT 0gT 0gT(0;0[0[0[0[ )0[ )0[ )0[ )0[ )0[ )0[)0[0[0[ )0[ )0[ )0[ )0[ )0[ )0[ )0[)0[(0;0nd0(0f0f(0f0h +0h+0h +0h+0h +0h+0h +0h+0h(0f0j0j<0j<0j<0j(0f80ym0m80ym +0 n+0 n+0 n +0 n0 n +0 n0 n0 n(0f80+t0Ft80+t0u80+t0v80+t0wH0w0ZxH0w0yH0w0(zH0w0,{H0w0v}H0w0~80+tH00X0 )0J )0J )0J)0JX0 )0 U )0!U )0"U )0#U )0gU )0gU )0gU)0UX0 )0$H )0H )0H )0H )0H)0HX0 )0% )0& )0')0H0 +06 +06+06 +06 +06+06 +06 +06 +06 +06+06 +06 +06 +06 +06+060606H00È0È0ÈB0ÈB0È B0È B0È 0È B0ÈB0È B0ÈB0È B0ÈB0È 0È B0ÈB0È B0ÈB0È B0ÈB0È 0È B0È B0È B0ÈB0È 0È B0ÈB0ÈB0ÈB0È B0ÈB0È B0È 0È B0ÈB0È B0ÈB0È B0È 0È B0ÈB0È B0ÈB0È B0È 0È B0ÈB0ÈB0È B0È B0È 0È 80+tH0 )0(+ )0)+ )0*+ )0++ )0,+ )0-+)0+)0+ 0+ )0+H0 )0.  )0/ )0 H0 )00. )01.)0.H0 )02ԑ)0ԑH0 )03b )04b)0bH0 )05 )06 )07H0 )08ʔ )09ʔ)0ʔH0 )0: )0; )0< )0=)0H0080+t0SH0S )0> )0?)0H0S )0@ )0A )0B )0C)0H0S )0D )0E )0 )0 )0 )0F )0G0B0B0 B0 B0 B0 0 B0 B0 B0 B0 0 B0 B0 B0 B0 0 080+tH0՚ )0H )0I)0B0B0 B0 B0 B0 0 B0 B0 B0 B0B0 0 B0 B0 B0 B0 0 B0 B0 B0 B0B0 0 B0 B0B0 B0 B0 0 B0 B0 B0 B0B0 0 0 )0J )0K )0L)0B0B0B0B0B0B0B0B0B0 0 0 00080+t0H00` )0M` )0N` )0O`)0`H00a +0a +0a +0a +0aX0a )0P )0Q)0X0a )0R6 )0S6)0606 )0T6 )0U6 )0V6 )0W6)0606 )0X6 )0Y6 )0Z6 )0[6 )0\6 )0]6)0606 )0^6 )0_6 )0`6 )0a6 )0b6 )0c6 )0d6 )0e6)0606 )0f6 )0g6 )0h6 )0i6 )0j6 )0k6)0606 )0l6 )0m6)060606 )0n6)0606 )0o6)06X0a0 )0p)00 )0q )0r)00 )0s)00 )0t )0u )0v)080+tH0 )0w )0ϴ )0x )0y )0z )0{ )0|)0H0 )0}׷ )0~׷ )0׷ )0׷ )0׷)0׷H0 )0{ )0{)0{H0 )08 )08 )08 )08)08H0 )0m )0m )0m)0mH0 )0w)0wH0 )0 )0 )0 )0)0H0 )0x )0x )0x)0xH0 )0)0H0 )04 )04)04H0 )0! )0! )0!H0 )0)0H0 )0 )0 )0 )0)0H0 )0? )0? )0?)0?H0 )0$ )0$)0$H0 )0' )0' )0')0'H0 )00(0P0{(0P0b0bB0bB0b B0b 0b B0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0b B0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0bB0b 0b (0P00 )0 )0 )0 )0 )0)000B0 B0B0 0 B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0 B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0 0 (0P )0\ )0\ )0\ )0\ )0\(0P0S +0S+0S +0S +0S +0S +0S +0S +0S+0S +0S +0*S +0*S +0*S+0S80S +0+0 +0+0 +0+0 +0+0 +0+0 +0+0 +0+0 +0+00+0+0+0+0+0+0 +0+0 +0 +0 +0 +0 +0 +0 +0 +0080S0 )0 )0 )0 )0 )0)0)0)0)0H0 )0& )0& )0& )0& )0& +0& +0& +0&+0& )0& )0& )0& +0& +0 & +0& +0&(0P800d0d0d0d0d800 )0 )0 )0)080 )0 )0 )0 )0;0800i0i800G0G0G0G0G0G0G0G0G80 )0 )0 )0 )0 )0 )0 )0 )0 )0 )0)00 )0 )0 )0 )0 )0)000 )0 )0 )0 )0 )0 )0)000000080 +0=+0=B0=B0= B0= 0= B0=B0=B0=B0=B0=B0=B0= B0= 0= B0=B0=B0=B0=B0=B0=B0= B0= 0= ;0= +0=+0=B0= B0= B0=B0= 0= B0=B0= B0= B0= 0= B0=B0= B0= B0= 0=  +0=B0=0=0=0= 0= 0=0= 0= 0=0= 0= B0=0=0=0= 0= 0=0= 0= 0=0= 0= B0=0=0=0= 0= 0=0= 0= 0=0= 0= B0= +0=0=0= 0= 0=0= 0= 0=0= 0= 0= 0= 0= 0= 0=0= 0= 0=0= 0= +0= +0=0=0= 0= 0=0= 0= 0= 0= 0= 0= 0=0= 0= 0=0= 0= 0=0= 0= +0= +0= +0=0=0= 0= 0=0= 0= 0=0= 0= 0=0= 0= 0=0= 0= +0= +0=0=0= 0= 0<0<0<0<0<0<0<0<0<0<0<000"0"0"0"0"0"0"0"0"0"0"0"0"00H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0H0(00B0B0 B0B0 0 B0B0B0B0B0B0B0B0B0B0B0 B0B0 )0 )0)0 )0 )0)0 )0B0 0 B0B0B0 B0B0 0 B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0 B0 )0 )0 )0B0B0 )0 )0 )0 )0 )0B0 )0 )0B0 )0 )0 )0B0 )0 )0 )0 )0 0 000B0 B0B0 B0 0 B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0 B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0 B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0B0 0 B00H0 )0)0H0 )0 )0)0H0 )0 +0 +0 +0+0000 +0 +0+000000000000000000@,0,0,0,0,0,0,0000000 GG r  %  N1ulv`&VK}bI8vZ[.U] #H&}'+*!478F999H: GJJKTKKK8LLM(QR.Vb cycd[dd2eee/fmvgoÕ<ߖ!ORW§(aʨ0q'cp[$}QhZ':v| ^Q1t%s#[      !"#$%&'()*[  /4OQRTs.013Rn!#$&EVqstv   +D_abd3Lgjkm (4ORSUt#>ABDcm2568Wq4 O R S U t   7 : ; = \ d  + F I J L k w   - 0 1 3 R  o  #$&ESnqrtE`cdfe tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%tX%t̕ !v9Rw!!!!!!!   R$T' T`GR6*;^2$djQx'_Y?Tb$+ۄb d.54b$?LbGze0gR$04I5y{)_&Bc b$n*ޏui v+b$WҖFZ0n/b$?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~"#++/EggggggggRffffffff9"9"9"9"9"9"9"9"9"|$|$|$|$|$|$|$|$|$M3s:s:s:s:s:s:s:s:s:;;;;;;;;;;=??????????@@@@@@@@@yHyHyHyHyHyHyHyHyHIIIIIIII_K_K_K_K_K_K_K_K_KtOOOOOOOOO~T~T~T~T~T~T~T~T~T[[[[[[[[[wdwdwdwdwdwdwdwdwdfffffffffghjjjjjjjj&jmmmmmmmmmmmmmmmmmnnnnnnnnEtEtEtEtEtEtEtEtEtPtPtPtPtPtPtPtPtuuuuuuuuvvvvvvvvxxxxxxxxKKKKKKKK؈؈؈؈؈؈؈؈********vvvvvvvvzzzzzzzzzjjjjjjjjjkAAAAAAAA########c+Uf7e T$e he e F e Te D"e $e gI e |$e D{$e $H e Îe ~$Le tMe Ne |Qe |$e "e "e "e T"e e Ԏ"e ԍ"e "e te gF e ڍe TpN e d݉e le ǎe JLEL,M1MNOeOtOOP0Q=QQQQRR:RCRQRfRlRRRRR-S;SPW[W]WiWX!X7XCXXX;YJYYYYYYYc`n`Qa]a_anasaaaac#cqexeee8f@fijjjljqjPkUkMlSl5n?nooooq qxx{yyyyzzzz{{{{{*{*|2||}#}/}8}D}̀lMXZeɆ׆Շއ co̊ي׌{MR.5:CDKʔ֔CNSg0:bl&/!.>FGRS_muvS[enƟ-5s{̠ڠ9@=H]fHT#ӧܧ?JLTV`bi~qz|,ϯݯɰY`Vbµڷ̹ع;GWaʺ<Nٻ߻ 7GӼlu[fʿ &MUhn~)4m|/5>G#v  \`,.DMAF58EL)1szHOhoz|nvV\"LNRi5=oyfxZe *0<DEPQ]ny8E      w    "&VZCPv Yv%`e#cp#.5O{6P^cfA#|!~!""2223343<<@@VG[GGGkkmHmwwyy>ELWJQYoصܵ ({jqtTV UBLN^ik,35=oySZW\&   c  QS#.5O{6P^cf:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::4R1n$Vt DbLk4S#Bm6q4 S  ; d + J w  1 o $SrEd""Wk^kcylyyykkGQNOVZٞRX#$'<FOPj  #.f#.^f|<{H^}6]~@$L\T`R[T>TPP9S@Rl8WZNw#Kڡ@ڡl)=lv?CZ~W+JHj"ROdl*jfQڡ_~hd(laP?."wx)^`.^`.88^8`.^`. ^`OJQJo( ^`OJQJo( 88^8`OJQJo( ^`OJQJo(hh^h`.pp^p`o(.@ @ ^@ `.L^`L.^`.^`.L^`L.PP^P`.  ^ `.L^`L. @ @ ^@ `OJQJo(  ^ `o(.x^`o(.xx^x`o(()^`o(()HH^H`o(()^`o(.^`o(.^`o(. @ @ ^@ `OJQJo(  ^ `o(.x^`o(.xx^x`o(()^`o(()HH^H`o(()^`o(.^`o(.^`o(.   ^ `OJQJo( ^`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o PP^P`OJ QJ o(   ^ `OJQJo( ^`OJ QJ o(o !!^!`OJ QJ o( pp^p`CJo(.  ^ `o(.@  ^@ `o(.  ^ `o(()^`o(()xx^x`o(()^`o(.HH^H`o(.^`o(.   ^ `OJQJo( ^`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o PP^P`OJ QJ o(   ^ `OJQJo( ^`OJ QJ o(o !!^!`OJ QJ o(88^8`o(.  ^ `o(.@ 0@ ^@ `0o(..@ 0@ ^@ `0o(...   ^ `o( ....   ^ `o( ..... `^``o( ...... `^``o(....... xx^x`o(........  ^ `CJo(.@ @ ^@ `o(. ^ `o(.^`o(()xx^x`o(()^`o(()HH^H`o(.^`o(.^`o(.hp ^p`o(.h @  ^@ `OJQJo(hxLx^x`L.hHH^H`.h^`.hL^`L.h^`.h^`.hX LX ^X `L.   ^ `OJQJo(  ^ `o(.x^`o(.xx^x`o(()^`o(()HH^H`o(()^`o(.^`o(.^`o(. p^`OJQJo(   ^ `OJ QJ o(o xx^x`OJ QJ o( HH^H`OJQJo( ^`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o X X ^X `OJ QJ o(#la_RO."w?C?Cp&J ?C&J ?C|'J ?CT'J jfQ?Cl'J l)=J?C8 'J ?C$8(J K@?C<(J ?C?C?C (J ?Ct)J ?C(h)J ?C()J ?C*J Nw#~}|I?AGhr\nVK<M  hSVu/bWT        $6"x$6"x$6"x        $6"x        "n`       \(         @ @ @  ut d !~$_Q"&rnr%Huh0+/fgPQV :;AHIJc}~!+","/////w0x00001F1G1f1111112H2I2M3s:;;=??@A-B:BDBEBOBPBUBkBlBtBBBBBBBBBBBBCCC2C3CRSTUVWXYi}›Ûכ ()?JVabp{ʜ˜P{bk_Pcxy [\&'(9:;<yz tvwyz|} 78d 1 2  #$'12:=>f@lNJXBCDEFe@@@J@L@N@P@@@@Unknown Gz Times New Roman5Symbol3& z Arial5& zaTahoma3z TimesABook AntiquayMonotype SortsWP MultinationalB Courier7&  Verdana7& ChicagoK,Bookman Old Style?5 z Courier New;Wingdings#1Jhкh f{ f*8*8Y4d 3QHX ?H2Frank MacDonald RN, MNFaculty of NursingDesktop Technology Program\               Oh+'0 $0 P \ h tFrank MacDonald RN, MNFaculty of Nursing Normal.dotDesktop Technology Program18Microsoft Office Word@`@@"J@r8*՜.+,D՜.+,X hp  University of Calgary Frank MacDonald RN, MN Title  8@ _PID_HLINKSA 8 _Toc200187218 _Toc20018720; _Toc20018719; _Toc20018718; _Toc20018717; _Toc20018716; _Toc20018715; _Toc20018714; _Toc20018713; _Toc20018712; _Toc20018711; _Toc20018710: _Toc20018709: _Toc20018708: _Toc20018707: _Toc20018706: _Toc20018705: _Toc20018704: _Toc20018703: _Toc20018702: _Toc20018701: _Toc200187003 _Toc200186993z _Toc200186983t _Toc200186973n _Toc200186963h _Toc200186953b _Toc200186943\ _Toc200186933V _Toc200186923P _Toc200186913J _Toc200186902D _Toc200186892> _Toc2001868828 _Toc2001868722 _Toc200186862, _Toc200186852& _Toc200186842  _Toc200186832 _Toc200186822 _Toc200186812 _Toc20018680= _Toc20018679= _Toc20018678  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./012345678:;<=>?@BCDEFGHSRoot Entry F[UData %A1TableFWordDocumentISummaryInformation(9DocumentSummaryInformation8ACompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q